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Abstract 
Food intake is controlled by the coordinated action of numerous brain regions but 
a complete understanding of the process remains elusive. The nucleus of the 
solitary tract (NTS), located in the brainstem dorsal vagal complex (DVC) is the 
first site for integration of visceral synaptic and hormonal cues that act to inhibit 
food intake. NTS neurons receive synaptic input from sensory neurons of the 
vagus nerve that relay signals of gastrointestinal stretch and nutrient content. In 
response to these signals of ingestion, NTS neurons signal to higher brain 
centres in the hypothalamus and midbrain to inhibit hunger and promote meal 
termination. 
A role for astrocytes in brain circuits controlling food intake has begun to be 
identified. Hypothalamic astrocyte signalling has been implicated in regulating 
energy homeostasis. Despite a wealth of evidence showing astrocytes in the 
NTS/DVC are involved in synaptic integration of vagal signals and control of 
autonomic physiology, the potential role of these cells in feeding control has not 
been investigated. 
We hypothesised that NTS astrocytes, and those in the wider DVC, would be 
responsive to increases in food intake and, in turn, their activation would act in 
concert with NTS neurons to drive a corresponding suppression of food intake. 
To investigate this prospect we used dietary manipulation, 
immunohistochemistry, selective chemogenetic manipulation of DVC astrocytes, 
behavioural assays and electrophysiology in mice. 
The key findings of these studies show that in response to acute nutrient excess 
and gastric distention NTS astrocytes increase their expression of the 
cytoskeletal glial fibrillary acidic protein and adopt a more ramified morphology, 
indicative of activation. We also show that selective activation of Gq-protein-
coupled receptor signalling in DVC astrocytes suppresses nocturnal food intake 
and refeeding after a fast. These studies provide evidence that astrocytes may 
be integrators and effectors of satiety signals and appropriate feeding responses 
in the DVC. 
 
 
3 
 
Acknowledgements 
I have been very fortunate to be surrounded by supportive people throughout this 
PhD including my supervisory team. I would like to thank my primary supervisor 
Dr Kate Ellacott for her insight, for encouraging me to take all the amazing 
opportunities I have had and for giving me the freedom to shape the project to 
what interests me most. I would also like to thank my second supervisor Professor 
Tony Pickering for hosting me in his lab and providing his expertise and guidance. 
Finally I would like to thank my third supervisor Dr Craig Beall for giving great 
advice in a familiar accent. 
I have also been lucky to be surrounded by a great team of lab mates. In particular 
I would like to thank Dr Fiona Holmes for facilitating my experiments in Bristol 
and for her hospitality during that time. In addition I would like to thank Dr Lydia 
Hanna facilitating my electrophysiology experiments in Exeter. I would also like 
to thank members of the Ellacott, Beall and Pickering labs past and present, 
especially; Nicole, Josie, Ben, Paul, Ana, Katherine, Nadia, Hannah and Julia for 
making the lab such a nice environment to work in.  
I would very much like to thank everyone who made my time at Washington State 
University so special. It was truly a highlight of the PhD. In particular Professor 
Suzanne Appleyard who accommodated me in her lab and her family who 
accommodated me in their home. I must also thank Drew Neyens, who took a 
month out of his own busy schedule to show me the ropes in the lab and the 
sights of Washington State outside of it. 
I of course would like to thank my family; my parents Jennifer and Hector, and 
my brothers Andrew and William. Their support and encouragement from 
applying for the PhD all the way to its completion has been brilliant and I hope I 
have made them proud. My trips home to visit them and our holidays in Spain 
have been the perfect PhD breaks. 
Finally I must thank my partner, Erica Brady, for moving to the farthest end of the 
country with me to start our PhD journeys. I would not have been able to do this 
without her help. Her support and patience are endless and I thank her for always 
having time to help me or just listen. Knowing that she believes in me and that 
we are doing this together is my main source of motivation.  
4 
 
Table of Contents 
Title page............................................................................................................ 1 
Abstract .............................................................................................................. 2 
Acknowledgements ............................................................................................ 3 
Publications arising from this thesis ................................................................. 11 
List of abbreviations ......................................................................................... 12 
List of figures .................................................................................................... 17 
List of tables ..................................................................................................... 21 
Author’s declaration .......................................................................................... 22 
Chapter 1 ......................................................................................................... 23 
1.1 | Food intake is controlled by the brain to maintain energy balance ........ 24 
1.2 | An overview of key neural circuits controlling food intake ..................... 27 
1.2.1 | Hypothalamic circuits ...................................................................... 28 
1.2.2 | Midbrain and Hindbrain circuits controlling food intake ................... 37 
1.2.3 | Peripheral circuits ........................................................................... 51 
1.2.4 | An ARCAgRP hunger-based framework of central appetite control ... 54 
1.3 | Astrocytes ............................................................................................. 58 
1.3.1 | Homeostatic functions of astrocytes ............................................... 59 
1.3.2 | Ca2+ ionic signalling ........................................................................ 60 
1.3.3 | Gliotransmission and synaptic modulation ...................................... 63 
1.3.4 | Astrocyte structural plasticity ........................................................... 64 
1.4 | Hypothalamic astrocytes and feeding behaviour ................................... 64 
1.5 | NTS astrocytes ...................................................................................... 72 
1.5.1 | Astrocytes modulate synaptic transmission in the NTS .................. 72 
1.5.2 | Physiological and environmental stimuli modulate the morphology of 
NTS astrocytes .......................................................................................... 78 
1.5.3 | Regulation of cardiorespiratory physiology by NTS astrocytes ....... 83 
1.5.4 | Regulation of blood glucose and the counter-regulatory response by 
NTS astrocytes .......................................................................................... 85 
5 
 
1.5.5 | Regulation of food intake by NTS astrocytes .................................. 87 
1.6 | Summary and Statement of Aims .......................................................... 89 
Chapter 2 ......................................................................................................... 91 
2.1 | Key Materials ........................................................................................ 92 
2.2 | Mice ...................................................................................................... 97 
2.3 | Methods used in Chapter 3 ................................................................... 99 
2.3.1 | Dark-phase high-fat feeding studies ............................................... 99 
2.3.2 | Dark-phase fasting studies.............................................................. 99 
2.3.3 | Diet induced obese studies ............................................................. 99 
2.3.4 | GFAP immunohistochemistry ........................................................ 100 
2.3.5 | Image acquisition and analysis ..................................................... 100 
2.4 | Methods used in Chapter 4 ................................................................. 103 
2.4.1 | AAV vector injection ...................................................................... 103 
2.4.2 | Immunohistochemistry of AAV injected mice ................................ 104 
2.4.3 | AAV injection mapping .................................................................. 107 
2.4.4 | Validating AAV transduction of astrocytes .................................... 107 
2.4.5 | Validating DREADD activation of astrocytes ................................. 107 
2.4.6 | c-FOS quantification ..................................................................... 107 
2.4.7 | Dark phase food intake measurements ........................................ 108 
2.4.8 | Fast induced re-feeding experiments ............................................ 108 
2.4.9 | Conditioned place aversion ........................................................... 108 
2.4.10 | Home cage food seeking ............................................................ 109 
2.4.11 | Tail flick test ................................................................................ 110 
2.5 | Methods used in Chapter 5: Mutli-electrode array (MEA) recordings .. 110 
2.5.1 | Solutions ....................................................................................... 110 
2.5.2 | Coronal NTS slice preparation ...................................................... 111 
2.5.3 | Data processing and analysis ....................................................... 112 
2.6 | Methods used in Chapter 5: Whole cell patch clamp recordings ......... 113 
6 
 
2.6.1 | Solutions ....................................................................................... 113 
2.6.2 | Horizontal NTS slice preparation .................................................. 114 
2.6.3 | Whole cell patch clamp electrophysiology..................................... 115 
2.6.4 | Data analysis ................................................................................ 115 
2.7 | Statistical analysis ............................................................................... 116 
Chapter 3 ....................................................................................................... 117 
3.1 | Introduction ......................................................................................... 118 
3.2 | Aims and hypotheses .......................................................................... 119 
3.3 | Results ................................................................................................ 120 
3.3.1 | High fat chow induced acute hyperphagia in mice ........................ 120 
3.3.2 | High fat chow hyperphagia increased the number of GFAP 
immunoreactive astrocytes in the postremal NTS .................................... 123 
3.3.3 | High fat chow induced hyperphagia increased the morphological 
complexity of GFAP immunoreactive astrocytes in the postremal NTS ... 125 
3.3.4 | Overnight fasting did not increase the number of GFAP 
immunoreactive astrocytes in the NTS .................................................... 128 
3.3.5 | Overnight fasting increased the morphological complexity of pNTS 
GFAP immunoreactive astrocytes ........................................................... 130 
3.3.6 | Prolonged consumption of a high fat diet results in greater body 
weight ...................................................................................................... 132 
3.3.7 | GFAP immunoreactivity in the NTS was not increased in mice after 
13-weeks of consumption of a high fat diet .............................................. 134 
3.3.8 | 13 week consumption of a high fat diet increased the process 
number and maximum process length of pNTS astrocytes ...................... 136 
3.3.9 | Using nested analysis to evaluate the effect of mouse on cellular 
morphology .............................................................................................. 138 
3.4 | Discussion ........................................................................................... 141 
3.4.1 | Comparisons between NTS and hypothalamic astrocyte responses 
to energy balance manipulation ............................................................... 141 
7 
 
3.4.2 | Comparisons to other stimuli shown to modify NTS astrocyte GFAP 
expression or morphology ........................................................................ 142 
3.4.3 | Evidence for physiological consequences of astrocyte reorganisation
 ................................................................................................................. 143 
3.4.4 | Opposing stimuli generate similar responses................................ 145 
3.4.5 | Potential signals that activate NTS astrocytes .............................. 145 
3.5 | Conclusion .......................................................................................... 147 
Chapter 4 ....................................................................................................... 149 
4.1 | Introduction ......................................................................................... 150 
4.2 | Aims and hypothesis ........................................................................... 152 
4.3 | Results ................................................................................................ 153 
4.3.1 | A viral-genetic strategy for chemogenetic activation of DVC 
astrocytes ................................................................................................ 153 
4.3.2 | Quantification of viral infection ...................................................... 155 
4.3.3 | Cell type specificity of viral infection .............................................. 157 
4.3.4 | Chemogenetic activation of DVC astrocytes induced morphological 
plasticity ................................................................................................... 159 
4.3.5 | Chemogenetic activation of DVC astrocytes suppressed food intake
 ................................................................................................................. 162 
4.3.6 | Expression of hM3Dq outside the DVC did not account for the effect 
of CNO on food intake ............................................................................. 165 
4.3.7 | Chemogenetic activation of DVC astrocytes reproducibly suppressed 
food intake ............................................................................................... 167 
4.3.8 | Chemogenetic activation of DVC astrocytes suppressed food intake 
at a lower dose of CNO............................................................................ 170 
4.3.9 | Chemogenetic activation of DVC astrocytes suppressed food intake 
following an overnight fast ....................................................................... 173 
4.3.10 | Chemogenetic activation of DVC astrocytes did not induce 
conditioned place aversion ...................................................................... 175 
8 
 
4.3.11 | Chemogenetic activation of DVC astrocytes did not acutely effect 
locomotion ............................................................................................... 178 
4.3.12 | Chemogenetic activation of DVC astrocytes reduced food seeking 
independent of locomotion and drinking .................................................. 180 
4.3.13 | Chemogenetic activation of DVC astrocytes is not analgesic ..... 184 
4.3.14 | Chemogenetic activation of DVC astrocytes reduced nocturnal 
feeding and refeeding after a fast in mice with restricted viral transduction
 ................................................................................................................. 186 
4.3.15 | Chemogenetic activation of DVC astrocytes induced c-FOS 
immunoreactivity in the NTS and AP ....................................................... 189 
4.3.16 | Chemogenetic activation of DVC astrocytes induced c-FOS 
immunoreactivity in the lPBN ................................................................... 191 
4.3.17 | Chemogenetic activation of DVC astrocytes did not induce c-FOS 
immunoreactivity in the PVH .................................................................... 193 
4.3.18 | Stimulation of Gi-GPCR signalling in DVC astrocytes did not alter 
nocturnal food intake in DVC::GFAPhM4Di mice ........................................ 195 
4.3.19 | A greater dose of CNO did not alter feeding behaviour in 
DVC::GFAPhM4Di mice .............................................................................. 199 
4.3.20 | Stimulation of Gi-GPCR signalling in DVC astrocytes did not affect 
refeeding after a 12 hour fast in DVC::GFAPhM4Di mice ............................ 202 
4.3.21 | Stimulation of Gi-GPCR signalling in DVC astrocytes attenuated 
cholecystokinin-induced satiety ............................................................... 204 
4.3.22 | Stimulation of Gi-GPCR signalling in DVC astrocytes did not induce 
c-FOS immunoreactivity in the NTS ......................................................... 207 
4.4 | Discussion ........................................................................................... 209 
4.4.1 | Comparisons to ARC astrocytes ................................................... 209 
4.4.2 | Potential mechanisms of astrocyte-neuron communication 
underlying the effects induced by chemogenetic activation of DVC 
astrocytes ................................................................................................ 210 
4.4.3 | Absence of conditioned place aversion following chemogenetic DVC 
astrocyte activation or LPS conditioning .................................................. 211 
9 
 
4.4.4 | Does chemogenetic activation recapitulate physiological activity of 
NTS astrocytes ........................................................................................ 213 
4.4.5 | Technical limitations of viral spread .............................................. 214 
4.4.6 | Specificity of CNO for hM-DREADDs ............................................ 215 
4.4.7 | Factors underlying the differential effects of DVC::GFAPhM3Dq and 
DVC::GFAPhM4Di activation on feeding ..................................................... 215 
4.5 | Conclusion .......................................................................................... 216 
Chapter 5 ....................................................................................................... 217 
5.1 | Introduction ......................................................................................... 218 
5.2 | Aims and hypotheses .......................................................................... 220 
5.3 | Results ................................................................................................ 220 
5.3.1 | Perforated Multi-Electrode Array allows population recording in the 
NTS.......................................................................................................... 220 
5.3.2 | High fat chow hyperphagia increased the firing rate of NTS channels 
at baseline ............................................................................................... 224 
5.3.3 | High fat chow hyperphagia increased the firing rate of pNTS 
channels at baseline ................................................................................ 229 
5.3.4 | Firing rate of channels in cNTS and rNTS at baseline .................. 233 
5.3.5 | NMDA increased MU firing rate in pNTS channels and this effect 
was potentiated by co-application of D-serine ......................................... 235 
5.3.6 | In the pNTS channels from high fat chow fed mice showed greater 
responses to NMDA-R agonists ............................................................... 242 
5.3.7 | Whole-cell patch clamp in the horizontal slice to investigate glial 
glutamate reuptake .................................................................................. 247 
5.3.8 | DHK reduced the size of evoked EPSCs into NTSTH neurons ...... 249 
5.3.9 | DHK did not affect the frequency of spontaneous or asynchronous 
EPSCs into NTSTH neurons...................................................................... 252 
5.4 | Discussion ........................................................................................... 255 
5.4.1 | Perforated Multi-Electrode Array allows population recording in the 
NTS.......................................................................................................... 255 
10 
 
5.4.2 | Assessment of the differential contribution of NMDA-R agonist 
binding sites to MU firing rate .................................................................. 256 
5.4.3 | Mechanisms underlying EAAT2 blockade reducing evoked EPSC in 
NTSTH neurons ......................................................................................... 257 
5.5 | Conclusion .......................................................................................... 258 
Chapter 6 ....................................................................................................... 260 
6.1 | Key findings and contributions to scientific knowledge ........................ 261 
6.2 | Core limitations of work ....................................................................... 265 
6.2.1 | Reliance on inducible manipulations to infer function ................... 265 
6.2.2 | Reliance on ex vivo and post-mortem measurements to infer real 
time activity .............................................................................................. 266 
6.2.3 | Use of male mice .......................................................................... 267 
6.3 | Outstanding questions and future directions ....................................... 267 
6.3.1 | Signal detection: What are the cues that activate NTS astrocytes?
 ................................................................................................................. 267 
6.3.2 | Signal processing: What is the real time Ca2+ ‘code’ of NTS/DVC 
astrocytes and how does it relate to food intake? .................................... 271 
6.3.3 | Signal propagation: How do astrocytes modulate vagal and NTS 
signalling to reduce food intake? ............................................................. 271 
6.3.4 | Outstanding conceptual questions ................................................ 276 
6.4 | Conclusion .......................................................................................... 277 
References .................................................................................................... 278 
 
 
 
 
 
 
 
11 
 
Publications arising from this thesis 
MacDonald AJ, Holmes FE, Beall C, Pickering AE, Ellacott KLJ. Regulation of 
food intake by astrocytes in the brainstem dorsal vagal complex. Glia. 2019; 
epub ahead of print. https://doi.org/10.1002/glia.23774 
MacDonald AJ, Robb JL, Morrissey NA, Beall C, Ellacott KLJ. Astrocytes in 
neuroendocrine systems: An overview. Journal of Neuroendocrinology. 2019; 
31(5), e12726. https://doi.org/10.1111/jne.12726 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
12 
 
List of abbreviations 
For the convenience of the reader abbreviations are defined in the following list: 
 
2-DG 2-deoxyglucose 
3V third ventricle 
4V fourth ventricle 
5-HT 5-hydroxytryptamine/serotonin 
5-HT2CR serotonin receptor 2C 
6-OHDA 6-hydroxydopamine 
α-MSH 
β-MSH 
alpha-melanocyte stimulating hormone 
beta-melanocyte stimulating hormone 
AAV adeno associated viral vector 
ACBP acyl-CoA binding protein 
Ach acetylcholine 
aCSF artificial cerebrospinal fluid 
Ado adenosine 
AgRP agouti-related protein 
AMPA α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
AMPA-R α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid 
receptor 
ANLS astrocyte-neuron lactate shuttle 
ANOVA analysis of variance 
AP area postrema 
ARC arcuate nucleus of the hypothalamus 
ATP adenosine triphosphate 
BNST bed nucleus of the stria terminalis 
CA1 cornu ammonis 1 
Calc-R calcitonin receptor 
CCK cholecystokinin 
CCK-R cholecystokinin receptor 
CeA central extended amygdala 
CGRP calcitonin gene related peptide 
ChAT choline actetyltransferase 
13 
 
CNO clozapine-N-oxide 
CNS central nervous system 
cNTS caudal nucleus of the solitary tract 
CPA conditioned place aversion 
CRR counterregulatory response to hypoglyceamia 
CSF cerebrospinal fluid 
DAPI 4',6-diamidino-2-phenylindole 
DBH dopamine beta hydroxylase 
DHK dihydrokainate 
DIO diet induced obesity 
diORF double-inverted open reading frame 
DMX/X dorsal motor nucleus of the vagus 
DREADDs designer receptors exclusively activated by designer drugs 
DVC dorsal vagal complex 
E embryonic day 
EAAT1 excitatory amino acid transporter 1 
EAAT2 excitatory amino acid transporter 2 
EGFP enhanced green fluorescent protein 
EGTA ethylene glycol-bis(β-aminoethyl ether)-N,N,N',N'-tetraacetic 
acid 
EPSC excitatory postsynaptic current 
EPSP excitatory postsynaptic potential 
FAC fluoroacetate 
FC fluorocitrate 
Flp flippase 
FRT flippase recognition target 
GABA γ-amino butyric acid 
GDF15 growth differentiation factor 15 
GFAP glial fibrillary acidic protein 
GFRAL glial cell-derived neurotrophic factor receptor alpha-like 
GHSR1A growth hormone secretagogue receptor 1A 
GI gastrointestinal 
GLAST glutamate aspartate transporter 
GLP1 glucagon-like peptide 1 
14 
 
GLP1-R glucagon-like peptide 1 receptor 
GLT1 glutamate transporter 1 
GLUT glucose transporter 
GPCR G-protein coupled receptor 
GS glutamine synthetase 
GTP guanosine triphosphate 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid 
hGFAP human glial fibrillary acidic protein promoter 
HGN hypoglossal nucleus 
i.c.v intracerebroventricular 
i.p. intraperitoneal 
IHC immunohistochemistry 
IKA A-type potassium current 
IP3 inositol trisphosphate 
IP3R2 inositol trisphosphate receptor type 2 
IPSC inhibitory postsynaptic current 
IR immunoreactivity 
LCPFC prefrontal cortex projecting locus coeruleus neurons 
LepRb longform leptin receptor 
LH lateral hypothalamus 
LiCl lithium chloride 
loxP locus of crossing over P 
lPBN lateral parabrachial nucleus 
LPS lipopolysaccharide 
mACh-R muscarinic acetylcholine receptor 
MC4R melanocortin 4 receptor 
MCT monocarboxylate transporter 
MEA multi-electrode array 
mGlu-R metabotropic glutamate receptor 
mRNA messenger RNA 
MU multi unit 
MUA multi unit activity 
NAc nucleus accumbens 
nACh-R nicotinic acetylcholine receptor 
15 
 
NDS normal donkey serum 
NeuN neuronal nuclear protein 
NF-κB nuclear factor kappa B 
NG nodose ganglion/nodose ganglia 
NMDA N-methyl-D-aspartate 
NMDA-R N-methyl-D-aspartate receptor 
NPY neuropeptide Y 
NTS nucleus of the solitary tract 
ODN octadecaneuropeptide 
OXT oxytocin 
OXTR oxytocin receptor 
P postnatal day 
PAR protease activated receptor 
PBS phosphate buffered saline 
PDYN prodynorphin 
PFA paraformaldehyde 
Pfkfb3 6-phosphofructo-2-kinase 
pMEA perforated multi-electrode array 
pNTS postremal nucleus of the solitary tract 
POMC proopiomelanocortin 
PPG preproglucagon 
pSTAT3 phospho-signal transducer and activator of transcription 3 
PVH paraventricular nucleus of the hypothalamus 
PVHM paraventricular nucleus of the hypothalamus, magnocellular 
region 
PYY peptide tyrosine tyrosine 
RM ANOVA repeated measures analysis of variance 
rNTS rostral nucleus of the solitary tract 
scRNA-seq single cell RNA sequencing 
SIDS sudden infant death syndrome 
SIM1 single minded 1 
SON supraoptic nucleus of the hypothalamus 
SST somatostatin 
ST solitary tract 
16 
 
STZ streptozotocin 
TAA thioacetamide 
TBOA threo-β-benzyloxyaspartic acid 
TeLC tetanus toxin light chain 
TH tyrosine hydroxylase 
VEGF vascular endothelial growth factor 
VGAT vescular γ-amino buytric acid transporter 
VGKC voltage gated potassium channel 
VIP vasoactive intensinal polypeptide 
VLM ventrolateral medulla 
VTA ventral tegmental area 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
List of figures 
Figure 1.1 The brain integrates cues from the periphery to regulate food intake. 
Figure 1.2.1 ARCAgRP neurons send distinct projections to subcortical nuclei to 
drive food intake. 
Figure 1.2.2 A simplified schematic diagram of the neurochemical organisation of 
appetite controlling populations in the NTS. 
Figure 1.2.3 Brain circuits engaged by hunger and satiety. 
Figure 1.4.1 Schematic summary of potential homeostatic and maladaptive 
responses of ARC astrocytes to short and long term deviations in 
energy balance. 
Figure 1.5.1 A simplified schematic of astrocyte modulation of synaptic 
transmission in the NTS. 
  
Figure 2.3.1 Demonstration of specificity of anti-mouse AlexaFluor 568 secondary 
antibody binding. 
Figure 2.4.1 Demonstration of specificity of anti-mouse and anti-rabbit AlexaFluor 
488 secondary antibody binding. 
  
Figure 3.3.1 High fat chow feeding induced hyperphagia in mice. 
Figure 3.3.2 High fat chow induced hyperphagia increased the number of GFAP 
immunoreactive astrocytes in the postremal NTS. 
Figure 3.3.3 Sholl analysis permits quantitative analysis of GFAP immunoreactive 
astrocyte morphology. 
Figure 3.3.4 High fat chow induced hyperphagia increased the morphological 
complexity of GFAP immunoreactive astrocytes in the pNTS. 
Figure 3.3.5 Overnight fasting did not change the number of GFAP 
immunoreactive astrocytes in the NTS. 
Figure 3.3.6 Overnight fasting increased the morphological complexity of GFAP 
immunoreactive astrocytes in the pNTS. 
Figure 3.3.7 13 weeks of high fat diet intake increased body weight in mice. 
Figure 3.3.8 13 weeks of high fat diet intake did not change the number of GFAP 
immunoreactive astrocytes in the NTS. 
18 
 
Figure 3.3.9 13 weeks of high fat diet intake increased the number of processes 
and enclosing radius of GFAP immunoreactive astrocytes in the 
pNTS. 
Figure 3.3.10 Morphological analysis with mouse as a nested variable. 
Figure 4.3.1 Strategy for chemogenetic control of DVC astrocytes. 
Figure 4.3.2 AAV vector spread in individual DVC::GFAPhM3Dq mice. 
Figure 4.3.3 Expression of hM3Dq_mCherry in DVC astrocytes. 
Figure 4.3.4 Chemogenetic activation increased morphological complexity of DVC 
astrocytes. 
Figure 4.3.5 Chemogenetic activation of DVC astrocytes suppressed food intake. 
Figure 4.3.6 Expression of hM3Dq outside the DVC did not account for the effect 
of CNO on food intake. 
Figure 4.3.7 Chemogenetic activation of DVC astrocytes reproducibly suppressed 
food intake. 
Figure 4.3.8 Chemogenetic activation of DVC astrocytes with 0.3 mg/kg CNO 
suppressed food intake. 
Figure 4.3.9 Chemogenetic activation of DVC astrocytes suppressed food intake 
during re-feeding after a 12 hour fast. 
Figure 4.3.10 Chemogenetic activation of DVC astrocytes did not induce 
conditioned place aversion. 
Figure 4.3.11 Chemogenetic activation of DVC astrocytes did not suppress 
locomotion. 
Figure 4.3.12 Chemogenetic activation of DVC astrocytes suppressed food 
seeking independent of locomotion or drinking. 
Figure 4.3.13 Chemogenetic activation of DVC astrocytes did not increase tail-flick 
latency. 
Figure 4.3.14 Lower AAV vector injection volume is still sufficient to supress 
feeding. 
Figure 4.3.15 Chemogenetic activation of DVC astrocytes induced c-FOS 
immunoreactivity in the NTS and AP. 
Figure 4.3.16 Chemogenetic activation of DVC astrocytes induced c-FOS 
immunoreactivity in the lPBN. 
Figure 4.3.17 Chemogenetic activation of DVC astrocytes induced c-FOS 
immunoreactivity in the PVH. 
19 
 
Figure 4.3.18 Stimulation of Gi-GPCR signalling in DVC astrocytes did not increase 
food intake. 
Figure 4.3.19 Stimulation of Gi-GPCR signalling in DVC astrocytes with 1 mg/kg 
CNO did not increase food intake. 
Figure 4.3.20 Stimulation of Gi-GPCR signalling in DVC astrocytes did not increase 
food intake after a 12 hour fast. 
Figure 4.3.21 Stimulation of Gi-GPCR signalling in DVC astrocytes attenuated 
CCK-induced satiety after a 12 hour fast. 
Figure 4.3.22 Stimulation of Gi-GPCR signalling in DVC astrocytes did not induce 
c-FOS immunoreactivity in the NTS. 
  
Figure 5.3.1 pMEA recording set up for NTS. 
Figure 5.3.2 Recording protocol and drug treatments. 
Figure 5.3.3 Food intake and stomach contents of experimental mice. 
Figure 5.3.4 Analysis pipeline for pMEA recordings. 
Figure 5.3.5 Greater baseline MU firing rate of channels across the NTS from mice 
fed high fat chow for 12 hours compared to standard chow fed 
controls. 
Figure 5.3.6 Greater baseline MU firing rate of channels in the postremal NTS 
from mice fed high fat chow for 12 hours compared to standard chow 
fed controls. 
Figure 5.3.7 Firing was greater in slices from high fat chow mice in the cNTS are 
rNTS. 
Figure 5.3.8 
 
Figure 5.3.9 
Figure 5.3.10 
Bath application of NMDA increases MU firing rate in the pNTS and 
this effect is potentiated by co-application of D-serine. 
NMDA-R agonists enhance MU firing in pNTS slices. 
Representative spike waveforms 
Figure 5.3.11 Total capacity of NMDA-R mediated firing and co-agonist capacity of 
NMDA-R mediated firing are greater in pNTS channels from high fat 
chow fed mice. 
Figure 5.3.12 Patch clamp recording in the horizontal brainstem slice. 
Figure 5.3.13 Effect of DHK on evoked EPSCs in NTSTH neurons. 
Figure 5.3.14 DHK did not affect the frequency of spontaneous and asynchronous 
EPSCs in NTSTH neurons 
  
20 
 
Figure 6.1.1 Summary of the main findings of this thesis as they relate to the 
overarching hypothesis 
Figure 6.3.1 Proposed signals leading to NTS astrocyte activation. 
Figure 6.3.2 Potential mechanisms of astrocyte-neuron communication in the 
NTS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
List of tables 
Table 1.5.1 Summary of studies which have examined impact of experimental 
manipulations on NTS astrocyte immunoreactivity and/or 
morphology.  
Table 2.1.1 Summary of antibodies used in the described studies.  
Table 2.1.2 Summary of viral vectors used in the described studies.  
Table 2.1.3 Summary of chemicals used in the described studies. 
Table 2.1.4 Summary of mouse strains and mouse diets used in the described 
studies. 
Table 2.1.5 Summary of software used in the described studies. 
Table 2.1.6 Summary of equipment used in the described studies. 
Table 2.2.1 Description of mice used for each experiment.  
Table 2.5.1 Concentrations of molecules in the 10mM Glucose artificial 
cerebrospinal fluid (aCSF). 
Table 2.5.2  Concentrations of molecules in the 5mM Glucose artificial 
cerebrospinal fluid (aCSF). 
Table 2.5.3 Concentrations of molecules in the slicing solution. 
Table 2.6.1 Concentrations of molecules in the external artificial cerebrospinal 
fluid (aCSF). 
Table 2.6.2 Concentrations of molecules in the internal recording pipette solution. 
 
 
 
 
 
 
 
 
 
22 
 
Author’s declaration 
All work was conducted by the author at the University of Exeter Medical School 
laboratories, the University of Bristol School of Physiology, Pharmacology and 
Neuroscience laboratories or the Washington State University Integrative 
Pharmacology and Neuroscience laboratories with the exception of the following: 
Chapter 4 
Dr Fiona Holmes performed the tail-flick latency assay described in section 
4.3.13 and figure 4.3.13. 
 
 
 
 
 
 
 
 
 
 
 
 
 
23 
 
 
 
 
 
 
Chapter 1 
 
 
 
 
 
Introduction 
 
 
 
 
 
 
 
 
 
 
 
 
 
24 
 
1.1 | Food intake is controlled by the brain to maintain energy balance 
Energy balance is the process by which energy intake and energy expenditure 
are matched to ensure the metabolic demands of an organism are met (Hall et 
al., 2012). In mammals, energy intake is in the form of food intake while energy 
expenditure comprises of the body’s basal metabolic processes required for 
physiological function in addition to that required for the physical activities 
necessary for survival (Hall et al., 2012). Energy balance is considered to be 
under the control of the brain which integrates hormonal and nervous cues to 
modulate food intake and energy balance to ensure the metabolic needs are met 
(Kishi and Elmquist, 2005; Rui, 2013). Given the evolutionary pressures that 
guided development of this system in mammals, energy balance seems to be 
more protective against starvation than energy surplus (Krashes, Lowell and 
Garfield, 2016). This is presumably due to starvation being more prohibitive to 
reproductive success. The appropriate regulation of food intake is essential to 
defend a mammal against prolonged energy imbalance. Two key brain areas 
receive information from the periphery in order to regulate food intake: the 
hypothalamus and the dorsal vagal complex.  
The hypothalamus, located on the ventral surface of the brain, is adjacent to the 
third ventricle (3V) and the circumventricular organ the median eminence. These 
two features allow hypothalamic cells access to circulating factors in the 
cerebrospinal fluid (CSF) and blood, respectively (Mullier et al., 2010). Indeed, 
this brain area is a primary site of action of the two canonical energy balance 
hormones, leptin and ghrelin which suppress and promote food intake, 
respectively (Valassi, Scacchi and Cavagnini, 2008). Hypothalamic cells also 
directly sense nutrients in the form of amino acids (Blouet et al., 2009). Different 
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nuclei of the hypothalamus are believed to predominantly control food intake and 
energy expenditure. 
The dorsal vagal complex (DVC), located in the brainstem is the second primary 
sensor of peripheral energy regulatory cues (Grill and Hayes, 2012). In addition 
to containing a circumventricular organ, the area postrema (AP), the DVC 
contains a neuronal hub, the nucleus of the solitary tract (NTS) where neurons of 
the afferent vagus nerves project. These nerves innervate the stomach and 
intestine and signal nutrient content and physical stretch to the brain following a 
meal (Berthoud and Neuhuber, 2000; Williams et al., 2016; Bai et al., 2019). Their 
activity is also modulated by hormones predominantly those released from the 
gut (Cork, 2018). 
The hypothalamus and DVC communicate with each other directly via neuronal 
projections and indirectly via downstream integratory nuclei in the midbrain 
(Figure 1.1) (Andermann and Lowell, 2017). This signalling regulates energy 
balance to ensure appropriate food seeking and ingestion to match energy 
requirements. In order to ensure food intake the brain generates a feeling of 
hunger. Once the appropriate amount of food is ingested, the brain integrates 
neuronal and hormonal cues and generates a signal of satiation. Satiety refers to 
a state where hunger is suppressed so an animal will stop eating and not begin 
again until hunger resumes. Hunger and satiety are sensations in opposition that 
act to promote and suppress food intake, respectively. In a coordinated action 
with brain circuits regulating energy expenditure this system ensures energy 
balance. The details of the key brain circuitry underlying this are discussed below. 
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Figure 1.1 | The brain integrates cues from the periphery to regulate food 
intake. Simplified diagrammatic representation of rodent brain regions controlling 
food intake. Specific brain nuclei in the hypothalamus (red) and brainstem (light 
green) are sensitive to hormonal and neuronal input from the rest of the body 
which reflect internal energy state. Activity of neurons in these brain regions and 
midbrain integratory centres (blue) drive or suppress food intake in response to 
these peripheral signals to maintain energy balance. Inset, these same nuclei are 
found in a corresponding anatomical arrangement in the human brain indicating 
these systems are evolutionarily conserved. 
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1.2 | An overview of key neural circuits controlling food intake 
Feeding is a highly conserved behaviour critical to the evolutionary success of a 
species. It is one of the fundamental behaviours and for humans a basic need in 
Maslow’s hierarchy of needs (Maslow, 1943). A key goal of systems 
neuroscience is to understand how networks of neurons act together to generate 
behaviour. Feeding has received a lot of attention in the field and as a result the 
circuitry underlying this behaviour is some of the best understood (Andermann 
and Lowell, 2017). 
Rodents are a common model organism used to study food intake since they 
have relatively similar digestive anatomy to other mammals, show stereotyped 
patterns of food intake under laboratory conditions, and (especially in the case of 
the mouse) they are genetically tractable allowing for the dissection of neuronal 
circuitry at a very rich level of detail (Luo, Callaway and Svoboda, 2008; Ellacott 
et al., 2010). 
In the last fifteen years there has been a rapid adoption of technologies which 
allow for the selective manipulation and monitoring of defined neuronal (and non-
neuronal) cell populations. Optogenetics employs light sensitive ion channels to 
allow for selective stimulation or inhibition of neurons with direct pulses of light 
(Boyden et al., 2005; Boyden, 2011; Deisseroth, 2015). Chemogenetics applies 
a similar principle but utilises modified G-protein coupled receptors (GPCRs) 
which recognise a synthetic ligand (e.g. clozapine-N-oxide [CNO]) (Armbruster et 
al., 2007; Roth, 2016). Cell populations can also be either selectively ablated 
(killed) or have vesicular release blocked by the expression of the diphtheria toxin 
receptor or the tetanus toxin light chain (TeLC), respectively (Yamamoto et al., 
2003; Luquet et al., 2005). Finally by expressing variants of the genetically 
encoded Ca2+ indicator GCaMP, relative neuronal intracellular Ca2+ concentration 
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([Ca2+]i) and population activity can be monitored in freely moving animals which 
can be related to behaviour (Tian et al., 2009). Combining these techniques with 
mice expressing Cre-recombinase in specific cell types of interest has greatly 
enhanced our understanding of how the brain regulates food intake in mice 
(Andermann and Lowell, 2017). 
1.2.1 | Hypothalamic circuits 
Since the discovery that hypothalamic and not pituitary lesions in rats, cats, dogs 
and humans produces dramatic weight gain (Hetherington and Ranson, 1940; 
Brobeck, 1946), the hypothalamus has been at the centre of research into the 
brain’s control of food intake. This structure, situated on the ventral surface of the 
brain beneath the thalamus, consists of anatomically distinct nuclei 
predominantly associated with driving behaviours that govern survival, 
homeostasis and reproduction (Sternson, 2013). 
1.2.1.1 | The Arcuate Nucleus 
Commonly considered to be an ‘entry’ point into the brain’s control of food intake, 
the arcuate nucleus (ARC) is the primary site of detection for signals driving food 
intake (Cone, 2005). Its proximity to the third ventricle and median eminence (a 
circumventricular organ) allow for sensing of circulating factors and signals in the 
CSF (Yulyaningsih et al., 2017).  
Canonically, the ARC is home to two functionally opposed neuronal populations 
that bi-directionally modulate food intake. These cells are identified by their 
expression of agouti-related protein (AgRP [ARCAgRP neurons]) or pro-
opiomelanocortin (POMC [ARCPOMC neurons]). ARCAgRP neurons release AgRP 
along with neuropeptide Y (NPY) and γ-amino butyric acid (GABA) (Atasoy et al., 
2012). There is substantial evidence that ARCAgRP neurons are the main (and 
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perhaps sole) homeostatic hunger-signalling (orexigenic) population in the brain, 
although dopaminergic reward pathways outside of the hypothalamus can also 
drive food intake (Luquet et al., 2005; Denis et al., 2015). In adult mice, selective 
chemical ablation of ARCAgRP neurons results in starvation showing their 
importance for survival (Luquet et al., 2005). Furthermore, one of the most robust 
findings in the field is that the selective activation of ARCAgRP neurons by 
chemogenetic or optogenetic methods drives voracious eating for the duration of 
stimulation (Krashes et al., 2011, 2013, 2014; Aponte, Atasoy and Sternson, 
2011; Atasoy et al., 2012; Betley et al., 2013; Dietrich et al., 2015; Garfield et al., 
2015; Padilla et al., 2016; Y. Chen et al., 2016; Burnett et al., 2016, 2019; Su, 
Alhadeff and Betley, 2017; Essner et al., 2017; Alhadeff et al., 2018, 2019b; 
Goldstein et al., 2018; X.-Y. Li et al., 2019).  
These neurons are greatly activated by fasting as evidenced by expression of the 
immediate early gene protein product, c-FOS (a marker of active neurons) in 
ARCAgRP neurons of fasted mice (Wu et al., 2014). In ex vivo slices from fasted 
mice, ARCAgRP neuronal action potential firing and intrinsic electrical excitability 
are greater than in slices from ad libitum fed control mice (Takahashi and Cone, 
2005). Crucially, in vivo, [Ca2+]i is elevated in ARCAgRP neurons by fasting (Betley 
et al., 2015).  
In addition to driving feeding it appears that fasting inhibits competing behaviours 
to prioritise food seeking, ensuring survival. This is recapitulated by selective 
optogenetic or chemogenetic activation of ARCAgRP neurons. Behaviours shown 
to be inhibited include anxiety, fighting, mating, socialising (Burnett et al., 2016; 
Padilla et al., 2016), sleep (Goldstein et al., 2018), nest building (X.-Y. Li et al., 
2019) and even perception of inflammatory pain (Alhadeff et al., 2018). In the 
absence of food, selective optogenetic and chemogenetic activation of ARCAgRP 
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neurons stimulates food seeking behaviours like burrowing (Dietrich et al., 2015). 
Across these studies bulk optogenetic or chemogenetic activation of ARCAgRP 
neurons mimics the effects of fasting in mice.  
These neurons send restricted projections to a number of subcortical nuclei in a 
one-to-one fashion (i.e. an individual ARCAgRP neuron projects to only one target) 
(Betley et al., 2013). Of these targets only a subset appear to mediate effects on 
feeding while others likely act to suppress competing behaviours (Betley et al., 
2013; Essner et al., 2017; Alhadeff et al., 2018) (Figure 1.2.1). Thus, in states of 
starvation, ARCAgRP neurons drive feeding and suppress other behaviours to 
ensure prioritisation of food intake and survival. 
In recent work the activity of ARCAgRP neurons has been measured using in vivo 
Ca2+ imaging (Betley et al., 2015), fibre photometry (Chen et al., 2015), and 
electrophysiology (Mandelblat-Cerf et al., 2015).This has revealed that ARCAgRP 
neuron activity is reduced following the presentation of food and to conditioned 
cues signalling food intake (Betley et al., 2015; Chen et al., 2015; Mandelblat-
Cerf et al., 2015). This ‘anticipatory’ reduction in activity is transient unless food 
is then consumed, at which point the reduction in activity is sustained (Betley et 
al., 2015; Chen et al., 2015; Beutler et al., 2017; Su, Alhadeff and Betley, 2017). 
Anticipatory reductions in ARCAgRP activity are mediated predominantly by visual 
detection of food and to a lesser degree olfactory detection (Chen et al., 2015).  
Direct intra-gastric infusion of liquid diet or individual macronutrients 
(carbohydrate, sugar and fat) is sufficient to reduce ARCAgRP activity in fasted 
mice in a calorie dependent manner as is injection with gut peptides 
cholecystokinin (CCK), peptide tyrosine tyrosine (PYY) and amylin (Beutler et al., 
2017; Su, Alhadeff and Betley, 2017). This gut-brain suppression of ARCAgRP 
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activity is dependent on vagal signalling since it is abolished by vagotomy and 
chemogenetic activation of satiety signalling vagal neurons is sufficient to reduce 
ARCAgRP activity in fasted mice (Alhadeff et al., 2019b; Bai et al., 2019). These 
data showing the dynamics of ARCAgRP neuron activity in vivo has led to the view 
that ARCAgRP neurons drive food seeking behaviours and once food is both 
present and consumed this drive is rapidly and sustainably diminished. 
As mentioned above, ARCPOMC neurons are the functionally opposing population 
to ARCAgRP neurons within the hypothalamus. ARCPOMC neurons release α- and 
β-melanocyte stimulating hormone (α-MSH and β-MSH respectively; cleavage 
products of the POMC prohormone) and GABA. Although less robust, their 
sustained activation with optogenetics or chemogenetics reduces food intake in 
mice (Aponte, Atasoy and Sternson, 2011; Zhan et al., 2013). Their major 
projection targets appear to generally match those of ARCAgRP neurons including 
the central extended amygdala (CeA), paraventricular nucleus of the 
hypothalamus (PVH), lateral hypothalamus (LH) and lateral parabrachial nucleus 
(lPBN)  (Betley et al., 2013; D. Wang et al., 2015).  
The actions of ARCAgRP and ARCPOMC derived transmitters bi-directionally 
regulate the melanocortin 4 receptor (MC4R). At the MC4R, α-MSH and β-MSH 
are agonists and AgRP is an inverse agonist (Haskell-Luevano and Monck, 2001; 
Raffan et al., 2016). MC4R is found in many projection targets of ARCAgRP and 
ARCPOMC neurons including the CeA, PVH, LH and lPBN (Mountjoy et al., 1994; 
Liu et al., 2003). Of these nuclei, it appears that MC4Rs in the PVH are the 
predominant population in mediating effects on food intake (Shah et al., 2014; 
Garfield et al., 2015) (See section 1.2.1.2 below).  
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Importantly, ARCAgRP neurons directly inhibit ARCPOMC neurons via GABA release 
(Atasoy et al., 2012). In fasted mice, ARCPOMC neuron [Ca2+]i rapidly increases 
upon food presentation and shows sustained elevation following food ingestion 
(Chen et al., 2015). Their activity is directly inverse to ARCAgRP neurons 
suggesting these rises in activity are owing to disinhibition (i.e. a reduction in 
GABAergic tone from ARCAgRP neurons allowing for a net excitation of ARCPOMC). 
These studies show that ARCPOMC neurons signal satiety following food intake. 
In times of caloric need ARCPOMC neurons are inhibited directly and their actions 
are antagonised at projection targets by ARCAgRP neurons to ensure caloric needs 
are met. 
The ARC and its resident AgRP and POMC neurons have been identified as 
effectors of two major appetite-regulating hormones, ghrelin and leptin. Ghrelin 
is a hormone released from the stomach: its release is elevated by fasting and 
inhibited by food intake (Kojima et al., 1999; Ariyasu et al., 2001). Plasma ghrelin 
also peaks prior to mealtimes in humans (Cummings et al., 2001). Delivery of 
exogenous ghrelin either into the circulation or directly to the brain ventricles 
(intracerebroventricular, i.c.v.) increases food intake in rats and induces c-FOS 
expression in ARCAgRP neurons (Dickson and Luckman, 1997; Nakazato et al., 
2001). Ghrelin has been shown to directly activate ARCAgRP neurons via the 
growth hormone secretagogue receptor 1A (GHSR1A) (Cowley et al., 2003). In 
turn, this inhibits the firing of ARCPOMC neurons and is accompanied by an 
increase in inhibitory postsynaptic currents (IPSCs) in these cells, likely from 
inhibitory ARCAgRP inputs (Cowley et al., 2003).  
Leptin is a hormone released from white adipose tissue and plasma leptin levels 
reflect body mass leading to the view that leptin is an adipostat (i.e. a hormone 
that signals the level of energy stored as fat) (Zhang Y et al., 1994; Frederich et 
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al., 1995). In addition to this homeostatic signal, acutely plasma leptin is very low 
in fasted mice which is likely a mechanism to promote food intake (Ahlma et al., 
1996). Leptin  activates ARCPOMC neurons directly via the long form leptin receptor 
(LepRb) and indirectly by inhibition of ARCAgRP neurons (Cowley et al., 2001). 
Correspondingly, deletion of LepRb from only POMC neurons results in mild 
obesity and leptin resistance but not to the same extent as total LepRb deletion 
(Balthasar et al., 2004). This shows POMC neurons including ARCPOMC are a 
principal, but not the sole, target of leptin for energy homeostasis. Thus, the two 
populations of ARC neurons are bi-directionally modulated by peripheral signals 
that stimulate (ghrelin) and inhibit (leptin) food intake. 
1.2.1.2 | The Paraventricular Nucleus of the Hypothalamus 
One of the best studied projection targets of ARC neurons is the PVH. Sitting 
adjacent to the third ventricle (3V), neurons in this nucleus receive dense 
innervation from ARCAgRP and ARCPOMC neurons (Bagnol et al., 1999; Haskell-
Luevano et al., 1999). In the classic view, ARCPOMC neurons release POMC-
derived melanocortins (i.e. α-MSH and β-MSH) to stimulate MC4Rs on PVH 
neurons. Conversely, these same PVH neurons are inhibited by AgRP and NPY 
released from ARCAgRP neurons via inverse agonism of MC4R and potentiation 
of GABAergic inputs, respectively (Cowley et al., 1999; Cone, 2005).  
The majority of neurons in the PVH are marked by expression of the transcription 
factor single-minded 1 (SIM1) which specifies PVH development (Michaud et al., 
1998, 2001). Mc4r deficient mice and humans with MC4R mutations have 
increased food intake (hyperphagia) and develop obesity (Huszar et al., 1997; 
Vaisse et al., 1998; Yeo et al., 1998). Restoration of the MC4R in PVHSIM1 
neurons of Mc4r-/- mice is sufficient to reduce hyperphagia and obesity associated 
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with Mc4r-deficiency, highlighting the PVH as a key site of MC4R action in the 
regulation of energy homeostasis (Balthasar et al., 2005).  
Indeed, further studies have shown that PVH neurons expressing the MC4R 
(PVHMC4R neurons) are an important PVH population mediating satiety. Site-
specific deletion of the MC4R from the PVH results in hyperphagia and weight 
gain in mice (Shah et al., 2014). PVHMC4R neurons express c-FOS in the fed state 
and following refeeding after a fast (Garfield et al., 2015; M. M. Li et al., 2019). 
PVHMC4R neurons are direct recipients of inhibitory synaptic input from ARCAgRP 
neurons and disruption of this inhibitory pathway attenuates food intake induced 
by optogenetic stimulation of ARCAgRP neurons (Garfield et al., 2015). Numerous 
lines of evidence show that optogenetic and chemogenetic stimulation of 
PVHMC4R neurons reduces food intake (Garfield et al., 2015; C. Li et al., 2019; M. 
M. Li et al., 2019). In turn, chemogenetic silencing induces hyperphagia and 
TeLC-mediated inhibition of transmitter release over long time scales (weeks) 
leads to weight gain (Garfield et al., 2015; C. Li et al., 2019; M. M. Li et al., 2019).  
PVHMC4R neurons exert their satiating effects by providing excitatory 
glutamatergic drive to neurons of the lPBN in the midbrain which act to suppress 
appetite (Shah et al., 2014; Garfield et al., 2015; M. M. Li et al., 2019). As 
mentioned above, under the classical model of ARC to PVH signalling, PVHMC4R 
neurons are directly activated by melanocortin peptides released from ARCPOMC 
neurons while this activation is antagonised by AgRP release from ARCAgRP 
neurons. In addition it appears that the rapid effect of ARCAgRP activation on food 
intake is mediated by GABA and NPY (Aponte, Atasoy and Sternson, 2011; 
Atasoy et al., 2012). This is consistent with evidence that the AgRP/POMC/MC4R 
system governs long term energy balance while fast neurotransmitters govern 
rapid changes in intake (Krashes et al., 2013). 
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 A second population of PVH neurons, identified by expression of prodynorphin 
(PVHPDYN neurons) additively control satiety with PVHMC4R neurons, collectively 
accounting for the effects of chemogenetic activation of PVHSIM1 neurons (M. M. 
Li et al., 2019). PVHPDYN neurons show minimal overlap with PVHMC4R neurons 
and chemogenetic activation of each population separately produces around 
50% of the effects of chemogenetic activation of both populations simultaneously 
or PVHSIM1 neurons (M. M. Li et al., 2019). Therefore, PVH satiety neurons consist 
of two, largely independent populations expressing PDYN or MC4R which 
additively govern satiety and prevent obesity.  
PVH neurons additionally receive input from brainstem nuclei and both 
cholecystokinin receptor (CCK-R) and glucagon-like peptide1 receptor (GLP1-R) 
expressing populations suppress appetite (D’Agostino et al., 2016; C. Li et al., 
2019) suggesting PVH neurons are regulated by ‘bottom-up’ signalling from the 
brainstem in addition to ‘top-down’ signalling from the ARC (discussed in more 
detail below see section 1.2.2.1). 
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Figure 1.2.1 | ARCAgRP neurons send distinct projections to subcortical 
nuclei to drive food intake. a, ARCAgRP neurons send projections to the PVH. 
Selective activation of this projection increases food intake in satiated mice. 
Selective activation of ARCAgRP projections to the lPBN increases food intake in 
mice injected with satiating and nauseating agents. b, ARCAgRP neurons project 
within the hypothalamus to inhibit ARCPOMC neurons and PVHSIM1 neurons. 
Activation of the subtypes of PVHSIM1 neurons (PVHMC4R and PVHPDYN) additively 
reduce food intake. ARCPOMC neurons excite PVHMC4R neurons signalling satiety. 
AgRP = agouti-related protein, ARC = arcuate nucleus of the hypothalamus, 
CGRP = calcitonin gene related peptide, lPBN = lateral parabrachial nucleus, 
MC4R = melanocortin 4 receptor, PDYN = prodynorphin, POMC= 
proopiomelanocortin, PVH = paraventricular nucleus of the hypothalamus. 
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1.2.2 | Midbrain and Hindbrain circuits controlling food intake  
1.2.2.1 | The Nucleus of the Solitary Tract 
If the ARC is to be considered the ‘entry point’ for signals of hunger then the 
nucleus of the solitary tract (also known as Nucleus Tractus Solitarii [NTS], known 
as the solitary nucleus in humans) is the entry point for internal satiety signals. 
The NTS is situated in the dorsal portion of the caudal medulla oblongata. Along 
with the adjacent AP and the dorsal motor nucleus of the vagus (DMX) it is a 
component of the dorsal vagal complex (DVC). The AP is a circumventricular 
organ which allows some circulating factors to enter the NTS e.g. hormones, 
glucose. The DMX is a preganglionic parasympathetic nucleus whose neurons 
make up the motor (efferent) branch of the vagus nerve.  
Neurons in the NTS are uniquely placed to integrate information from the 
periphery since they receive synaptic input from the facial and vagal cranial 
nerves. These inputs are roughly topographically ordered with gustatory 
information from the facial nerve innervating the tongue (chorda timpani branch) 
projecting to the rostral NTS (rNTS) (J. Zhang et al., 2019) while viscerosensory 
neurons of the vagus nerves terminate in the postremal and caudal NTS (pNTS 
and cNTS, respectively) (Chang et al., 2015; Williams et al., 2016; Han et al., 
2018; Min et al., 2019). The vagus nerve innervates almost all of the major organ 
systems in mammals including the majority of the gastrointestinal (GI) tract from 
the pharynx to the colon (Berthoud and Neuhuber, 2000). Vagal neurons that 
innervate the stomach and upper intestine terminate in the pNTS and cNTS 
(Williams et al., 2016; Han et al., 2018; Bai et al., 2019). 
Vagal neurons enter the brain in a bundle called the solitary tract (ST) and form 
glutamatergic synapses with second order NTS neurons (i.e. NTS neurons 
directly receiving peripheral input from the vagus nerve) (Andresen and Yang, 
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1990; Doyle and Andresen, 2001). Stimulation of the ST results in short latency, 
low failure excitatory postsynaptic currents (EPSCs) in second order NTS 
neurons which show frequency dependent depression and are sensitive to 
AMPA-R antagonists (Doyle and Andresen, 2001; Doyle et al., 2004). This shows 
that NTS-terminating vagal afferents have a high probability of glutamate release 
from large readily-releasable pools that are rapidly depleted. 
Ingestion of food results in neuronal activation in the rodent NTS as indicated by 
c-FOS expression in response to scheduled feeding or binge eating following a 
fast (Johnstone, Fong and Leng, 2006; Wu et al., 2014). In addition, injection of 
the gut peptide cholecystokinin (CCK) induces c-FOS expression in the NTS 
indirectly by excitation of vagal afferent neurons (Fan et al., 2004; Appleyard et 
al., 2005). Optogenetic activation of stomach and intestine innervating vagal 
afferent terminals in the NTS reduces food intake providing causal evidence of 
the sufficiency of this gut to brain pathway to induce satiety (Han et al., 2018). 
Vagal afferents with sensory receptors in the stomach and upper intestine sense 
food intake by detection of stomach stretch and intestinal nutrients (Williams et 
al., 2016; Bai et al., 2019). These neurons terminate in the cNTS and pNTS 
(Williams et al., 2016; Han et al., 2018; Bai et al., 2019). Accordingly, optogenetic 
and chemogenetic activation of specific populations of these gut innervating 
neurons suppresses food intake (Han et al., 2018; Bai et al., 2019). In addition to 
innervation from the periphery, the NTS receives afferent inputs from a diverse 
range of brain nuclei, possibly as a negative feedback mechanism (Holt, 
Pomeranz, et al., 2019). 
Given their anatomical location, connectivity to neurons innervating the stomach 
and activation by food intake it was hypothesised that NTS neuronal firing signals 
satiety and results in termination of feeding. Indeed, causal evidence using 
39 
 
chemogenetic modulation of genetically and anatomically defined populations of 
NTS neurons supports this hypothesis, given that these excitatory manipulations 
all (with one exception) suppress food intake in some form (Zhan et al., 2013; 
D’Agostino et al., 2016, 2018; Roman, Derkach and Palmiter, 2016; Alhadeff et 
al., 2017; Gaykema et al., 2017; Roman, Sloat and Palmiter, 2017; Shi et al., 
2017; Boychuk et al., 2019; Holt, Richards, et al., 2019; Aklan et al., 2020).  
In contrast to the ARC, the organisational logic of neuronal populations in the 
NTS is not yet clear. Neurons here express a diverse range of neurotransmitters, 
neuropeptides and neuromodulators (Garfield et al., 2012). The principal 
populations identified are discussed below but a proper understanding of the 
neurochemical organisation of NTS neurons is sorely lacking. In future, the 
application single-cell RNA sequencing (scRNA-seq) to NTS neurons may reveal 
markers for functionally distinct subgroups. 
1.2.2.1.1 | NTSTH neurons 
Neurons in the NTS that express tyrosine hydroxylase (TH; NTSTH neurons) have 
been identified as one of the key NTS neuronal populations involved in mediating 
satiety. NTSTH neurons co-express the noradrenaline synthesis enzyme 
dopamine-beta hydroxylase (DBH) meaning these neurons are noradrenergic 
(Roman, Derkach and Palmiter, 2016). In addition to noradrenaline, they also 
release glutamate (Roman, Derkach and Palmiter, 2016; Aklan et al., 2020). 
These neurons are monosynaptically connected to vagal afferents and show a 
distinctive response to ST stimulation in ex vivo slices (Appleyard et al., 2007). 
Synaptic integration in these neurons is modulated by ghrelin, extracellular 
glucose concentration, nicotine, serotonin (5-HT) and opioids (Cui, Li and 
Appleyard, 2011; Cui, Roberts, Zhao, Andresen, et al., 2012; Cui, Roberts, Zhao, 
Zhu, et al., 2012; Roberts et al., 2017; Page, Zhu and Appleyard, 2018).  
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Critically these NTSTH neurons express c-FOS in response to scheduled feeding 
and refeeding after a fast (Johnstone, Fong and Leng, 2006; Roman, Derkach 
and Palmiter, 2016). Accordingly, their chemogenetic activation produces 
hypophagia (reduced food intake) (Roman, Derkach and Palmiter, 2016; Aklan 
et al., 2020). NTSTH neurons mediate their effect on food intake by activating 
calcitonin gene related peptide (CGRP) expressing neurons in the lPBN 
(lPBNCGRP neurons) by glutamate release (Roman, Derkach and Palmiter, 2016). 
Of note, a small population of NTSTH neurons (~20%) do not project to the lPBN 
and instead have the opposing function and project to the ARC and stimulate 
ARCAgRP neurons to increase food intake (Aklan et al., 2020). These neurons are 
glucose-sensitive and utilise this function to drive food intake when blood glucose 
is low (Aklan et al., 2020). These ARC projecting NTSTH neurons are the first (and 
to date only) example of NTS neurons which increase food intake. 
 Within the NTS, NTSTH neurons are subject to modulation from local neurons. 
For example, NTSTH neurons are excited by chemogenetic activation of NTS 
neurons expressing CCK (Roman, Derkach and Palmiter, 2016). NTSTH neurons 
are also recipients of innervation from NTS neurons expressing pre-proglucagon 
(PPG) which release glucagon-like peptide1 (GLP1) for which NTSTH neurons 
express the relevant receptor, GLP1-R (Card et al., 2018).  
1.2.2.1.2 | NTSCCK neurons 
NTS neurons expressing the peptide CKK (NTSCCK neurons) are a distinct 
population from NTSTH neurons (Roman, Derkach and Palmiter, 2016; Cheng et 
al., 2020). NTSCCK neurons also show c-FOS immunoreactivity in response to 
food intake, gastrointestinal amino acid contents and gastrointestinal sucrose 
(D’Agostino et al., 2016). The synaptic relationship between NTSCCK neurons and 
vagal afferents is currently unknown and as such it is not clear if these neurons 
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are second-order (i.e. direct recipients of vagal input) or higher-order (i.e. indirect 
sensors of satiety signals) viscerosensory neurons. Chemogenetic activation of 
all NTSCCK neurons or optogenetic stimulation of NTSCCK terminals in the PVH 
suppresses food intake in a CCK-R dependent manner (D’Agostino et al., 2016; 
Roman, Derkach and Palmiter, 2016). These neurons also project to lPBNCGRP 
neurons to suppress food intake (Roman, Derkach and Palmiter, 2016; Roman, 
Sloat and Palmiter, 2017; Cheng et al., 2020). Optogenetic stimulation of NTSCCK 
terminals in the lPBN induces short latency, low-jitter, glutamatergic EPSCs in 
lPBNCGRP neurons showing these neurons directly release glutamate in the lPBN 
to exert their feeding suppressive effects (Roman, Derkach and Palmiter, 2016). 
In contrast, the effect of chemogenetic activation of all NTSCCK neurons and 
optogenetic stimulation of NTSCCK projections to the PVH are mediated, at least 
in part, by CCK receptors (D’Agostino et al., 2016). 
NTSCCK neurons appear to encode some affective properties of food intake since 
stimulation of NTSCCK terminals in the PVH is rewarding while stimulation of 
NTSCCK terminals in the lPBN is aversive (D’Agostino et al., 2016; Roman, Sloat 
and Palmiter, 2017). Stimulation of NTSCCK neurons in general is sufficient to 
condition avoidance of a paired flavour (conditioned taste aversion), providing 
further evidence for aversive salience of NTSCCK signals (Cheng et al., 2020). 
Given the aversive nature of lPBNCGRP neuronal activation (Campos et al., 2018; 
Palmiter, 2018) and the direct connection with NTSCCK neurons (Roman, Derkach 
and Palmiter, 2016) it seems likely that the net effect of these neurons’ activation 
produces aversion. 
1.2.2.1.3 | NTSPOMC neurons 
A population of NTS neurons express POMC (NTSPOMC). Similarly to NTSTH 
neurons, NTSPOMC neurons express c-FOS in response to food intake and CCK 
42 
 
administration (Fan et al., 2004; Appleyard et al., 2005). NTSPOMC neurons are 
monosynaptically connected to vagal afferents (Appleyard et al., 2005). 
Chemogenetic activation of NTSPOMC suppresses food intake on a shorter time 
scale (2 -8 hours) to their hypothalamic (ARCPOMC) counterparts (24 hours) (Zhan 
et al., 2013). Chemogenetic activation of NTSPOMC neurons induces c-FOS 
expression in both NTSPOMC and NTS-POMC negative neurons, suggesting these 
cells send local, excitatory projections (Zhan et al., 2013).  
Their function seems to be diverse; in a second study chemogenetic activation of 
NTSPOMC neurons resulted in cardiorespiratory depression (indicative of an 
increase in parasympathetic tone) and analgesia mediated by endogenous 
opioids (β-endorphin is another cleavage product of the POMC prohormone) 
(Cerritelli et al., 2016). This led the authors to propose NTSPOMC as autonomic 
‘output’ neurons of the NTS given these observed effects and the finding that 
NTSPOMC neurons send selective projections to a diverse range of brainstem 
targets including the lPBN (D. Wang et al., 2015; Cerritelli et al., 2016). It appears 
that POMC (and its cleavage products) are essential for the initial phase of 
hypophagia induced by injection of a 5-HT2C-R agonist lorcaserin since deletion 
of the POMC protein from the NTS removes this effect (D’Agostino et al., 2018). 
This shows that POMC cleavage products are at least one of the transmitters 
used by this group of cells. 
1.2.2.1.4 | NTSPPG neurons 
The NTS is also home to a unique population of neurons expressing 
preproglucagon (PPG; NTSPPG neurons). PPG is a prohormone that can be 
cleaved by prohormone convertase to yield GLP1. In the periphery GLP1 is 
released from enteroendocrine cells in the GI tract to excite GLP1-R expressing 
vagal afferents in response to a meal (reviewed in Cork, 2018). Owing to its short 
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half-life, peripheral GLP1 likely does not reach the brain making NTSPPG neurons 
the sole source of GLP1 in the central nervous system (CNS) (Kieffer, Mc Intosh 
and Pederson, 1995; Holt, Richards, et al., 2019). Given that the GLP1-R is 
widely expressed in the brain these neurons likely have diverse functions 
although this remains to be conclusively demonstrated (Cork et al., 2015). Similar 
to all NTS neuronal populations described previously, chemogenetic activation of 
NTSPPG neurons suppresses food intake under normal conditions, after a fast, in 
obese mice and in the presence of palatable food (Gaykema et al., 2017; Shi et 
al., 2017; Holt, Richards, et al., 2019). Activation of NTSPPG neurons also 
improves glucose tolerance, likely through modulation of neuronal populations 
controlling hepatic glucose production (Holt, Richards, et al., 2019).  
Similarly to NTSCCK neurons the synaptic relationship of NTSPPG neurons to vagal 
afferents is unknown; however, Cre-mediated monosynaptic rabies retrograde 
viral tracing from NTSPPG neurons does yield labelling in vagal sensory neurons 
indicating at least some of this population are second order interoceptive neurons 
(Holt, Pomeranz, et al., 2019). NTSPPG project to the PVH and ARC where their 
activation induces c-FOS expression (Llewellyn-Smith et al., 2011; Gaykema et 
al., 2017; Shi et al., 2017). In turn, selective chemogenetic activation of PVHGLP1-
R neurons reduces food intake while chronic silencing with TeLC leads to the 
development of obesity, illustrating the importance of GLP1 signalling in satiety 
(C. Li et al., 2019).  
The presence of projections from NTSPPG neurons to the ventral tegmental area 
(VTA) and nucleus accumbens (NAc) suggests that NTSPPG neurons may encode 
the rewarding nature of food intake (Llewellyn-Smith et al., 2011; Alhadeff, 
Rupprecht and Hayes, 2012). In support of this, delivery of a GLP1-R agonist or 
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antagonist to the NAc or VTA reduces or increases intake of palatable food, 
respectively (Alhadeff, Rupprecht and Hayes, 2012). 
1.2.2.1.5 | NTSGABA neurons 
The NTS also contains inhibitory GABAergic neurons (NTSGABA). These neurons 
again are monosynaptically connected to viscerosensory vagal afferents (Bailey 
et al., 2008). NTSGABA neurons are activated by low extracellular glucose and 
project to preganglionic motor neurons in the DMX, marked by expression of 
choline acetyltransferase (ChAT; DMXChAT neurons) (Boychuk et al., 2015). The 
effects of chemogenetic activation of NTSGABA neurons on food intake has not 
been described. However, their activation does cause an elevation in blood 
glucose via inhibition of DMXChAT neurons (Boychuk et al., 2019).  
A sub-population of NTSGABA neurons co-express the peptide somatostatin (SST) 
although not all NTSSST neurons are GABAergic (Thek et al., 2019). These 
NTSSST neurons are synaptically excited by ST stimulation and provide local 
inhibition to other NTS neurons to precisely gate synaptic transmission via 
feedforward inhibition (Thek et al., 2019). 
1.2.2.1.6 | NTS neurons expressing receptors for peripheral cues 
In addition to these populations identified by their neuropeptide expression, a 
number of NTS neuronal populations identified by expression of specific 
receptors also contribute to food intake suppression. The glial cell-derived 
neurotrophic factor receptor alpha-like (GFRAL) is exclusively expressed in the 
NTS and AP and is the target of growth and differentiation factor 15 (GDF15), a 
known hypophagia-inducing stimulus produced by damaged tissue (Zimmers et 
al., 2005; Hsu et al., 2017). GFRAL knockout mice show increased weight gain 
on a high fat diet compared with wild type controls and are resistant to 
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hypophagia induced by cisplatin, a chemotherapy agent. When GFRAL neurons 
are activated by GDF15, c-FOS expression is observed in the DVC and 
additionally in the lPBN and CeA; centres controlling satiety and aversion, 
respectively (Carter et al., 2013; Hsu et al., 2017).  In addition, administration of 
GDF15 alongside a novel food is sufficient to cause avoidance of that food on 
subsequent exposures (Patel et al., 2019). It has therefore been suggested that 
this GDF15-GFRAL system mediates the nausea and hypophagia induced by 
peripheral tissue damage (Hsu et al., 2017). 
Leptin, the adipose derived hormonal signal reflecting body fat mass, appears to 
exert part of its satiating effect by direct action on neurons in the NTS. Peripheral 
leptin administration induces phospho-signal transducer and activator of 
transcription 3 (pSTAT3) immunoreactivity in NTSPOMC neurons, in addition to 
other unidentified NTS neurons in mice (Ellacott, Halatchev and Cone, 2006). 
pSTAT3 is a second messenger downstream of LepRb indicating the direct action 
of peripheral leptin in the NTS. LepRb are expressed on NTSPOMC, NTSPPG and 
NTSCCK neurons and notably are absent from NTSTH, NTSGABA and DMXChAT 
neurons, indicating that its expression is not a uniform feature of NTS neurons 
(Garfield et al., 2012). Functionally, delivery of leptin to either the fourth ventricle 
(4V) or DVC reduces food intake in rats (Grill et al., 2002). Conversely, genetic 
deletion of the leptin receptor mRNA or gene from the DVC increases food intake 
and weight gain on a high fat diet in rats and mice, respectively (Hayes et al., 
2010; Scott et al., 2011). Taken together this shows the NTS and wider DVC are 
a crucial site of action for leptin. 
A population of NTS neurons also express the calcitonin receptor (Calc-R 
[NTSCalc-R]) and deletion of this receptor from the mouse NTS abolishes the 
satiating but not the aversive effect of peripheral calcitonin injection (Cheng et al., 
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2020). Around 25% of cells expressing Calc-R in the NTS are NTSTH cells, but 
CalcR is absent from NTSCCK cells and NTS cells expressing the LepRb. 
Chemogenetic activation of NTSCalcR neurons reduces food intake and activates 
non-CGRP expressing lPBN neurons. Conversely, their chronic inhibition by 
expression of TeLC attenuates c-FOS activation and hypophagia induced by 
vagally acting agents (CCK and the GLP1-R agonist exendin-4). Their inhibition 
in this fashion also increases weight gain on a high-fat diet (Cheng et al., 2020). 
Finally, it has been shown that NTS neurons directly sense nutrients in the form 
of amino acids and extracellular glucose (Blouet and Schwartz, 2012; Lamy et 
al., 2014). This nutrient sensing acts to suppress appetite and sensing is impaired 
following consumption of a high fat diet (Blouet and Schwartz, 2012; Cavanaugh, 
Schwartz and Blouet, 2015). In contrast, sensing of local hyperglycaemia drives 
hepatic glucose production and glucoprivic feeding (Lamy et al., 2014; Boychuk 
et al., 2019; Aklan et al., 2020). 
Taken together these studies indicate that the NTS is populated by neurons that 
integrate nutritional, hormonal and vagal afferent cues from the periphery and 
signal these to local DMXCHAT neurons to modulate autonomic outflow and higher 
brain centres to suppress food intake (Figure 1.2.2). One of the most consistent 
projection targets of NTS satiety signalling neurons is the lPBN where they 
engage both lPBNCGRP and non-CGRP neurons to suppress food intake. 
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Figure 1.2.2 | A simplified schematic diagram of the neurochemical 
organisation of appetite controlling populations in the NTS. For simplicity the 
left portion of the nucleus shows representative vagal inputs and local 
microcircuitry while the right portion of the nucleus shows representative long 
range projections shown to suppress food intake and modulate digestion. AP = 
area postrema, CCK = cholecystokinin, ChAT = choline acetyl transferase, GI = 
gastrointestinal, lPBN = lateral parabrachial nucleus, NTS = nucleus of the 
solitary tract, POMC = proopiomelanocortin, PPG = preproglucagon, PVH = 
paraventricular nucleus of the hypothalamus, TH = tyrosine hydroxylase, SST = 
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somatostatin, X = dorsal motor nucleus of the vagus, VGAT = vesicular gamma-
amino-butric acid transporter. 
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1.2.2.2 | The Lateral Parabrachial Nucleus 
Within the midbrain the lPBN is located lateral to the superior cerebellar peduncle, 
close to the locus coeruleus. As described above it is the major direct projection 
target of NTS neurons including NTSTH, NTSCCK and NTSPOMC in addition to non-
identified NTS neurons that receive input from the gut (D. Wang et al., 2015; 
Cerritelli et al., 2016; Roman, Derkach and Palmiter, 2016; Han et al., 2018; Bai 
et al., 2019). The best characterised neurons in the lPBN are identified by the 
expression of CGRP (lPBNCGRP neurons) (Carter et al., 2013; Palmiter, 2018). Of 
note, these neurons receive glutamatergic inputs from the NTS in mice and rats 
(Roman, Derkach and Palmiter, 2016; Alhadeff et al., 2017). lPBNCGRP neurons 
are bi-directionally connected to forebrain regions including the hypothalamus, 
CeA and bed nucleus of the stria terminalis (BNST) leading to the view that they 
relay information from the NTS to the forebrain and in return are modulated by 
the same forebrain regions (Palmiter, 2018). lPBNCGRP neurons express c-FOS 
following food intake or intraperitoneal injection of anorexia inducing stimuli 
lipopolysaccharide (LPS) and lithium chloride (LiCl) (Carter et al., 2013; Campos 
et al., 2016). In turn, chemogenetic activation of lPBNCGRP neurons reduces food 
intake while their chemogenetic inhibition preserves food intake in situations 
where it is normally reduced (e.g. after injection LiCl or LPS, or AgRP neuron 
ablation) (Carter et al., 2013; Campos et al., 2016).  
As mentioned above, optogenetic stimulation of NTS neuronal terminals or 
chemogenetic activation of lPBN-projecting NTS neurons reduces food intake via 
glutamatergic neurotransmission in mice and rats (Roman, Derkach and 
Palmiter, 2016; Alhadeff et al., 2017). These NTS populations relay satiety 
signals from the gut since chemogenetic activation of gut innervating 
mechanoreceptor neurons induces c-FOS expression in lPBNCGRP neurons (Bai 
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et al., 2019). The satiety signal generated by CGRP neurons appears to encode 
negative valence since pairing of optogenetic stimulation of CGRP neurons with 
a novel food causes avoidance of that food (conditioned taste aversion) and in 
turn their inhibition with chemogenetics or TeLC attenuates LiCl-mediated 
conditioned taste aversion (Carter, Han and Palmiter, 2015). They are thought to 
encode this negative valence by projections to the CeA (Campos et al., 2016). 
In addition to this ‘bottom-up’ signalling from the NTS, the lPBN is also subject to 
‘top-down’ input from forebrain regions to regulate appetite (Campos et al., 2016). 
ARCAgRP neurons provide direct GABAergic input to lPBNCGRP neurons (Wu, 
Boyle and Palmiter, 2009). When ARCAgRP neurons are chemically ablated in 
adult mice these animals cease to eat (Luquet et al., 2005). In mice with ARCAgRP 
neuronal ablation, lPBNCGRP neurons are hyper-excited, an effect which is 
rescued by delivery of GABA receptor agonists to the lPBN (Wu, Boyle and 
Palmiter, 2009). This intervention also restores feeding in these mice (Wu, Boyle 
and Palmiter, 2009). Secondly, optogenetic stimulation of AgRP terminals in the 
lPBN prolongs meal length (Campos et al., 2016). Optogenetic stimulation of 
ARCAgRP terminals in the PBN is sufficient to overcome the hypophagia induced 
by exogenous administration of CCK, amylin and LiCl (Essner et al., 2017). These 
studies indicate that this ARC to lPBN projection exists to inhibit lPBNCGRP neuron 
activity which permits food intake.  
It appears that reductions in lPBNCGRP neuron activity are permissive for food 
intake since the [Ca2+]i of individual lPBNCGRP neurons is reduced immediately 
prior to food intake (Campos et al., 2018). Consistent with a role in satiety, [Ca2+]i 
of these cells gradually increases with food intake which precedes meal 
termination (Campos et al., 2018). Finally, the activity of lPBNCGRP is lower 
following a fast, presumably due to increased inhibitory input from ARCAgRP and 
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reduced excitatory drive from the NTS (Campos et al., 2018). This shows that 
lPBNCGRP neurons are modulated by bottom-up (i.e. NTS) and top-down (i.e. 
hypothalamic) signals to permit or suppress feeding. 
The lPBN also contains many CGRP-negative neurons which have also been 
shown to regulate appetite. As discussed above PVHMC4R neurons project to the 
lPBN to reduce food intake but these neurons make no connection to lPBNCGRP 
neurons (Garfield et al., 2015). In keeping with this, PVHMC4R lPBN terminal 
activation is rewarding to hungry mice which suggests a population of appetite 
controlling lPBN neurons (independent of lPBNCGRP) that encode positive valance 
(Garfield et al., 2015). In support of this suggestion, NTSCalc-R neurons do not 
mediate aversion and terminate in the lPBN outside areas of CGRP 
immunoreactivity while NTSCCK  neurons whose chemogenetic activation can 
induce conditioned taste aversion terminate within the CGRP immunoreactive 
portion of the lPBN (Cheng et al., 2020). Similarly, reward-encoding NTS neurons 
(recipients of input from reward signalling vagal sensory neurons, see below) 
terminate outside the CGRP immunoreactive portion of the lPBN, these lPBN 
neurons project to midbrain dopamine neurons to encode rewarding properties 
of food intake (Han et al., 2018). The interaction of pathways regulating reward 
and aversion in food intake is an area of growing interest (Rossi and Stuber, 
2018). 
1.2.3 | Peripheral circuits  
1.2.3.1 | Vagal Sensory Neurons of the Nodose Ganglia 
As discussed above, vagal sensory neurons are key to relaying information from 
the periphery to the brain. In rodents, these neurons account for roughly 80% of 
vagal fibres, the other 20% being pre-ganglionic parasympathetic neurons in the 
DMX and nucleus ambiguus (Berthoud and Neuhuber, 2000). These neurons 
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obey a pseudounipolar morphology and have cell bodies located outside the brain 
in the nodose ganglia (NG), a bilateral structure located near the jugular vein. In 
most mammalian species vagal sensory neurons monitor the majority of organ 
systems including the heart, lungs and digestive tract (Berthoud and Neuhuber, 
2000). The activity of chemosensory vagal afferents is regulated by gut-derived 
hormones, their activity is increased by post prandial signals such as CKK, GLP1 
and 5-HT and inhibited by ghrelin (Date et al., 2002; Chambers, Sandoval and 
Seeley, 2013). 
With the advent of genetic technologies, vagal sensory neurons are beginning to 
be understood in unprecedented detail. Of relevance to this discussion are 
primarily vagal sensory neurons which innervate the stomach and intestine. In a 
seminal study, Williams et al described two distinct populations of vagal sensory 
neurons marked by differential expression of two receptors, GLP1-R and GPR65 
(Williams et al., 2016). NGGLP1-R neurons were found to preferentially innervate 
the stomach and were predominantly mechanosensory, responding to physical 
distension of the stomach. In contrast NGGPR65 neurons innervate the upper 
intestine and are chemosensory, responding to nutrients. The projection patterns 
of both populations were mapped and were shown to predominantly terminate in 
overlapping domains in the pNTS. In functional studies, it was shown that 
optogenetic stimulation of these populations modulated gastric motility 
suggesting these neurons drive vago-vagal reflexes controlling digestion 
(Williams et al., 2016). 
A complementary approach using intersectional viral labelling has allowed for 
stomach innervating vagal sensory neurons to be identified independent of 
genetic identity (Han et al., 2018). This study revealed a stark lateralisation of the 
termination fields of these neurons with those in the right NG terminating broadly 
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in the pNTS while those of the left NG send restricted projections to the AP. 
Although interesting, in the absence of independent replication it is unclear 
whether this represents a true lateralisation or a methodological artefact of the 
position of ‘starter’ virus injections into the stomach and intestine. This study also 
demonstrated causal evidence of the sufficiency of these neurons to induce 
satiety by optogenetic activation of stomach innervating NG neural terminals in 
the NTS. This stimulation reduced food intake and produced conditioned place 
preference showing that this connection serves to signal satiety and positive 
affective properties of ingested food. NTS neurons receiving input from stomach 
innervating NG neurons were found to project onwards to the lPBN, PVH and the 
midbrain dopamine system (Han et al., 2018). 
ScRNA-seq has revealed 18 distinct clusters of vagal sensory neuron, each with 
differential expression of genes involved in signal transduction (Kupari et al., 
2019). This suggests that vagal neurons are highly specialised and modality-
specific in contrast to other, more ‘generic’ sensory neurons (e.g. jugular ganglion 
neurons) (Kupari et al., 2019).  
ScRNA-seq has also been utilised and combined with functional techniques to 
better understand the specialisation of NG neurons innervating the GI tract and 
their role in feeding (Bai et al., 2019). This, study examined the genetic profiles 
of cells innervating specific targets in the GI tract and selected four populations 
for further validation. Of these, chemogenetic activation of GLP1-R or oxytocin 
receptor (OXTR)-expressing vagal neurons or optogenetic activation of their 
terminals in the NTS was sufficient to suppress food intake in fasted mice. Both 
receptor-defined subtypes label mechanosensory neurons innervating the 
stomach and intestine, respectively. Activation of chemosensory Gpr65 or 
vasoactive intestinal polypeptide (VIP) expressing neurons in the same fashion 
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did not suppress food intake, suggesting that the main signal for satiety is 
physical distention of the stomach and intestine. In support of this, chemogenetic 
activation of GLP1-R and OXTR expressing NG cells induced c-FOS expression 
in TH and non-TH neurons of the NTS and CGRP and non-CGRP neurons in the 
lPBN, in addition to rapidly inhibiting ARCAgRP neurons.  
This shows that stomach and intestine innervating vagal sensory neurons exert 
potent bottom-up signalling to both stimulate satiety circuits and inhibit hunger 
circuits. Since the only projection target of these neurons is the NTS, the NTS 
must be the principal brain centre mediating these effects. 
1.2.4 | An ARCAgRP hunger-based framework of central appetite control  
It is helpful here to summarise the wealth of evidence describing neural control 
of food intake into a conceptual framework of appetite regulation where hunger, 
and its suppression are the primary drivers and inhibitors of food intake (Figure 
1.2.3). From the evidence discussed above we arrive at a model in which 
ARCAgRP neurons drive hunger by direct inhibition of PVHSIM1 and lPBNCGRP 
neurons (Atasoy et al., 2012; Essner et al., 2017; M. M. Li et al., 2019). In addition, 
excitatory inputs from the NTS to lPBNCGRP neurons are presumably reduced in 
times of hunger owing to reduced GI-derived vagal input and active suppression 
by ghrelin (Date et al., 2002; Cui, Li and Appleyard, 2011). Thus, ARCAgRP 
neurons exert a potent ‘brake’ on lPBNCGRP excitability in times of hunger, which 
in the absence of excitatory drive from the NTS is unopposed (Campos et al., 
2016). Furthermore, ARCAgRP neurons project to other brain nuclei to suppress 
other behaviours and competing needs to ensure food seeking is prioritised 
(Burnett et al., 2016; Padilla et al., 2016; Alhadeff et al., 2018; Goldstein et al., 
2018; X.-Y. Li et al., 2019). 
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Once food is found/presented, ARCAgRP activity is rapidly reduced by top-down 
sensory processing (Betley et al., 2015; Chen et al., 2015). For this to persist, 
food must be ingested (Beutler et al., 2017; Su, Alhadeff and Betley, 2017). 
lPBNCGRP neurons reduce their activity immediately prior to feeding indicating this 
is permissive to food intake (Campos et al., 2018). Presumably this pre-ingestive 
inhibition is mediated by the second phase of ARCAgRP activation following 
detection but before ingestion (Beutler et al., 2017; Su, Alhadeff and Betley, 
2017).  
Once food is eaten, mechanosensory neurons innervating the stomach and 
intestine excite neurons of the NTS which in turn excite lPBN neurons (including 
lPBNCGRP) and, by an unknown circuit, inhibit ARCAgRP (Beutler et al., 2017; Su, 
Alhadeff and Betley, 2017; Han et al., 2018; Alhadeff et al., 2019a; Bai et al., 
2019). lPBNCGRP neuron activity accumulates throughout a meal, presumably 
driven by increased NTS input, and once a certain threshold is reached feeding 
is terminated (Campos et al., 2018).  
In this model the main driver of food intake is ARCAgRP neuron activity which is 
unopposed during hunger. During the switch to satiety, signals from the NTS 
dominate, inhibiting ARCAgRP and providing excitation to the PVH and lPBN to 
suppress hunger and reduce further food intake. This illustrates the importance 
of NTS satiety signalling since in the absence of this pathway, the sole focus of 
an animal would be food intake and seeking regardless of how much energy was 
already ingested. 
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Figure 1.2.3 | Brain circuits engaged by hunger and satiety. In a state of 
hunger ARCAgRP neurons are active and inhibiting anorexigenic neurons in the 
PVH and lPBN. There is a low level of input from GI-tract innervating NG neurons 
to the NTS and thus the ARCAgRP signal dominates, inhibiting the other circuit 
nodes. Upon food intake NG neurons sense gastric and intestinal stretch and, in 
turn, excite neurons of the NTS. NTS neurons reduce further food intake via 
projections to the PVH and lPBN. In addition, ARCAgRP are rapidly inhibited 
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following ingestion in a vagal (and therefore NTS) dependent fashion via an 
unknown circuit reducing inhibition into PVH and lPBN. Therefore, with increased 
NTS tone and decreased ARCAgRP activity the satiety signal prevails. AgRP = 
agouti related protein, ARC = arcuate nucleus of the hypothalamus, lPBN = lateral 
parabrachial nucleus, NG = nodose ganglion, NTS = nucleus of the solitary tract, 
PVH = paraventricular nucleus of the hypothalamus. 
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1.3 | Astrocytes 
In addition to neurons, the CNS consists of neuroepithelium-derived macroglia 
and mesoderm-derived microglia. Of the macroglia, astrocytes and 
oligodendrocytes are the predominant cell types. Oligodendrocytes principally 
myelinate axons but can also actively communicate with neurons to ensure 
energy demands of axons are met (Saab et al., 2016). Astrocytes differentiate 
from neural progenitor cells late in prenatal development (i.e. after neurogenesis, 
E10-E16 in mice) and continue to populate the CNS in early postnatal 
development (Molofsky and Deneen, 2015). They likely evolved to meet the 
increased homeostatic and information processing demand of an expanding 
nervous system since their number and functions become greater as the 
complexity of the brain increases (Nedergaard, Ransom and Goldman, 2003; 
Oberheim et al., 2006). Under normal conditions astrocytes tightly control the 
CNS microenvironment by transport and buffering of ions and neurotransmitters 
(Verkhratsky and Nedergaard, 2016). In cases of brain injury or disease 
astrocytes adopt an inflammatory phenotype induced by factors secreted from 
microglia, the brain’s resident macrophages (Liddelow et al., 2017). This appears 
to be a maladaptive response since inflamed astrocytes lose their homeostatic 
functions and promote cell death (Liddelow et al., 2017; Yun et al., 2018). 
Astrocytes are highly ramified glial cells that tile the entire CNS and provide 
structural and metabolic support to neurons. They have small cell bodies relative 
to neurons and typically have ~5 primary processes which highly ramify into 
numerous small processes that contact individual synapses (Ogata and Kosaka, 
2002; Reeves, Shigetomi and Khakh, 2011; Shigetomi et al., 2013). As a result, 
astrocytes occupy a very large volume (or territory) and have minimal overlap 
with other astrocytes, although this varies between brain regions (Ogata and 
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Kosaka, 2002; SheikhBahaei et al., 2018). In addition to contacting neuronal 
synapses, astrocyte processes can contact cerebral blood vessels. These 
processes are referred to as ‘endfeet’. Because of this feature, astrocytes are 
uniquely positioned to contact both synapses and the circulation and have been 
proposed to mediate neurovascular coupling (Zonta et al., 2003). However, in 
vivo evidence does not fully support this since observed and evoked [Ca2+]i 
events in astrocytes do not alter blood vessel diameter in the mouse visual cortex 
(Bonder and McCarthy, 2014) 
1.3.1 | Homeostatic functions of astrocytes 
The best described and understood functions of astrocytes are to maintain ionic 
and chemical homeostasis in the brain. 
For example, one of the main functions of astrocytes is the transport of glutamate 
from the synaptic cleft (Bak, Schousboe and Waagepetersen, 2006). This 
maintains glutamate levels within a narrow range to prevent excitotoxicity and 
preserve the tight temporal fidelity of synaptic transmission. Astrocytes express 
two excitatory amino acid transporters (EAATs). EAAT1 (also known as 
glutamate-aspartate transporter [GLAST]) is predominantly expressed in the 
cerebellum and circumventricular regions. EAAT2 (also known as glutamate 
transporter 1 [GLT-1]) is the major glutamate transporter in the majority of the 
brain parenchyma (Lehre et al., 1995). Once transported into the astrocyte, 
glutamate is rapidly metabolised to glutamine by glutamine synthetase (GS) 
which can then be returned to the presynaptic neuron by low affinity transporters 
(van den Berg and Garfinkel, 1971; Martinez-Hernandez, Bell and Norenberg, 
1977). In the presynaptic neuron glutamine is metabolised back to glutamate and 
can be repackaged into synaptic vesicles and released again. This is known as 
the glutamate-glutamine shuttle (Erecinska and Silver, 1990). 
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Astrocytes are also believed to be the predominant source of lactate in the brain. 
Astrocytes and neurons have distinct cellular metabolism. Astrocytes express an 
enzyme 6-phosphofructo-2-kinase (Pfkfb3), which regulates metabolism of 
glucose by glycolysis (Herrero-Mendez et al., 2009). This provides lactate as a 
fuel for the tricarboxylic acid cycle. Pfkfb3 is absent from neurons explaining their 
low glycolytic rate; neurons cannot utilise glycolysis even under cellular stress 
(Herrero-Mendez et al., 2009). Under normal conditions neurons utilise oxidative 
phosphorylation to generate ATP (Bélanger, Allaman and Magistretti, 2011).  
Due to this apparent cellular compartmentalisation of glucose metabolism within 
the brain, a model has emerged of energetic support of neurons by astrocytes 
termed the astrocyte-neuron lactate shuttle (ANLS) (Pellerin et al., 1998; Pellerin 
and Magistretti, 2012). According to the ANLS model, astrocytes are able to take 
up circulating glucose via glucose transporters (GLUT) expressed on vessel-
contacting endfeet. This glucose is then metabolised to lactate in the astrocyte 
before being released via monocarboxylate transporters (MCT) and absorbed by 
neurons and used for cellular fuel. This model was (Chih, Lipton and Roberts, 
2001) and remains a subject of controversy (Bak and Walls, 2018; Barros and 
Weber, 2018). 
1.3.2 | Ca2+ ionic signalling 
Astrocytes are not generally considered electrically excitable cells since they 
have a hyperpolarised resting membrane potential and show a roughly linear 
membrane potential changes in response to current steps (Lalo et al., 2006; 
Panatier et al., 2011). This meant for some time that they were ignored as 
signalling cells within the brain. However, with concurrent advances in fluorescent 
Ca2+ imaging and astrocyte cell culture in the 1990s it was discovered that in fact 
astrocytes increase their [Ca2+]i in response to exogenously applied glutamate 
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(Cornell-Bell et al., 1990). This finding, initially shown in vitro, has since been 
demonstrated in ex vivo brain slices and crucially in vivo in response to sensory 
stimulation in mice (Porter and McCarthy, 1996; Wang et al., 2006). Thus, this 
provides an ionic mechanism by which astrocytes can sense local synaptic 
activity and raises the possibility that these Ca2+ signals drive a response.  
Since this initial discovery astrocytes in various brain regions have been shown 
to express receptors for, and increase [Ca2+]i in response to, almost all known 
neurotransmitters including the ‘fast’ transmitters glutamate (Wang et al., 2006) 
and GABA (MacVicar et al., 1989). In addition astrocytes have also been shown 
to respond to neuromodulators such as dopamine (Vaarmann, Gandhi and 
Abramov, 2010; Jennings et al., 2017), 5-HT (Schipke, Heuser and Peters, 2011), 
acetylcholine (Araque et al., 2002) and noradrenaline (Duffy and MacVicar, 1995; 
Ding et al., 2013) and non-canonical transmitters like endocannabinoids (Martín 
et al., 2015). 
Astrocyte Ca2+ signalling appears to operate over a diverse range of activity 
(Volterra, Liaudet and Savtchouk, 2014; Bazargani and Attwell, 2016). Large Ca2+ 
transients in the soma and major processes of astrocytes are thought to be 
downstream of Gq-GPCR activation and inositol trisphosphate (IP3) production. 
Activation of Gq-GPCRs on astrocytes with a cocktail of agonists for metabotropic 
glutamate receptors (mGlu-R), histamine receptors and muscarinic acetylcholine 
receptors (mACh-R) induces IP3 production (Petravicz, Fiacco and McCarthy, 
2008). This activates release of Ca2+ from intracellular stores via IP3 receptors 
type 2 (IP3R2) (Petravicz, Fiacco and McCarthy, 2008). Spontaneous and ATP-
evoked somatic Ca2+ elevations are greatly reduced in IP3R2 knock out mice 
while there are no clear alterations in synaptic transmission, neurovascular 
coupling or performance in laboratory behavioural tasks (Petravicz, Fiacco and 
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McCarthy, 2008; Nizar et al., 2013; Bonder and McCarthy, 2014; Petravicz, Boyt 
and McCarthy, 2014). However, this model is a germline knockout model which 
may have some developmental compensatory effects versus an inducible 
knockout model (El-Brolosy and Stainier, 2017). 
In addition to this large-scale slow activity, rapid Ca2+ transients have been 
observed in microdomains of fine astrocyte process and can occur independently 
of somatic activity and other microdomains (Kanemaru et al., 2014). This 
desynchronised, focal activity persists in IP3R2 knockout mice (although with a 
lower amplitude than wild type) and is therefore mechanistically distinct from 
larger, global transients to some degree (Kanemaru et al., 2014; Srinivasan et 
al., 2015). These focal events are observed in response to sensory and synaptic 
stimulation implicating them in neural information processing (Srinivasan et al., 
2015; Bindocci et al., 2017). It has been proposed that focal Ca2+ events in 
astrocytes summate to drive larger global events in a manner analogous to the 
summation of excitatory postsynaptic potentials (EPSPs) to action potentials in 
neurons (Kanemaru et al., 2014; Bazargani and Attwell, 2016). A second 
interesting suggestion is the possibility that astrocytes integrate local synaptic 
activity (represented by focal events) and neuromodulatory tone (driven by 
activation of GPCRs and global events) and act as coincidence detectors or relay 
neuromodulatory signals to active synapses (Bazargani and Attwell, 2017; 
Papouin, Dunphy, et al., 2017). Therefore it appears that [Ca2+]i signalling in 
astrocytes consists of a diverse range of signalling in individual micro domains 
and slower signalling in the soma and across the whole cell (Volterra, Liaudet 
and Savtchouk, 2014; Bazargani and Attwell, 2016). 
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1.3.3 | Gliotransmission and synaptic modulation 
Along with an appreciation for astrocyte Ca2+ dynamics came the concept of 
‘gliotransmission’. Gliotransmission refers to the process whereby astrocytes 
respond to synaptic transmission (e.g. glutamate) by elevating [Ca2+]i which 
causes the release (via vesicular transmission) of neuroactive molecules (termed 
gliotransmitters) that modulate transmission at the synapse (Nedergaard, 1994; 
Parpura et al., 1994; Araque et al., 1999, 2014; Mothet et al., 2005). Further 
studies showed mixed evidence for the existence of gliotransmission under 
physiological conditions (Hamilton and Attwell, 2010; Fiacco and McCarthy, 
2018). For this reason, gliotransmission remains controversial and is publicly 
debated in the pages of Trends in Neurosciences (Wolosker, Balu and Coyle, 
2016, 2017; Papouin, Henneberger, et al., 2017) and The Journal of 
Neuroscience (Fiacco and McCarthy, 2018; Savtchouk and Volterra, 2018). 
Despite this controversy there is good evidence that astrocytes release or control 
extracellular levels of glutamate, D-serine and ATP (Papouin, Dunphy, et al., 
2017; Schwarz et al., 2017; Durkee et al., 2019). The area most studied in this 
context is the cornu Ammonis 1 (CA1) region of the hippocampus, where 
gliotransmitters have been observed to modulate neuronal excitability and 
mediate forms of synaptic plasticity. Stimulation of GPCRs selectively expressed 
on CA1 astrocytes leads to elevated extracellular glutamate which increases the 
frequency of NMDAR-dependent slow inward currents in CA1 neurons that 
increase neuronal excitability (Durkee et al., 2019). Secondly, D-serine (a co-
agonist of the NMDAR) is released from CA1 astrocytes which enhances long 
term potentiation (Papouin, Dunphy, et al., 2017; Adamsky et al., 2018; Robin et 
al., 2018). The third major gliotransmitter is ATP, which is rapidly converted in the 
synapse to adenosine. In CA1, stimulation of astrocytes by Ca2+ uncaging 
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depresses synaptic transmission at some synapses by activation of neuronal 
adenosine receptors (Covelo and Araque, 2018). This mechanism potentially 
improves the specificity of long term potentiation (Covelo and Araque, 2018). This 
shows that selective manipulation of astrocytes alters the availability of 
gliotransmitters at synapses to modulate neuronal activity and information 
processing. 
1.3.4 | Astrocyte structural plasticity 
Astrocytes throughout the brain show dynamic expression of the cytoskeletal glial 
fibrillary acidic protein (GFAP), which is regulated in response to local variations 
in the brain microenvironment (Hajós and Kálmán, 1989; Kálmán and Hajós, 
1989; Li et al., 2020). For example, cortical astrocytes show low basal GFAP 
expression but dramatically upregulate this protein in response to tissue injury 
suggesting that this change serves as a reactive and possibly neuroprotective 
role (Hirrlinger et al., 2006). Since GFAP forms intermediate filaments that make 
up the astrocyte cytoskeleton, changes in its expression result in altered 
morphology and increased branching of the cells. Precisely how this 
morphological change relates to cell function is still unclear, but it may allow 
dynamic ensheathment of synapses. Broadly speaking, high GFAP expression 
and branched morphology is considered to be indicative of astrocyte activation 
(also known in some pathophysiological cases as astrogliosis) (Sofroniew, 2015). 
1.4 | Hypothalamic astrocytes and feeding behaviour  
Given that astrocytes regulate neuronal activity by sensing neurotransmitters and 
altering both homeostatic and active processes accordingly, it is unsurprising that 
astrocytes in the ARC and wider hypothalamus are regulated by changes in food 
intake. In turn, it appears their response to changes in food intake alters the 
activity of ARCAgRP and ARCPOMC neurons to restore energy balance. 
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Astrocyte activation (commonly measured by GFAP immunoreactivity) reflects 
energy states in genetically obese and diet induced obese (DIO; chronic feeding 
of only a high fat diet typically over a number of weeks) mice and rats (Horvath 
et al., 2010; Thaler et al., 2012; Buckman et al., 2013; Douglass et al., 2017). 
ARC GFAP gene expression and astrocytic ensheathment of ARCPOMC neurons 
is increased in DIO rats (Horvath et al., 2010). In these rats this large number of 
astrocyte contacts on ARCPOMC cell bodies is accompanied by a decrease in the 
number of synaptic inputs to these cells (Horvath et al., 2010). This may impair 
synaptic integration in ARCPOMC and thus reduced neural activity critical for the 
inhibition of food intake, biasing the rats towards eating.  
Following this seminal study, other groups demonstrated that DIO mice and rats 
show an increase in GFAP expression (both at the gene and protein level) and 
altered morphology of astrocytes in the ARC and other hypothalamic nuclei 
(Thaler et al., 2012; Buckman et al., 2013). Hypothalamic astrogliosis is also seen 
in Mc4r-/- mice which become obese on standard chow diet due to excess food 
intake, suggesting that the gliosis can occur because of obesity in the absence 
of high-fat diet consumption (Buckman et al., 2013). Returning DIO mice to a 
standard chow diet results in weight loss and reversal of the astrogliosis, 
highlighting the plastic nature of this response (Berkseth et al., 2014).  
The physiological significance of these changes is reinforced by studies 
indicating that inducing inflammatory signalling by stimulating the nuclear factor 
kappa B (NF-κB) pathway selectively in astrocytes results in obesity, while 
preventing inflammation by suppressing the same pathway preserves astrocytic 
function, protecting against weight gain on a high fat diet (Zhang et al., 2017). 
Supporting this supposition, brain-wide inhibition of astrocyte NF-κB signalling 
during the induction of DIO is protective against hypothalamic inflammation and 
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prevents subsequent weight gain (Douglass et al., 2017). Together, these studies 
implicate astrocyte inflammatory processes, under the control of the NF-κB 
pathway, in the development and maintenance of DIO. This could potentially be 
mediated by a loss of homeostatic functions and structural plasticity in chronically 
activated astrocytes (Liddelow et al., 2017; Zhang et al., 2017). 
While supportive evidence for obesity-associated glial changes from human 
studies is limited, there is a positive correlation between body mass index and 
signatures of hypothalamic gliosis, measured by image hyper-intensity in 
magnetic resonance imaging scans (Thaler et al., 2012), suggesting that the 
obesity-associated changes seen in rodents are present in humans.  
The response of hypothalamic astrocytes in rodents to a high-fat diet appears to 
be biphasic: there is an initial increase in expression of GFAP and pro-
inflammatory markers during the first 24-72h on a high-fat diet, which then 
transiently subsides before returning after 14 days on the diet (Thaler et al., 2012; 
Buckman et al., 2015; Balland and Cowley, 2017). Inhibition of astrocyte NF-κB 
mediated inflammatory signalling in mice during the initial phase of high-fat 
feeding (24 hours) abolishes diet-associated changes in hypothalamic GFAP 
expression and augments high-fat diet-induced binge eating (Buckman et al., 
2015). This has led to the suggestion that the initial phase of astrogliosis is partly 
a homeostatic physiological response to maintain energy balance while the 
second inflammatory phase is a pathophysiological response to prolonged 
energy imbalance.  
Further evidence for a role of astrocytes in the physiological response to energy 
variation comes from experiments where mice are pushed out of homeostasis 
into negative energy balance by fasting. In fasted rats there is a greater 
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expression of GFAP in the hypothalamus when compared with ad libitum fed 
controls (Fuente-Martín et al., 2012). In mice fasting results in changes to the 
primary (GFAP immunoreactive) and fine (GFAP negative) astrocytic cytoskeletal 
processes in the ARC (N. Chen et al., 2016; Zhang et al., 2017). Taken together 
these studies indicate that hypothalamic astrocytes are sensitive to acute 
deviations in energy homeostasis. 
In common with ARC neurons, ARC astrocytes can directly sense and respond 
to appetite-modulating hormones via receptors expressed on their surface. 
Astrocytes neighbouring the 3V express LepRb and this expression is increased 
in obese mice (Cheunsuang and Morris, 2005; Pan et al., 2008; Hsuchou et al., 
2009). Functional studies indicate that chronic (14 day) i.c.v delivery of 
exogenous leptin increases hypothalamic expression of GFAP and increases 
astrocyte process length in rats (García-Cáceres et al., 2011). The same 
treatment also reduces expression of synaptic proteins, suggesting increased 
glial ensheathment of neurons obstructs synapse formation, which may impair 
integration of feeding cues by these neurons (García-Cáceres et al., 2011). I.c.v 
delivery of leptin for 14 days in mice decreases the expression of astrocyte 
glucose and glutamate transporters in the hypothalamus, possibly leading to 
elevated synaptic glutamate which may further disrupt synaptic transmission in 
this key brain region (Fuente-Martín et al., 2012).  
Selective inducible deletion of LepRb from astrocytes in adult mice revealed 
reduced ensheathment of ARC neurons by astrocytes (Kim et al., 2014). In 
accordance with this, these mice showed reduced sensitivity to leptin and 
increased sensitivity to ghrelin (Kim et al., 2014). These results suggest LepRb 
on astrocytes are crucial for anatomical wiring of ARCAgRP and ARCPOMC circuits 
and that this wiring ensures appropriate responses to endocrine signals that 
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modulate food intake. These data are supported by evidence from a second 
mouse model with germline astrocyte-specific deletion of leptin receptors which 
shows an increased body-weight and fat-mass gain on a high fat diet, 
accompanied by greater hypothalamic leptin resistance and increased gliosis 
compared with wild-type controls (Y. Wang et al., 2015). This suggests the action 
of leptin on astrocytes is protective against obesity in mice. 
Like leptin, i.c.v treatment with the orexigenic hormone ghrelin regulates the 
expression of a number of proteins expressed by hypothalamic astrocytes 
including structural proteins (GFAP) and transporters (glucose and glutamate 
transporters) (Fuente-Martín et al., 2016). Immunohistochemical staining 
identifies GHSR-1A co-localised with GFAP in the rat ARC (Fuente-Martín et al., 
2016).  
Together these studies on leptin and ghrelin provide evidence that in addition to 
ARC neurons, ARC astrocytes are direct sensors of endocrine signals regulating 
energy balance and they may mediate, at least in part, some of the physiological 
effects of these hormones in the CNS. 
The application of chemogenetic technologies for manipulation of ARC astrocyte 
signalling has provided causal evidence for activation of these cells modulating 
ARCAgRP and ARCPOMC neurons and correspondingly, feeding behaviour. In 2015, 
Yang and colleagues reported that chemogenetic activation of Ca2+ signalling via 
a Gq-GPCR (hM3Dq) in ARC astrocytes caused a decrease in both nocturnal 
and ghrelin-induced food intake while enhancing the satiating effects of leptin 
(Yang, Qi and Yang, 2015). Their work suggests this was mediated by astrocyte-
derived adenosine inhibiting ARCAgRP neurons via activation of adenosine A1 
receptors (Yang, Qi and Yang, 2015). However, the effect of ARC astrocyte 
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activation appears to be state-dependent since during the light phase, when mice 
are typically satiated, chemogenetic activation of ARC astrocytes increased food 
intake (Yang, Qi and Yang, 2015). A second independent research group, 
employing a similar hM3Dq chemogenetic methodology, similarly found that 
activating Ca2+ signalling in hypothalamic astrocytes increased food intake during 
the light phase (N. Chen et al., 2016). This was due to a general activation of 
neighbouring neurons. Due to the circuit architecture in the ARC (i.e. ARCAgRP 
neurons inhibit ARCPOMC neurons), chemogenetic astrocyte activation led to 
excitation of ARCAgRP neurons relative to ARCPOMC (N. Chen et al., 2016).  
This suggests that the effects of ARC astrocyte activation on feeding behaviour 
may be dependent on the current state of ARCAgRP and ARCPOMC circuitry. If 
ARCAgRP activity drives feeding during the dark phase then artificial 
(chemogenetic) ARC astrocyte activation inhibits this to suppress feeding (Yang, 
Qi and Yang, 2015). While in satiated mice, where ARCAgRP neuron activity is 
lower and ARCPOMC dominates (Chen et al., 2015), chemogenetic activation of 
ARC astrocytes stimulates ARCAgRP resulting in inhibition of ARCPOMC and driving 
food intake (N. Chen et al., 2016). This is consistent with the hypothesis that the 
endogenous function of ARC astrocyte activation is to restore energy balance 
(Buckman et al., 2015) since with chemogenetic activation these ARC circuits are 
‘reset’ (i.e. the action of the dominant population at the time of activation is 
inhibited). 
In summary, astrocytes in the ARC are responsive to short-term and prolonged 
deviations in energy homeostasis. These cells can directly sense appetite-
regulating hormones and adjust their morphology, expression of transporters, 
and potentially release of gliotransmitters accordingly, to alter the firing of 
neurons that control food intake. Prolonged astrocyte activation in diet-induced 
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and genetic obesity may be a maladaptive, pathophysiological response that 
impairs the function of ARC feeding circuits. In contrast, short-term activation 
induced by fasting or acute intake of a high fat diet may exist to help restore 
energy balance as evidenced by the state-dependent effects of chemogenetic 
ARC astrocyte activation (Figure 1.4.1). 
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Figure 1.4.1 | Schematic summary of potential homeostatic and 
maladaptive responses of ARC astrocytes to short and long term deviations 
in energy balance. a, Astrocytes in the ARC alter their cytoskeletal morphology, 
expression of transporter proteins and potentially gliotransmitter release in 
response to acute deviations in food intake. Inhibition of this process exacerbates 
acute high fat diet intake while mimicking astrocyte activation with chemogenetics 
drives ARC circuit dynamics towards homeostasis. b, In diet induced obesity 
hypothalamic astrocytes show chronic inflammation. This disrupts their normal 
function and alters synaptic contacts on ARC neurons. This may lead to impaired 
signal integration in these neurons and preventing appropriate homeostatic 
control of food intake. AgRP = agouti related protein, ARC = arcuate nucleus, 
POMC = proopiomelanocortin. 
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1.5 | NTS astrocytes 
In contrast to the ARC, extrahypothalamic astrocytes have not been extensively 
studied in the control of food intake. Since astrocytes are of growing interest in 
understanding neural control of food intake and the NTS is the major brain area 
outside the hypothalamus that regulates food intake, we now consider the 
evidence that astrocytes in the NTS and wider DVC might regulate synaptic 
activity. Much is known about these cells in the context of cardiorespiratory 
physiology, but their potential role in regulating food intake is relatively 
understudied. 
1.5.1 | Astrocytes modulate synaptic transmission in the NTS 
Synaptic transmission between vagal afferent terminals and second-order 
viscerosensory neurons allows for the appropriate autonomic and behavioural 
response to physiological challenges. Vagal afferents entering the NTS via the 
ST release glutamate onto postsynaptic neurons (Andresen and Yang, 1990). 
This can be modelled experimentally in ex vivo brain slices where electrical 
stimulation of the ST produces short-latency, glutamate-mediated, EPSCs in 
second-order NTS neurons (Doyle and Andresen, 2001; Doyle et al., 2004). 
Astrocytes ensheathe glutamatergic synapses in the NTS providing structural 
evidence for a role in synaptic transmission (Chounlamountry and Kessler, 2011). 
Indeed, several functional studies (described below) have demonstrated that 
astrocytes are critically involved in this process.  
NTS astrocytes express Ca2+ permeable AMPA receptors (AMPA-R). Using Ca2+ 
imaging from astrocytes and neurons in ex vivo NTS rat brain slices, McDougal 
and colleagues demonstrated that astrocytes can detect glutamate released 
following electrical ST stimulation and respond with increases in [Ca2+]i, both from 
extra- and intracellular sources (McDougal, Hermann and Rogers, 2011). This 
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ST stimulation evokes activation of AMPA-R on astrocytes allowing Ca2+ influx to 
the cell, which drives Ca2+-induced Ca2+-release, further increasing [Ca2+]i via 
liberation from intracellular stores. These ST-evoked astrocyte [Ca2+]i elevations 
are sensitive to the AMPA-R antagonist NBQX but not antagonists for mGlu-R 1 
or 5 nor NMDA-R (McDougal, Hermann and Rogers, 2011). Further supporting a 
role for astrocytic AMPA-R in integrating information encoded by the ST, in a 
separate study ST stimulation evoked time-locked, inward currents in astrocytes 
that were abolished by the AMPA-R antagonist DNQX (Accorsi-Mendonça et al., 
2013). Although not directly assessed, presumably these currents represent Ca2+ 
entering the cell. These studies show that NTS astrocytes are sensitive to 
incoming signals from the periphery via vagal afferent glutamate detection. 
In addition to sensing ST-derived glutamate, astrocytes also contribute to 
transmission across the ST-NTS neuron synapse as evaluated using a 
pharmacological inhibition approach. It is thought that astrocyte function can be 
selectively inhibited with fluoroacetate (FAC) and its gliotoxic metabolite 
fluorocitrate (FC). FC inhibits the TCA cycle and both FC and FAC preferentially 
effect astrocytes (Fonnum, Johnsen and Hassel, 1997). This is said to be due to 
the tendency of astrocytes and not neurons to take up and utilize acetate for 
cellular metabolism (Wyss et al., 2011). The specificity of FC and FAC for 
astrocytes is assumed but not conclusively proven and therefore, results using 
this technique should be interpreted with caution in the absence of additional 
supporting evidence.  
In the presence of FAC, both ST-evoked EPSC amplitude and spontaneous 
EPSC frequency are reduced in NTS neurons that project to the ventrolateral 
medulla (VLM) (Accorsi-Mendonça et al., 2013). This tonic, astrocytic contribution 
to synaptic transmission is likely mediated by release of ATP since antagonism 
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of P2X purinergic receptors with the broad-spectrum antagonist iso-PPADS 
recapitulates the effect of FAC, but the two do not have additive effects (Accorsi-
Mendonça et al., 2013). Furthermore, an increase in extracellular ATP observed 
in this study following ST-stimulation was reduced by FAC.  
Evidence also suggests that astrocytes can restrain neuronal excitability directly 
in NTS neurons; astrocyte inhibition with FAC reduces the NTS neuronal A-type 
potassium current (IKA) (Accorsi-Mendonca et al., 2015). Under normal 
conditions, this outward potassium current present at the beginning of the initial 
depolarisation acts to restrain neuronal action potential threshold and firing. While 
the underlying mechanism has not yet been fully explored in the NTS, in the 
hypothalamus IKA is inhibited when astrocytic glutamate uptake is reduced due 
to activation of extra-synaptic NMDA-Rs (Naskar and Stern, 2014). In 
postsynaptic neurons, ST-evoked AMPA EPSC amplitude is lower from brain 
slices in the presence of FAC while ST-evoked NMDA EPSC amplitude is greater 
(Accorsi-Mendonça, Bonagamba and Machado, 2019). This demonstrates that 
astrocytes provide tonic neuromodulation which has inverse effects on signalling 
via the two main types of ionotropic glutamate receptor. 
A second mechanism by which astrocytes may support ST-NTS 
neurotransmission is by active supply of the metabolite lactate (Nagase et al., 
2014). As discussed above (section 1.2.1), it has been proposed that in the brain, 
glucose is the main fuel source for astrocytes which metabolise this fuel to lactate. 
Astrocyte-derived lactate is then shuttled via monocarboyxlate transporters 
(MCTs) to neurons where it is metabolised to pyruvate and used to fuel the TCA 
cycle (Pellerin et al., 1998; Pellerin and Magistretti, 2012). When MCTs are 
pharmacologically inhibited with 4-CIN, phloretin or D-lactate in rat NTS brain 
slices, the amplitude of ST-evoked neuronal EPSCs is reduced. Since this effect 
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is rescued by providing extracellular lactate it was concluded that ST-NTS 
synaptic fidelity is reliant on lactate from astrocytes transported through MCTs on 
astrocytes and neurons (Nagase et al., 2014). 
A further mechanism by which astrocytes may modulate ST-NTS 
neurotransmission is by regulating synaptic glutamate availability. In the NTS 
astrocytic glutamate reuptake appears to be essential for normal synaptic 
function (Matott et al., 2016; Matott, Kline and Hasser, 2017; Yamamoto and 
Mifflin, 2018). Pharmacological blockade of both EAAT1 and EAAT2 with DL-
threo-β-benzyloxyaspartic acid (TBOA) elevates synaptic glutamate as 
evidenced by NTS neuronal depolarisation and action potential firing, and 
increased spontaneous EPSCs (Matott et al., 2016). Furthermore, in NTS 
neurons ST-evoked EPSCs are reduced by TBOA suggesting released 
glutamate is not being returned to the presynaptic terminal or that excess 
glutamate is activating presynaptic mGlu-Rs and suppressing transmission by 
negative feedback (Matott et al., 2016). These effects can be recapitulated by 
dihydrokainate (DHK), an EAAT2 blocker (Matott, Kline and Hasser, 2017; 
Yamamoto and Mifflin, 2018). In combination with immunohistochemical 
evidence (Chounlamountry and Kessler, 2011), this indicates that EAAT2 is the 
primary glutamate transporter responsible for glutamate reuptake and recycling 
at the ST-NTS synapse (Matott, Kline and Hasser, 2017; Yamamoto and Mifflin, 
2018).  
Taken together, this combined evidence from a number of independent research 
groups shows that astrocytes support synaptic transmission in the NTS by 
buffering and recycling synaptic glutamate (Matott et al., 2016; Matott, Kline and 
Hasser, 2017; Yamamoto and Mifflin, 2018), shuttling lactate to neurons (Nagase 
et al., 2014) and providing tonic purinergic neuromodulation (Accorsi-Mendonça 
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et al., 2013; Accorsi-Mendonca et al., 2015) (Figure 1.5.1). Interestingly, 
astrocytes are also able to directly detect vagal glutamate release (McDougal, 
Hermann and Rogers, 2011). This raises the possibility that astrocytes modulate 
their functions in response to increased vagal input making them key integrators 
of information at this important integrative site. To date this has not been 
investigated in the context of the systemic regulation of energy homeostasis. 
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Figure 1.5.1 | A simplified schematic of astrocyte modulation of synaptic 
transmission in the NTS. (1) Astrocytes respond to synaptic glutamate via 
AMPA-receptors (AMPA-R) expressed on the cell surface. (2) Astrocytes clear 
glutamate from the synapse to restrain neuronal firing and maintain presynaptic 
glutamate levels via EAAT2. (3) Astrocytes provide fuel to neurons in the form of 
lactate in order to maintain fidelity of synaptic transmission. (4) Astrocytes provide 
tonic modulation to synaptic transmission in the form of purinergic 
gliotransmission (release of ATP which may be converted to adenosine in the 
synaptic cleft). (5) By controlling extracellular glutamate levels astrocytes may 
modulate the presence of the NMDA-R regulated a-type potassium current (IKA) 
which restrains action potential firing. Abbreviations: Ado = adenosine, ATP = 
adenosine triphosphate, EAAT2 = excitatory amino acid transporter 2, MCT = 
monocarboxylate transporter, NTS= nucleus of the solitary tract, ST = solitary 
tract, VGKC = voltage gated potassium channel. 
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1.5.2 | Physiological and environmental stimuli modulate the morphology of NTS 
astrocytes 
In hypothalamus and other brain areas, expression of GFAP and astrocyte 
morphology is dynamic (Hirrlinger et al., 2006; N. Chen et al., 2016; Zhang et al., 
2017; Li et al., 2020). This is also true of the NTS. Notably within the NTS of rats, 
astrocytes are smaller, have a simpler morphology and greater overlapping 
domains than other brainstem autonomic nuclei (SheikhBahaei et al., 2018). 
Several studies have reported that NTS GFAP expression, commonly measured 
using immunoreactivity, is modulated by different experimental stimuli (Table 
1.5.1). For example, hypoxic conditions for 1 to 24 hours induced either by 
inhalation of ozone gas or low oxygen air increase GFAP immunoreactivity and 
astrocyte ensheathment of synapses within the caudal NTS in rats and mice 
(Araneda et al., 2008; Tadmouri, Champagnat and Morin-Surun, 2014; 
Chounlamountry et al., 2015; Stokes et al., 2017; De La Zerda et al., 2018). This 
effect may be secondary to activation of microglia since inhibition of microglia 
with minocycline attenuates the GFAP response to hypoxia (Stokes et al., 2017). 
Taken together this suggests that caudal NTS astrocytes are responsive to low 
oxygen are may be involved in mediating the central response to hypoxia (see 
section 1.5.3). 
In addition, NTS GFAP expression is regulated in a diverse range of disease 
models associated with inflammation (Table 1.5.1) (Ebel, Torkilsen and 
Ostrowski, 2017; Tsai et al., 2017; Fernandes-Junior et al., 2018; Melo et al., 
2019). In these studies, the authors report autonomic dysfunction phenotypes 
coincident with increased NTS GFAP immunoreactivity. Correlational evidence 
does not reveal whether this observed astrocyte plasticity is a cause of, a 
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consequence of or unrelated to the physiological phenotypes displayed by these 
models. 
In addition to those outlined above, a number of other studies have shown 
dynamic regulation of NTS astrocytes (Jacquin et al., 2000; Biondo et al., 2004; 
Alonso et al., 2007; Wu, Howell and Palmiter, 2008; Hermann and Rogers, 2009; 
Bartel, 2012; Hardy et al., 2018; Machaalani et al., 2019). While not discussed 
here, these are summarised in Table 1.5.1. Thus, taken together these studies 
show that GFAP expression is highly plastic in the NTS and is regulated by a 
myriad of stimuli. Future studies are needed to address the physiological 
consequences of this GFAP regulation, if/how NTS astrocytes differentiate 
between stimuli of different modalities, and how this mechanistically relates to 
other astrocyte functions. 
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Stimulus Outcome Species Ref 
Ozone 
inhalation (3 
hours) 
Greater VEGF expression in NTS 
astrocytes than normoxic controls, 
increased branching 
Rat (Araneda 
et al., 
2008) 
Ozone 
inhalation (24 
hours) 
Greater glial coverage of synapses in 
NTS compared with untreated 
controls 
Rat (Chounla
mountry 
et al., 
2015) 
10% Oxygen 
inhalation 
Greater NTS GFAP immunoreactivity 
(1 and 6 hours, compared with 
normoxic controls) 
Mouse (Tadmouri
et al., 
2014) 
10% Oxygen 
inhalation 
Greater GFAP immunoreactivity in 
NTS (4 and 24 hours, compared with 
normoxic controls) 
Rat (Stokes et 
al., 2017) 
10% Oxygen 
inhalation 
Greater GFAP immunoreactivity in 
NTS after 10 days compared with 
normoxic controls 
Rat (De La 
Zerda et 
al., 2018) 
TAA injection 
(liver damage 
model) 
Greater number of GFAP expressing 
cells in NTS compared with vehicle 
injected controls 
Rat (Tsai et 
al., 2017) 
Lateral 
ventricle STZ 
(neurodegen
eration 
model) 
Greater S100b immunoreactivity in 
commisural NTS compared with 
vehicle injected controls 
Rat (Ebel et 
al., 2017) 
Intrastriatal 6-
OHDA 
injection 
(Parkinsonian 
model) 
Lower GFAP immunoreactivity in 
NTS after 60 days compared with 
shorter durations 
Rat (Fernande
s-Junior et 
al., 2018) 
Two-kidney 
1-clip 
hypertension 
Greater  number of GFAP-positive 
pixels in NTS than in normotensive 
controls 
Rat (Melo et 
al., 2019) 
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Isoproterenol 
induced 
water 
drinking 
No difference in GFAP 
immunoreactivity in NTS 
Rat (Hardy et 
al., 2018) 
Age Greater GFAP immunoreactivity in 
NTS of aged (24 months) than young 
(6 months)  
Rat (Hardy et 
al., 2018) 
Prenatal (E11 
or E16) X-
irradiation 
Greater number of GFAP expressing 
cells in NTS at P7-14 for E11 
irradiated pups 
Rat (Jacquin 
et al., 
2000) 
Prenatal 
cigarette 
smoke 
inhalation 
No difference in GFAP 
immunoreactivity in NTS compared 
with non-exposed pups 
Mouse (Machaala
ni et al., 
2019) 
Sudden 
infant death 
syndrome 
Greater GFAP-positive cell density in 
NTS from SIDS victims than age-
matched controls 
Human (Biondo et 
al., 2004) 
Chronic 
morphine 
treatment 
Greater GFAP-positive cell density in 
NTS than vehicle treated 
Rat (Alonso et 
al., 2007) 
AgRP neuron 
ablation 
Greater  number of GFAP-positive 
pixels in NTS than control mice 
Mouse (Wu et al., 
2008) 
DVC tumor 
necrosis 
factor-α 
treatment 
Greater c-FOS expression by NTS 
astrocytes than vehicle injected 
controls 
Rat (Hermann 
and 
Rogers, 
2009) 
Unilateral 
chorda 
tympani 
nerve crush 
Greater GFAP immunoreactivity in 
rostral NTS compared with uninjured 
controls 
Mouse (Bartel, 
2012) 
 
Table 1.5.1 | Summary of studies which have examined impact of 
experimental manipulations on NTS astrocyte immunoreactivity and/or 
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morphology. 6-OHDA = 6-hydroxy-dopamine, AgRP = agouti-related protein, 
DVC = dorsal vagal complex, E = embryonic day, GFAP = glial fibrillary acidic 
protein, NTS = nucleus of the solitary tract, P = postnatal day, SIDS = sudden 
infant death syndrome, STZ = streptozotocin, TAA = thioacetamide, VEGF = 
vascular endothelial growth factor. 
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1.5.3 | Regulation of cardiorespiratory physiology by NTS astrocytes 
In addition to regulating food intake, the most caudal portion of the NTS is the 
initial CNS detector of cardiovascular parameters (Machado, 2001; Accorsi-
Mendonça and Machado, 2013). Specifically, peripheral baroreceptors in the 
aortic arch detect increases in arterial pressure and increase vagal tone into the 
NTS (Min et al., 2019). This NTS signal drives a corresponding decrease in heart 
rate and arterial pressure. This process is known as the baroreflex. The NTS also 
receives input from peripheral chemosensors which monitor blood O2 allowing for 
compensatory homeostatic chemoreflex responses to deviations in O2 or CO2 
(Accorsi-Mendonça and Machado, 2013).  
In a rat model of hypertension GFAP immunoreactivity is elevated in the caudal 
NTS (Melo et al., 2019), suggesting an astrocytic component to the physiological 
response. Indeed, functional work involving pharmacological manipulation of 
NTS astrocytes has shown this to be the case. Saporins are toxic agents that, in 
their unconjugated form, selectively kill astrocytes when delivered to the rat NTS 
(Lin et al., 2013). This ablation has severe consequences for cardiovascular 
function: lowering of 1) baroreflex sensitivity, 2) cardiopulmonary reflex sensitivity 
and 3) chemoreflex sensitivity. This suggests loss of correct physiological 
integration of peripheral cues by the NTS in these animals (Lin et al., 2013). Rats 
with NTS astrocyte ablation show large variations in arterial pressure also 
indicative of poor cardiovascular reflex control. Critically, these rats show damage 
to their myocardium and in some cases die due to sudden cardiac arrest (Lin et 
al., 2013). This failure of central cardiovascular control appears to be mediated 
by a loss of glutamate sensitivity since cardiovascular responses to NTS delivery 
of glutamate receptor agonists, AMPA and NMDA, are attenuated in NTS saporin 
treated rats (Talman, Dragon and Lin, 2017).  
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Recent evidence from a manuscript preprint posted on the server bioRxiv 
(therefore as yet not peer-reviewed), shows that astrocytes may fine-tune the 
baroreflex in rats (Mastitskaya et al., 2019). The study utilised an adeno-
associated viral (AAV) vector approach which allowed for TeLC to be selectively 
expressed by NTS astrocytes in vivo. This blocks vesicular release from 
astrocytes, but in contrast to saporin ablation spares the metabolic and structural 
functions of these cells. In awake rats expressing TeLC in NTS astrocytes the 
sensitivity of the baroreflex to spontaneous changes in arterial pressure is 
reduced compared to those expressing a control construct. Furthermore, in 
anaesthetised rats delivery of the P2Y1 antagonist MDS-2500 to the NTS also 
increases baroreflex response initiated by the α1-adrenergic receptor agonist 
phenylephrine (Mastitskaya et al., 2019). As with some other NTS mediated 
physiological responses (discussed below), this suggests that under normal 
conditions astrocytes modulate baroreflex sensitivity via purinergic signalling. 
In line with their role in integrating activity at the ST-NTS synapse, glutamate 
reuptake and recycling by NTS astrocytes is crucial for cardiovascular function. 
Blockade of all EAATs (by TBOA) or only EAAT2 (by DHK) causes cardiac 
depression and reduced baroreflex response to phenylephrine in rats (Matott et 
al., 2016; Matott, Kline and Hasser, 2017; Yamamoto and Mifflin, 2018). This 
effect is blocked by an AMPA-R antagonist suggesting that under normal 
conditions NTS astrocytes sequester synaptic glutamate in order to regulate NTS 
neuronal activity and resulting output from DMX neurons to the cardiorespiratory 
system (Matott, Kline and Hasser, 2017; Yamamoto and Mifflin, 2018). 
Under hypoxic conditions, chemoreflex responses are engaged which initiate 
compensatory increases in respiratory and heart rate. This effect persists even 
when animals are returned to normoxia, suggesting some central adaptation to 
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the low oxygen environment (Powell and Fu, 2008). In rats and mice, NTS 
astrocytes respond to the initial phase of hypoxia with an increase in GFAP 
immunoreactivity within 1-24 hours (Tadmouri, Champagnat and Morin-Surun, 
2014; Stokes et al., 2017). At the synaptic level, sustained hypoxia causes 
adaptations in the rat NTS: increased postsynaptic excitability mediated by 
decreased expression of IKA and greater amplitude NMDA and AMPA currents 
evoked by ST stimulation (Accorsi-Mendonca et al., 2015; Accorsi-Mendonça, 
Bonagamba and Machado, 2019). Importantly, inhibition of astrocytes with FAC 
recapitulates these effects in brain slices from hypoxia naïve rats, suggesting that 
reduced astrocyte modulation of synaptic transmission may be an adaptive 
mechanism to increase neuronal sensitivity and drive respiration in sustained 
hypoxia. In support of this, treatment with FAC produces no further decrease in 
IKA, NMDA or AMPA currents in brain slices from rats which received sustained 
hypoxia, indicating a ceiling effect (Accorsi-Mendonca et al., 2015; Accorsi-
Mendonça, Bonagamba and Machado, 2019). 
Together these studies illustrate the necessity for tight control of synaptic 
glutamate in the NTS to maintain cardiorespiratory function, and the importance 
of astrocytes in this process. Furthermore, the published studies on adaptation to 
hypoxia suggest that astrocytes adapt to compensate for changes physiological 
need. 
1.5.4 | Regulation of blood glucose and the counter-regulatory response by NTS 
astrocytes 
Orchestrated in part by the brain, the counter-regulatory response to 
hypoglycaemia (CRR) is initiated when blood glucose falls below the normal 
euglycemic range and is a multifaceted hormonal and neuronal response to 
restore blood glucose. The NTS is thought to be a critical site for the central 
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glucose detection and initiation of the  CRR (Ritter et al., 2011). Activation of a 
subpopulation NTS neurons in response to low glucose drives compensatory 
feeding and hepatic glucose production (Ritter et al., 2011; Boychuk et al., 2019; 
Aklan et al., 2020).  
In rat brain slices, 40% of NTS astrocytes increase their [Ca2+]i in response to low 
extracellular glucose (0.1 mM) or the non-metabolisable glucose analogue 2-
deoxyglucose (2-DG; a glucoprivic agent) indicating the glucose-sensitivity of 
these cells (McDougal, Hermann and Rogers, 2013). Delivery of 2-DG directly 
into the 4V increases blood glucose in anaesthetised rats; indicating that local 
reductions in brainstem glucose level are sufficient to drive compensatory 
changes in glucose homeostasis (Rogers, Ritter and Hermann, 2016). This blood 
glucose elevation is blocked by general inhibition of NTS astrocyte activity using 
FC delivered to the 4V or more specifically by the A1 adenosine-receptor 
antagonist DPCPX. This indicates that astrocyte-derived adenosine is a 
component in the detection and response to this glucoprivic stimulus (Rogers, 
Ritter and Hermann, 2016).  
Of critical importance to the CRR are a subpopulation (around 20%) of NTSTH 
neurons. In brain slices from mice, the Ca2+ response of NTSTH neurons to 2-DG 
is abolished by pre-treatment with either FC or the broad spectrum P2 purinergic 
receptor antagonist suramin (Rogers et al., 2018). The glucose transporter 
GLUT2 is a proposed glucose sensing protein and accordingly blockade of 
GLUT2 with quercetin abolishes astrocyte Ca2+ responses to low extracellular 
glucose and 2-DG in rat brain slices (Rogers et al., 2019). Consequently, it 
appears that NTS astrocytes are glucose sensors that in hypoglycaemic 
conditions relay this signal to, and/or enhance intrinsic glucose sensitivity of 
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NTSTH neurons via purinergic gliotransmission in order to drive the appropriate 
CRR.  
Therefore, it appears that in concert with glucose-inhibited NTS neurons, 
astrocytes in the NTS are involved in sensing low tissue glucose levels. Indeed 
the temporal response in rat and mouse brain slices suggests that NTS 
astrocytes are a primary detector of low glucose and may enhance responses of 
NTSTH neurons to low glucose at least in this experimental paradigm (McDougal, 
Hermann and Rogers, 2013; Rogers et al., 2018). 
1.5.5 | Regulation of food intake by NTS astrocytes 
There is a large body of evidence implicating NTS neurons in the integration of 
viscerosensory signals from the stomach and gastrointestinal tract, including 
encoding of satiety and meal termination (see Section 1.2.2.1). A role for 
astrocytes in this process has only recently began to be investigated. Reiner and 
colleagues investigated astrocytes as components of the GLP1 signalling system 
(Reiner et al., 2016). As discussed above, NTSPPG neurons are the sole source 
of brain GLP1 while GLP1-R is distributed at restricted sites throughout the brain 
(Llewellyn-Smith et al., 2011; Cork et al., 2015; Holt, Richards, et al., 2019). Both 
chemogenetic activation of NTSPPG neurons and direct delivery of GLP1 to the 
brain reduce food intake (Turton et al., 1996; Gaykema et al., 2017; Shi et al., 
2017; Holt, Richards, et al., 2019).  
In rats, peripheral or 4V injection of a fluorescent GLP1-R agonist (fluoro-exendin-
4) revealed binding to GLP1-Rs on both NTS neurons and astrocytes, an effect 
that is reduced by pre-treatment with a GLP1-R antagonist (Reiner et al., 2016). 
This is further supported by the finding that exendin-4 causes an increase in 
[Ca2+]i in 40% of NTS astrocytes in rat brain slices. Critically, NTS pre-treatment 
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with FC abolishes the inhibitory effect of exendin-4 directly delivered to the NTS 
on food intake. Taken together, these data suggest that NTS astrocytes are a 
component of the central GLP1 satiety system, although the molecular 
mechanism by which they exert their effects has not been fully investigated 
(Reiner et al., 2016). 
Although fluoro-exendin-4 binds to astrocytes in the rat NTS (Reiner et al., 2016), 
observations from a transgenic mouse line expressing green fluorescent protein 
in GLP1-R expressing cells indicate no labelling of NTS astrocytes (Cork et al., 
2015). It remains to be demonstrated whether the contrasting results of Reiner et 
al and Cork et al reflect a species difference or are the result of two different 
methodological approaches to visualise the cellular location of the GLP1-R, but 
raises the possibility that astrocytes may play this important role in rats but not 
mice. 
Using very similar methodology, a second study has shown that LepRb mRNA is 
expressed by NTS astrocytes in rats (Stein et al., 2020). Pretreatment of the NTS 
with FC attenuates the feeding suppression induced by delivery of leptin directly 
into this brain region (Stein et al., 2020). Again however, mice expressing a 
fluorescent protein (tdTomato) in LepRb expressing cells do not show labelling of 
astrocytes (Garfield et al., 2012). Similar to the GLP1-R distribution this may 
represent a true species difference or a contrast in methodology (direct detection 
by in situ hybridisation compared with indirect labelling of cells with a fluorescent 
protein).  
Further support for a key role of NTS astrocytes in the control of feeding comes 
from a series of studies on endozepines. NTS astrocytes (and tanycyte like cells 
of the AP  known as vagliocytes (Dallaporta et al., 2010)) express 
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octadecaneuropeptide (ODN) (Guillebaud et al., 2017), ODN is an endozepine 
cleaved from acyl-CoA-binding protein (ACBP) which acts to suppress food 
intake (Garcia de Mateos-Verchere et al., 2001). Delivery of ODN into the 4V 
suppresses food intake in rats and induces c-FOS expression in the NTS 
(Guillebaud et al., 2017). Thus, under normal conditions it is possible that NTS 
astrocytes and vagliocytes may secrete ODN to regulate food intake. Indeed, in 
the ARC, astrocytes release ACBP (cleaved extracellularly to ODN), which 
activates ARCPOMC neurons to suppress appetite via its G-protein coupled 
receptor ODN-GPCR (Bouyakdan et al., 2019). 
Evidence generated by these studies suggest that NTS astrocytes can modulate 
the effects of two endogenous satiety signals but their involvement has not yet 
been conclusively demonstrated. 
1.6 | Summary and Statement of Aims 
To summarise, food intake is under potent control by the brain with respect to 
generation of a strong hunger signal and subsequent suppression of that signal 
in response to food intake (satiety). The key brain area mediating satiety is the 
NTS, given its connectivity from the gut and outputs to higher brain centres 
including the midbrain and hypothalamus where hunger and satiety signals 
converge. Astrocytes are an active element of neural circuits and modulate the 
functions of neurons directly and by altering the synaptic microenvironment. 
Astrocytes in the ARC are regulated by feeding state and their activation serves 
to modulate the firing of hunger-driving ARCAgRP neurons. In the NTS, astrocytes 
are involved in synaptic transmission and regulation of cardiorespiratory 
physiology in addition to being regulated by various internal states. Despite the 
well-established role of the NTS in mediating satiety and the evidence that 
astrocytes in this nucleus are dynamically regulated there has yet to be a 
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description of the response of these cells to deviations in food intake. 
Furthermore, while genetic techniques have been applied to ARC astrocytes to 
demonstrate their ability to modulate appetite this same methodology has not 
been used to study NTS astrocytes and food intake.  
To this end, the studies described in this thesis address three main aims: 
1) Identify the responses of NTS astrocytes to short and long term deviations in 
food intake or energy balance 
2) Assess the consequence of astrocyte activation on food intake and related 
behaviours 
3) Examine potential mechanisms of astrocyte-neuron communication in the NTS 
with relevance to food intake 
At the core of these aims is the following overarching hypothesis:  NTS astrocytes 
sense increases in food intake in the form of vagal and non-vagal cues entering 
the brain after a large meal and in turn, alter their function to excite NTS neurons 
that signal satiety in order to drive a corresponding decrease in food intake. 
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2.1 | Key Materials 
Antibodies 
Reagent or Resource Source or Supplier Identifier 
Mouse anti-GFAP Merck MAB360 
Goat anti-mCherry Origene AB0081 
Rabbit anti-NeuN Abcam Ab104225 
Rabbit anti-c-FOS Cell Signalling 2250s 
Donkey anti-mouse 
AlexaFluor 568 
Invitrogen A10037 
Donkey anti-mouse 
AlexaFluor 488 
Invitrogen A21202 
Donkey anti-rabbit 
AlexaFluor 488 
Invitrogen A21206 
Donkey anti-goat 
AlexaFluor 594 
Invitrogen A11058 
Table 2.1.1 | Summary of antibodies used in the described studies. GFAP 
= glial fibrillary acidic protein. NeuN = neuronal nuclear protein. 
 
Viral Vectors 
Reagent or Resource Source or Supplier Identifier 
AAV5/2-hGFAP-
hM3Dq_mCherry 
ETH Zurich Viral vector facility V97 
AAV5/2-hGFAP-mCherry Vigene Bioscience N/A 
AAV5/2-hGFAP-
hM4Di_mCherry 
ETH Zurich Viral vector facility V103 
Table 2.1.2 | Summary of viral vectors used in the described studies. AAV 
= adeno associated viral vector. hGFAP = human GFAP promoter. 
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Chemicals 
Reagent or Resource Source or Supplier Identifier 
Paraformaldehyde Sigma Aldrich P6148 
Sucrose Melford S0809 
Sodium Chloride Sigma Aldrich S7653 
Sodium Phosphate Dibasic SAFC A702X 
Sodium Phosphate 
Monobasic 
Sigma Aldrich RDD007  
Triton X-100 Sigma Aldrich T8787 
Normal Donkey Serum Sigma Aldrich 566460  
Fluoroshield mounting 
medium with DAPI 
AbCam ab104139 
Clozapine-N-Oxide (CNO) Tocris Bioscience 4936 
Sodium Pentobarbital Animal Care Pentoject 
Ketamine Hydrochloride Covetrus Narketan 
Medetomidine Covetrus Domitor 
Atipamezole Covetrus Antisedan 
Buperonorphine Covetrus Vetergesic 
0.9% Saline for injection Aquapharm #1  
Carprofen Covetrus Rimadyl 
D-Glucose Sigma Aldrich G8270 
Cholecystokinin 
Octapeptide, Sulphated 
Tocris Bioscience 1166/1  
Lithium Chloride Sigma L4408 
N-methyl-D-aspartate Tocris Bioscience 0114 
D-serine Tocris Bioscience 0226 
Dihydrokainic acid Tocris Bioscience 0111 
Potassium chloride Sigma Aldrich P9333 
Sodium bicarbonate Sigma Aldrich S5761 
Magnesium sulphate Sigma Aldrich M7506 
Calcium chloride Sigma Aldrich 21115 
Sucrose Sigma Aldrich S7903 
Potassium phosphate Sigma Aldrich P5655 
Potassium gluconate Sigma Aldrich G4500 
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EGTA Sigma Aldrich E3889 
HEPES Sigma Aldrich H3375 
Magnesium chloride Sigma Aldrich 442615-M 
ATP Sigma Aldrich A1852 
GTP Sigma Aldrich G8877 
Table 2.1.3 | Summary of chemicals used in the described studies. 
 
Mouse strains 
Reagent or Resource Source or Supplier Identifier 
C57BL6/J University of Exeter Colony 
(Originally Charles River) 
N/A 
C57BL6/J Charles River N/A 
TH-EGFP Washington State University 
Colony  
MGI:3774290 
Mouse chow 
Standard Chow LabDiet EURodent 
diet [5LF2] 
High Fat Chow TestDiet D12492 
Table 2.1.4 | Summary of mouse strains and mouse diets used in the 
described studies. 
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Software 
Reagent or Resource Source or Supplier Identifier 
Leica Acquisition Suite X Leica LASX 
FIJI National Institiutes for Health 
(Schindelin et al 2012) 
N/A  
Ethovision XT Noldus N/A 
MATLAB Mathworks R2019a 
MC_Rack Multichannel Systems N/A 
pClamp Molecular Devices 10.3 
Clampfit Molecular Devices N/A 
Mini analysis program Synaptosoft Inc. N/A 
Prism 8 Graph Pad N/A 
Inkscape Inkscape.org N/A 
Table 2.1.5 | Summary of software used in the described studies. 
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Equipment 
Reagent or Resource Source or Supplier Identifier 
Sledge Microtome Bright Instruments 8000 
Upright Microscope Leica DM 4000 
Confocal Microscope Leica DMi8 
Stereotaxic Frame David Kopf Instruments N/A 
Injection controller Neurostar N/A 
Injection syringe Hamilton Neuros 
Injection controller Word Precision Instruments UMP3  
Conditioned Place 
Aversion Chamber 
University of Bristol Workshop N/A 
Vibrotome Leica VT1200 
Sapphire Vibratome Blade Delaware Diamond Knives N/A 
Perforated multi-electrode 
array 
Multichannel Systems 60Pmea 
100/30iR-
Ti-gr 
MEA interface and 
amplifier 
Multichannel Systems MEA1060 
Amplifier Molecular Devices Axopatch 
700B 
Digitiser Molecular Devices Digidata 
1440A 
Concentric bipolar 
stimulating electrode 
FHC incorporated 50 μm 
internal 
diameter 
Stimulator AMPI Isoflex 
stimulator 
Table 2.1.6 | Summary of equipment used in the described studies. 
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2.2 | Mice 
All animal studies performed in the UK were conducted in accordance with the 
UK Animals in Scientific Procedures Act 1986 (ASPA) and study plans were 
approved by the Institutional Animal Welfare and Ethical Review Body at the 
University of Bristol and/or Exeter. Experiments performed at Washington State 
University, USA were conducted with the approval of the Institutional Animal Care 
and Use Committee and in accordance with the US Public Health Service Policy 
on Human Care and Use of Laboratory Animals and the National Institutes of 
Health Guide for the Care and Use of Laboratory animals. 
 Adult (age > 8 weeks) male C57BL6/J mice (Charles River or University of Exeter 
Colony) were used for all experiments unless stated otherwise. All mice were 
individually housed at least 4 days prior to experiments and maintained on a 
12:12 light-dark cycle at 22 ± 2 °C, with unlimited access to standard laboratory 
rodent diet (EURodent diet [5LF2], LabDiet, UK) and water unless otherwise 
stated. Each cohort of mice used to generate data in specific figures is described 
in table 2.2.1. 
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Table 2.2.1 | Description of mice used for each experiment. AAV = adeno-
associated viral vector, GFAP = glial fibrillary acidic protein, IHC = 
immunohistochemistry. 
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2.3 | Methods used in Chapter 3 
2.3.1 | Dark-phase high-fat feeding studies 
Two independent cohorts of male C57BL6/J mice (16 weeks) were individually 
housed for 4-5 days. In the experimental group, standard chow (LabDiet) was 
substituted for high-fat chow (TestDiet) at lights off on the test day. Control mice 
were maintained on standard chow. 12-14 hours later mice were euthanized 
within two hours of lights on by intraperitoneal (i.p.) injection of sodium 
pentobarbital (1.6 g/kg) and transcardially perfused with 0.9% NaCl (Saline) 
containing heparin followed by 4% paraformaldehyde (PFA) in 0.01M phosphate 
buffered saline (PBS). Brains were post-fixed for 4-6 hours in 4% PFA PBS before 
being transferred to 30% sucrose in PBS. These brains were then removed from 
sucrose and stored at -80 °C until used for histology (see Section 2.3.4 below).  
2.3.2 | Dark-phase fasting studies 
A cohort of male C57BL6/J mice (16 weeks) were individually housed for 4-5 
days. In the experimental group, food was removed from the cage at lights off on 
the test day. Control mice were maintained on standard chow. 12-14 hours later 
mice were euthanized within two hours of lights on, perfused and brains stored 
as described above (Section 2.3.1).  
2.3.3 | Diet induced obese studies 
A cohort of male C57BL6/J mice (12 weeks) were assigned to receive either 
standard chow (LabDiet) or high fat chow (TestDiet). These mice were fed this 
diet for 13 weeks and body weight was measured weekly. At the end of the 
feeding period mice were euthanized within two hours of lights on, perfused and 
brains stored as described above (Section 2.3.1). 
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2.3.4 | GFAP immunohistochemistry 
For the brains collected in the above studies (Sections 2.3.1, 2.3.2, 2.3.3) 30 μm 
coronal sections of the brainstem were taken with a freezing sledge microtome 
(Bright Instruments) in 4 series, i.e. each section in a series was 120 μm apart. 
One series was washed (3x 5 minute washes) in 0.01M PBS then incubated in 
blocking solution (0.01M PBS containing 0.3% Triton X-100 and 5% normal 
donkey serum [NDS]) for 1 hour at room temperature. These sections were then 
incubated in mouse-anti glial fibrillary acidic protein (GFAP; Merck) diluted 1:5000 
in carrier solution (0.01M PBS containing 0.3% Triton X-100 and 1% NDS) 
overnight at 4 °C. Sections were then warmed to room temperature before being 
washed (8x 5 minute washes) in 0.01M PBS. Sections were incubated in donkey 
anti-mouse AlexaFluor 568 (Invitrogen) diluted 1:500 in 0.1M PBS containing 
0.3% Triton X-100 for 1 hour at room temperature. Sections were then washed 
(8x 5 minute washes) in 0.01M PBS, mounted on to glass slides and cover 
slipped with mounting medium with DAPI (AbCam). A separate set of sections 
was stained following this protocol but with the primary antibody substituted for 
carrier solution to assess non-specific staining (Figure 2.3.1 a).  
2.3.5 | Image acquisition and analysis 
Images for cell counting were acquired at 10X magnification on a fluorescence 
microscope (Leica). One image with the NTS in the field of view was acquired for 
sections corresponding to -7.08 mm from Bregma to -8 mm from Bregma in a 
brain atlas (Paxinos and Franklin, 2001). The number of GFAP expressing cells 
was counted using the cell counting plugin in FIJI (Schindelin et al., 2012) and 
the mean number of cells per section calculated for each animal. For regional 
analysis the NTS was sub-divided as follows: rostral = Bregma -7.08mm - -
7.2mm, postremal = Bregma -7.32mm - -7.64mm, caudal = Bregma -7.76mm - - 
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8mm and the mean number of GFAP expressing cells per section binned into 
these divisions. 
Images for morphological analysis were acquired at 20X magnification on a 
confocal microscope (Leica). Z-stacks were acquired for two pNTS sections per 
mouse. GFAP-immunoreactive cells in these images were marked with coloured 
dots using the cell counter plugin in FIJI, the original image was removed so only 
dots were visible to represent each cell then 5 of these cells were randomly 
selected for tracing. Semi-automated tracing was performed using the simple 
neurite tracer FIJI plugin (now known as SNT) (Ferriera et al., 2014). The number 
of processes per cell were counted and Sholl analysis was performed to give the 
Sholl profile and enclosing radius of each cell (Figure 3.3.3). The investigator 
was blinded to the diet of the mice during immunohistochemical staining, image 
acquisition and analysis. 
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Figure 2.3.1 | Demonstration of specificity of anti-mouse AlexaFluor 568 
secondary antibody binding. Representative images of NTS sections stained 
in the absence of the primary antibody and stained with the secondary donkey 
anti-mouse AlexaFluor 568. Left: 568 nm channel alone, Right: 568 nm channel 
with DAPI co-stain. AP = area postrema, NTS = nucleus of the solitary tract. Scale 
bars = 50 μm. 
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2.4 | Methods used in Chapter 4 
2.4.1 | AAV vector injection 
Initial injections were made at four sites across the NTS to ensure efficient 
targeting (mice described in Sections 4.3.1 – 4.3.13 and 4.3.15 – 4.3.17). Mice 
(8 – 12 weeks) were injected with adeno-associated viral (AAV) vectors to target 
the dorsal vagal complex (DVC). Mice were deeply anaesthetized with an i.p. 
injection of ketamine (70 mg/kg) and medetomidine (0.5 mg/kg) and placed in a 
stereotaxic frame (David Kopf Instruments) with the nose angled down by 20°. 
An incision from the occiput to the nape of the neck was made, the muscles were 
parted, and the atlanato-occipital membrane incised to expose the surface of the 
brainstem. Injections were made from a pulled glass pipette attached to an 
injection system (Neurostar) mounted on the stereotaxic frame at an angle of 35° 
relative to vertical, tip facing rostral. The pipette was inserted 400 μm lateral to 
the midline at the level of calamus scriptorius to a depth of 1mm. Four AAV 
injections of 180 nl were made bilaterally at angled depths of 1 mm, 750 μm, 500 
μm and 250 μm, respectively, at a rate of 100 nl/minute. Mice were injected with 
either AAV5/2-hGFAP-hM3Dq_mCherry (ETH Zurich Viral Vector Facility) or 
AAV5/2-hGFAP-mCherry (Vigene Bioscience). The pipette was left in place for 1 
minute after each injection. Following injection, the pipette was removed from the 
brain, the muscles were apposed with a loose suture and the skin sutured to allow 
the wound to heal. Mice were injected with atipamezole (1 mg/kg i.p) and 
buprenorphine (0.1 mg/kg subcutaneous) for anesthetic reversal and analgesia, 
respectively, and were transferred to a heated cage to recover. Following surgery 
mice were individually housed for the duration of the experiment. 
For subsequent experiments, injections were made at a single site in the pNTS 
to restrict viral spread. These mice are those described in Sections 4.3.14 and 
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4.3.18 – 4.3.22. Surgery was identical to those described above except that 
injections were made from a syringe (Hamilton) connected to an injection 
controller (World Precision Instruments). This syringe was inserted 200 μm lateral 
to the midline at the level of calamus scriptorius to a depth of 500 μm. Bilateral 
injections of 180 nl were made at a rate of 100 nl/minute. Mice were injected with, 
AAV5/2-hGFAP-hM3Dq_mCherry (ETH Zurich Viral Vector Facility), AAV5/2-
hGFAP-hM4Di_mCherry (ETH Zurich Viral Vector Facility), or AAV5/2-hGFAP-
mCherry (Vigene Bioscience) The syringe was left in place for 2 minutes following 
the injection. In addition to the analgesia described above these mice received 
an injection of carprofen (5 mg/kg subcutaneous) the following morning. 
All mice were allowed at least 3 weeks to recover from surgery and were 
individually housed before any experiments were performed. 
2.4.2 | Immunohistochemistry of AAV injected mice 
Mice received clozapine-N-oxide (CNO; 0.3 - 1 mg/kg i.p.) during the first 4 hours 
of the light phase and had food removed from the cage. 2-3 hours later mice were 
transcardially perfused and brains stored as described above (Section 2.3.2). 30 
μm coronal sections containing the brainstem, midbrain and hypothalamus were 
taken with a freezing sledge microtome (Bright Instruments) in 4 series, i.e. each 
section in a series was 120 μm apart. NTS sections from one series were washed 
(3x 5 minute washes) in 0.01M PBS then incubated in blocking solution (0.01M 
PBS containing 0.3% Triton X-100 and 5% normal donkey serum [NDS]) for 1 
hour at room temperature. These sections were then incubated in goat anti-
mCherry (Origene) diluted 1:1000 in carrier solution (0.01M PBS containing 0.3% 
Triton X-100 and 1% NDS) overnight at 4 °C. Sections were then warmed to room 
temperature before being washed (8x 5 minute washes) in 0.01M PBS. Sections 
were incubated in donkey anti-goat AlexaFluor 594 (Invitrogen) diluted 1:500 in 
105 
 
0.1M PBS containing 0.3% Triton X-100 for 1 hour at room temperature. Sections 
were then washed (8x 5 minute washes) in 0.01M PBS and incubated in mouse 
anti-GFAP (Merck) 1:5000 in carrier solution overnight at 4 °C. Sections were 
then warmed to room temperature before being washed (8x 5 minute washes) in 
0.01M PBS. Sections were incubated in donkey anti-mouse AlexaFluor 488 
(Invitrogen) diluted 1:500 in 0.1M PBS containing 0.3% Triton X-100 for 1 hour at 
room temperature. Sections were then washed (8x 5 minute washes) and 
mounted on to glass slides and cover slipped with mounting medium with DAPI 
(AbCam).  
NTS sections from a second series were stained in the same fashion but with 
rabbit anti-NeuN (AbCam) and donkey anti-rabbit AlexaFluor 488 (Invitrogen) 
replacing mouse anti-GFAP and donkey anti-mouse AlexaFluor 488, 
respectively. 
Hypothalamus, midbrain and brainstem sections from a third series were stained 
with rabbit anti-c-FOS (Cell Signalling) and donkey anti-rabbit AlexaFluor 488 
(Invitrogen). 
A separate set of sections was stained in parallel following this protocol but with 
the primary antibody substituted for carrier solution to assess non-specific 
staining of AlexaFluor 488 tagged secondary antibodies (Figure 2.4.1 a, b). 
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Figure 2.4.1 | Demonstration of specificity of anti-mouse and anti-rabbit 
AlexaFluor 488 secondary antibody binding. Representative images of NTS 
sections stained in the absence of the primary antibody and stained with a, the 
secondary donkey anti-mouse AlexaFluor 488 or b, the secondary donkey anti-
mouse AlexaFluor 488. Left: 488 nm channel alone, Right: 488 nm channel with 
DAPI co-stain. AP = area postrema, NTS = nucleus of the solitary tract. Scale 
bars = 50 μm. 
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2.4.3 | AAV injection mapping 
The AAV vectors used contained a sequence encoding mCherry to enable 
visualization of the viral transduction and spread. The distribution of mCherry 
immunoreactivity was manually mapped relative to corresponding sections in a 
mouse brain atlas (Paxinos and Franklin, 2001). The area of transduction was 
quantified using FIJI. To display this (Figure 4.3.2), transparent shapes (each 
one representing the spread in a single animal) were overlaid on a scale diagram 
of the NTS; where colours appear darkest is where the greatest overlap of 
transduction between mice occurred. 
2.4.4 | Validating AAV transduction of astrocytes 
Sections double stained for GFAP and mCherry-immunoreactivity or NeuN and 
mCherry-immunoreactivity were imaged on a confocal microscope (Leica) at 20X 
magnification. The total number of GFAP and NeuN expressing cells in the field 
of view and the number of each cell type also expressing mCherry were counted 
with the cell counter plugin in FIJI.  
2.4.5 | Validating DREADD activation of astrocytes 
Morphological analysis of NTS astrocytes from CNO treated mice was performed 
as described above (Section 2.3.5). 
2.4.6 | c-FOS quantification 
Sections stained for c-FOS immunoreactivity containing the paraventricular 
nucleus of the hypothalamus (Bregma -0.94 mm), lateral parabrachial nucleus 
(Bregma -5.02 mm) and pNTS (Bregma -7.56 mm) were imaged under 20X 
magnification with a confocal microscope (Leica). The number of c-FOS 
expressing cells within each brain region were manually counted using the cell 
counter plugin in FIJI. 
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In some experiments only the pNTS was imaged for c-FOS quantification. 
2.4.7 | Dark phase food intake measurements 
Mice were acclimatised to experimenter handling and i.p. injections for at least 4 
days. On test days mice received saline (i.p.) 15 – 30 minutes prior to the onset 
of the dark phase. Food intake was manually measured by the investigator at 2, 
4, 6, 12 and 24 hours after lights off (under red light illumination where 
necessary). In some experiments food weight was also measured at 1 hour after 
lights off. Body weight was measured either at 6 or 8 hours after lights-off. The 
following day mice received an injection of CNO (0.3 – 1 mg/kg i.p.) 15-30 
minutes prior to the onset of the dark phase. Food intake and body weight were 
again measured at the same time points. 
2.4.8 | Fast induced re-feeding experiments 
Body weight of mice was measured prior to fasting. To fast the mice, all food was 
removed from cages at the beginning of the dark phase. Subsequently, 15-30 
minutes prior to the onset of the light-phase mice received an injection of CNO 
(0.3-1 mg/kg i.p.) under red light illumination. At the onset of the light-phase food 
was returned to cages and intake was measured 1, 2, 4, 6, 8, 12 and 24 hours 
after lights on. In some experiments body weight was measured a second time, 
8 hours after lights on. In some experiments mice received a second injection of 
saline or cholecystokinin (CCK) (3.5 μg/kg i.p.) concurrently with food being 
reintroduced. In these experiments food intake was also measured 30 minutes 
after reintroduction. 
2.4.9 | Conditioned place aversion 
For conditioned place aversion testing an apparatus consisting of two distinct 
chambers joined by a clear plastic external corridor was used (University of Bristol 
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Workshop; Figure 4.3.10). The left chamber had horizontal black and white 
stripes on the walls and a perforated floor, and the right chamber had vertical 
black and white stripes on the walls and a floor with horizontal grating. A counter-
balanced paradigm was used to test conditioned place aversion. On the first day 
mice were given 20 minutes of free access to explore the whole apparatus. This 
session was recorded using a video camera and used to determine initial location 
preferences. On the second day (conditioning 1), mice were assigned to receive 
either CNO (0.3 mg/kg i.p.) or an equivalent volume of saline 15 minutes prior to 
being placed in either the left or right chamber for 45 minutes, with the access to 
the external corridor and second chamber blocked. On the third day (conditioning 
2) mice received the opposite treatment with their access restricted to the 
alternate chamber, compared to the second day. These sessions were recorded 
and used to measure locomotion following injection of CNO or saline. On the 
fourth/final day mice were given free access to the whole apparatus for 30 
minutes. Again, this session was recorded and used to determine conditioned 
preference. Recorded sessions were analyzed offline using Ethovision XT 
tracking software (Noldus). An independent cohort of C57BL6/J mice underwent 
the same conditioning protocol with the known aversive agent lithium chloride 
(LiCl, 150 mg/kg i.p. diluted in saline) as a positive control, replacing CNO as the 
experimental stimulus. 
2.4.10 | Home cage food seeking 
Individually housed mice were injected with CNO (0.3 mg/kg i.p.) 15 minutes prior 
to the beginning of the dark phase and their home cage placed under a video 
camera with food removed from the hopper and two pieces of food placed on the 
cage floor in the far corner from the nest. The activity was then recorded for 3 
hours and food intake at 3 hours was measured. Recorded sessions were 
110 
 
analyzed offline using Ethovision XT tracking software (Noldus) with a 6 cm2 zone 
centered around the pellets termed the ‘food zone’ and 4 cm x 3 cm zone centered 
around the water bottle spout termed the ‘spout zone’. 
2.4.11 | Tail flick test 
Individually housed mice were restrained by scruffing and the distal end of the tail 
submerged into 52 °C water. This induces a characteristic ‘tail flick’ escape 
response (Malmberg and Bannon, 2001) and the latency from submersion to this 
response was recorded. Three ‘baseline’ measurements were made separated 
by 15 minutes before an injection of CNO (0.3 mg/kg i.p.). Following injection, 
measurements were made at 15 minute intervals for 1 hour. 
2.5 | Methods used in Chapter 5: Mutli-electrode array (MEA) recordings 
2.5.1 | Solutions 
Molecule Concentration (mM) 
NaCl 124 
KCl 3 
NaHCO3 24 
NaH2PO4 1.25 
MgSO4.7H2O 1 
CaCl2 2 
D-Glucose 10 
Table 2.5.1 | Concentrations of molecules in the 10mM Glucose artificial 
cerebrospinal fluid (aCSF). 
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Molecule Concentration (mM) 
NaCl 124 
KCl 3 
NaHCO3 24 
NaH2PO4 1.25 
MgSO4.7H2O 1 
CaCl2 2 
D-Glucose 5 
Sucrose 5 
Table 2.5.2 | Concentrations of molecules in the 5mM Glucose artificial 
cerebrospinal fluid (aCSF). 
 
Molecule Concentration (mM) 
Sucrose 189 
D-Glucose 3 
NaHCO3 24 
KCl 1.25 
MgSO4.7H2O 1 
CaCl2 0.1 
NaH2PO4 1.25 
Table 2.5.3 | Concentrations of molecules in the slicing solution. 
 
2.5.2 | Coronal NTS slice preparation 
Mice were individually housed for at least 4 days prior to experiment and food 
intake was monitored daily. The day before the brain slices were made, mice 
were either maintained on standard chow or provided with high fat chow 
immediately prior to lights off. 12 hours later (at lights on) mice were culled by 
cervical dislocation. The brain was quickly removed, cut in the coronal plane at 
roughly –3.4 mm from Bregma and the rostral surface glued to the stage of a 
cutting chamber. The chamber was filled with ice cold, oxygenated, cutting 
112 
 
solution and mounted on a vibrotome (Leica). 300 µm coronal slices were taken 
with a stainless steel blade and slices containing the NTS were transferred to 10 
mM glucose aCSF at room temperature.  
In these animals the stomachs were also dissected out and weighed. Stomach 
contents were then emptied and the empty stomach was weighed and subtracted 
from the full stomach weight to calculate the mass of stomach contents. 
After at least an hour, a slice was placed in a perforated MEA (pMEA) recording 
chamber (Multichannel Systems) where the electrodes were arranged in a 6 x 10 
configuration separated by 100 μm. The slices was oriented such that the NTS 
was located on the electrode array and held down by a harp. 5 mM glucose aCSF 
heated to 33 °C was continuously perfused into the chamber from a top flow 
controlled by a peristaltic pump and a bottom flow controlled by a suction pump. 
The flow rate was 2.5 ml/minute. To aid analysis, images were acquired in situ of 
the array and of the slice positioned on the array. After 30 minutes of 
acclimatisation the recording began (Figure 5.3.3). Resting activity was recorded 
for 20 minutes before 30 µM N-methyl-D-aspartate (NMDA) in aCSF was 
perfused into the chamber for 10 minutes. Then aCSF containing 30 µM NMDA 
and 50 µM D-serine was perfused for 10 minutes. Following this, aCSF was 
perfused in the bath for 10 minutes (washout) and then the recording was 
concluded. Data were acquired at a sample rate of 50 kHz using the MC_Rack 
system (Multichannel Systems) and raw data was stored for offline analysis. 
2.5.3 | Data processing and analysis 
Raw data from the recordings were filtered (high-pass filter 200 Hz, second-order 
Butterworth; the data were not low-pass filtered) then thresholded in MC_Rack 
(Multichannel systems) to extract spikes from the recordings. The threshold used 
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was -16 µV as at this threshold spiking activity could be clearly separated from 
noise and non-spiking electrical activity. These thresholded data were then 
processed in MATLAB (Mathworks) using a modified script originally written by 
Dr Jon Brown (University of Exeter) and a bespoke script for discarding channels. 
Channels were considered to have meaningful spiking activity and considered in 
statistical analysis if they met the following criteria; 1, a resting firing rate of > 1Hz 
OR 2, a > 2-fold increase in firing rate between resting and NMDA AND 3, more 
than 300 spikes during the whole recording period AND 4 located in the NTS. For 
suitable channels meeting these criteria mean firing rates were calculated during 
the final 180s of each period of the recording and extracted to Prism for statistical 
analysis. To generate heatmaps the approximate x and y coordinates of each 
electrode were calculated relative to the central canal. These were plotted as a 
scatter plot with the colour of each point reflective of the firing rate of that 
electrode (Figure 5.3.6, 5.3.8). These plots were generated using a bespoke 
MATLAB script. 
2.6 | Methods used in Chapter 5: Whole cell patch clamp recordings 
2.6.1 | Solutions 
Molecule Concentration (mM) 
NaCl 125 
KCl 3 
NaHCO3 25 
KH2PO4 1.2 
MgSO4 1.2 
CaCl2 2 
D-Glucose 10 
Table 2.6.1 | Concentrations of molecules in the external artificial 
cerebrospinal fluid (aCSF). 
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Molecule Concentration (mM) 
NaCl 10 
K gluconate 130 
EGTA 11 
HEPES 10 
MgCl2.6H2O 2 
CaCl2 1 
ATP 2 
GTP 0.2 
D-glucose To osmolarity (297-300 mosM) 
Table 2.6.2 | Concentrations of molecules in the internal recording pipette 
solution. 
2.6.2 | Horizontal NTS slice preparation 
Female TH-EGFP mice (maintained on a C57BL6/J background) (Matsushita et 
al., 2002) aged 8-12 weeks were anesthetised with 4% isofluorane and killed by 
thoracic pressure. The hindbrain was quickly removed and placed in ice cold, 
oxygenated aCSF. The cerebellum was removed and a small wedge of tissue 
trimmed from the ventral surface of the hindbrain to correctly orient the ST and 
NTS in the cutting plane. The ventral surface tissue was then glued to the stage 
of a cutting chamber and submerged in ice cold oxygenated aCSF and the cutting 
chamber was mounted on a vibrotome (Leica). Under magnification and 
illumination the dura and blood vessels were removed from the dorsal surface of 
the hindbrain to expose the NTS. Small horizontal sections were taken with a 
sapphire blade (Delaware Diamond Knives) until the ST was clearly visible at the 
brain surface. Then a 250 µm thick slice was taken and immediately transferred 
to the recording chamber of a patch clamp rig. The slice was weighed down with 
a harp and perfused with room temperature aCSF for 1 hour. 
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2.6.3 | Whole cell patch clamp electrophysiology 
Following the acclimatisation period, the inflow heater was turned on and the slice 
was perfused with 33 °C aCSF. A bipolar concentric stimulating electrode (FHC 
incorporated) was placed on the ST (Figure 5.3.10). Pulled pipettes (tip 
resistance 3-5 mΩ) were filled with internal solution and mounted onto the 
headstage. Cells were identified within 200 µm of the obex and were selected by 
the presence of EGFP fluorescence. Upon formation of a gigaohm seal and break 
in, cells were recorded in voltage clamp configuration and held at a membrane 
potential of -60 mV. Recordings were made using a protocol of 6 second sweeps 
consisting of a 1 second rest period followed by 10 ST stimulations (50 Hz) then 
the remainder of the sweep. A run consisted of 10 sweeps with no intersweep 
interval. This protocol was continuous for the whole experimental period. The 
stimulus intensity was increased until clear evoked EPSCs were visible, if no 
evoked EPSCs were observed the cell was not recorded from further. Cells were 
recorded for 10 minutes in aCSF then 10 minutes in a bath perfusion 100 µM 
DHK before a 10 minute washout period. Control cells were recorded the same 
but with aCSF instead of DHK perfused through the drug delivery system. Data 
were acquired with pClamp (Molecular Devices) and stored for offline analysis. 
2.6.4 | Data analysis 
For measurements of evoked EPSC amplitude, files from the final minute of each 
recording epoch were loaded in Clampfit (Molecular Devices) and the difference 
between the holding current and the peak (trough) of the evoked EPSC were 
measured. The mean of 10 sweeps was calculated and used for statistical 
analysis. 
For measurements of spontaneous and asynchronous EPSCs the final 3 minutes 
of each recording epoch was loaded into Mini analysis program (Synaptosoft Inc.) 
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for event detection. The cumulative number of events in 100 ms bins was 
calculated for 30 sweeps and used for statistical analysis. 
2.7 | Statistical analysis 
Data are presented as mean ± SEM where appropriate with the exception of non-
normally distributed MEA data which are shown in violin plots and data are 
presented as median ± interquartile range. Data for all experiments were 
analysed in Prism 7 (Graph Pad) and the appropriate statistical tests conducted. 
Graphs were generated in Prism or MATLAB, representative images were 
prepared in FIJI, representative electrophysiology traces were prepared in 
MATLAB and figures were prepared in Inkscape (inkscape.org). 
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Chapter 3 
 
 
 
 
 
Response of NTS astrocytes to short- and long-term 
deviations in energy balance 
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3.1 | Introduction 
Astrocytes in specific nuclei of the hypothalamus, including the arcuate nucleus 
(ARC), contribute to inflammation in both diet induced and genetic obesity in rats 
and mice (Thaler et al., 2012; Buckman et al., 2013). This is best characterised 
by greater expression of the cytoskeletal glial fibrillary acidic protein (GFAP) and 
increased branching of the primary (GFAP immunoreactive) processes. 
Inflammatory signalling in astrocytes increases susceptibility to obesity (Zhang et 
al., 2017) while preventing astrocyte NF-κB signalling can be protective against 
weight gain (Douglass et al., 2017; Zhang et al., 2017). Taken together it appears 
that hypothalamic astrocyte inflammation in experimental models of obesity is a 
maladaptive response and serves to exacerbate weight gain, possibly by 
impairing the function of appetite governing hypothalamic circuits (Horvath et al., 
2010). 
Hypothalamic astrocyte activation in response to high fat chow ingestion occurs 
in two distinct phases (Thaler et al., 2012; Balland and Cowley, 2017). The initial 
phase occurs within the first 24 hours of high fat chow intake and appears to 
contribute to the homeostatic response to increased food intake since inhibiting 
astrocyte inflammatory signalling increases initial hyperphagia on a high fat diet 
(Buckman et al., 2015). However with continued intake (four weeks or more) a 
second phase of astrocyte activation emerges (Thaler et al., 2012; Balland and 
Cowley, 2017). Therefore it appears the acute activation of astrocyte 
inflammatory pathways is a mechanism to reduce food intake following 
hyperphagia while following continued high fat feeding, prolonged activation is 
detrimental to energy balance processing. 
ARC astrocytes are bi-directionally regulated by food intake. In addition to 
showing changes in activity in response to nutritional excess associated with high 
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fat feeding (as described above), fasting and chronic i.c.v leptin infusion (which 
reduces food intake) cause increases in GFAP and altered morphology of arcuate 
astrocytes in mice and rats (Fuente-Martín et al., 2012; N. Chen et al., 2016; 
Zhang et al., 2017). Given that neurons in the ARC can differentially mediate 
hunger and satiety it is likely that this acute astrocyte activation similarly serves 
to mediate food intake and restore energy levels in the face of fasting. In support 
of this, the outcome of direct ARC astrocyte activation using chemogenetics has 
differing effects depending on the energy state of the mouse, appearing to 
balance ARC neural circuit activity towards energy homeostasis (Yang, Qi and 
Yang, 2015; N. Chen et al., 2016). 
In addition to this established ARC astrocyte plasticity, there have been 
numerous demonstrations that GFAP expression and astrocyte morphology in 
the nucleus of the solitary tract (NTS) is dynamic and regulated in different 
experimental settings (Table 1.4.1). Despite the accepted role of the NTS in 
controlling food intake, and ARC astrocytes being regulated by energy state, the 
response of NTS astrocytes to perturbations in energy balance has not been 
reported. 
3.2 | Aims and hypotheses 
In this chapter we aimed to characterise the response of NTS astrocytes, as 
assessed by GFAP immunoreactivity and morphology, to deviations in food 
intake. To measure this cellular response to energy state, mice were fasted for 
12-14 hours or fed high fat chow for 12-14 hours or 13 weeks. We then measured 
the number and morphology of GFAP expressing astrocytes in the NTS, with a 
specific focus of those at the level of the area postrema since that is where 
stomach-innervating vagal afferents terminate (Williams et al., 2016; Han et al., 
2018; Bai et al., 2019). 
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Given that the NTS is considered to be principally concerned with meal 
termination (Grill and Hayes, 2012), we first hypothesised that NTS astrocytes 
would show greater GFAP immunoreactivity and morphological complexity in the 
acute high fat group as compared with the standard chow fed controls. 
Secondly, given that NTS astrocytes are capable of sensing low tissue glucose, 
we hypothesised that this process would drive astrocyte activation, detectable by 
our measurements, in fasted mice. 
Finally, given the profound astrocyte alterations seen in the hypothalamus of diet 
induced obese (DIO) mice (Buckman et al., 2013), we expected to see similar 
changes in the NTS.  
3.3 | Results 
3.3.1 | High fat chow induced acute hyperphagia in mice 
The response of mice to high fat chow availability is stereotypical and well 
characterised (Buckman et al., 2015; Douglass et al., 2017). It consists of two 
phases, an initial hyperphagia followed by homeostatic reductions in food intake 
to compensate for the increased caloric content of the food. Thus, short term 
hyperphagia can be reliably induced by providing mice with high fat chow for a 
short duration. To allow us to investigate the response of NTS astrocytes to 
increased food intake we allowed mice to eat high fat chow for 12-14 hours during 
the dark phase before either perfusion fixation or cervical dislocation. Control 
animals were maintained on standard chow. High fat chow fed mice tended to 
eat a greater mass of food but this did not reach statistical significance (Figure 
3.3.1 a, 3.31 ± 0.16 vs 3.62 ± 0.14 g, p = 0.16, unpaired t-test). Given the greater 
caloric density of the diet, high fat chow fed mice did however consume a greater 
number of calories than those on standard chow (Figure 3.3.1 b, 10.53 ± 0.51 vs 
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18.48 ± 0.74 kcal, p < 0.0001, unpaired t-test). In mice that were sacrificed by 
cervical dislocation, the contents of the stomach were measured and were found 
to be far greater in high fat chow fed mice compared with standard chow fed 
controls (Figure 3.3.1 c, d, 0.45 ± 0.07 vs 1.20 ± 0.22 g, p < 0.0001, unpaired t-
test). As anticipated, the contents of the stomach correlated positively with the 
caloric intake (Figure 3.3.1 e, r2 = 0.87, p < 0.0001 from zero) showing that mice 
on a high fat chow eat more calories and have prolonged gastric distention. These 
results demonstrate that this is a valid paradigm for stimulating hyperphagia and 
activating signals, including gastric distension that are relayed to the NTS. 
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Figure 3.3.1 | High fat chow feeding induced hyperphagia in mice. a, Food 
intake during the 12-14 hour period prior to perfusion of mice fed standard chow 
and high fat chow (n = 9-10 mice per group, 3.31 ± 0.16 vs 3.62 ± 0.14 g; p = 
0.16, unpaired t-test). b, Energy intake during the 12 – 14 hour period prior to 
perfusion of mice fed standard chow and high fat chow (n= 9 – 10 mice per group, 
10.53 ± 0.51 vs 18.48 ± 0.74 kcal; p < 0.0001, unpaired t-test). c, Stomachs 
dissected from mice fed either standard chow (top) or high fat chow (bottom). d, 
Stomach contents of mice fed either standard chow (S) or high fat chow (HF) (n 
= 5 mice per group, 0.45 ± 0.07 vs 1.20 ± 0.22 g; p < 0.0001, unpaired t-test). e, 
Relationship between the energy intake and stomach contents in mice fed either 
standard chow or high fat chow (n = 5 mice per group, r2 = 0.87, p < 0.0001 
different from zero). 
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3.3.2 | High fat chow hyperphagia increased the number of GFAP 
immunoreactive astrocytes in the postremal NTS 
In order to assess the impact of high fat chow induced hyperphagia on NTS 
astrocyte reactivity, we used immunohistochemistry against GFAP. In the NTS of 
high fat chow fed mice there was a striking increase in GFAP immunoreactivity 
(Figure 3.3.2 a, b). When quantified by counting the number of GFAP 
immunoreactive (GFAP+) cells across the rostro-caudal extent of the NTS, there 
were a greater number of GFAP+ cells per section in high fat chow fed mice when 
compared with standard chow controls (Figure 3.3.2 c, 43.09 ± 8.19 vs 67.90 ± 
7.47 cells, p = 0.038, unpaired t-test). Binning the counts into rostral (rNTS), 
postremal (pNTS) and caudal (cNTS) subdivisions of the NTS revealed that the 
difference between diet groups was greatest, and statistically significant at the 
level of the NTS proximal to the area postrema (Figure 3.3.2 d, p = 0.037, two-
way analysis of variance [ANOVA] with Sidak’s post-hoc test). 
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Figure 3.3.2 | High fat chow induced hyperphagia increased the number of 
GFAP immunoreactive astrocytes in the postremal NTS. a, Representative 
maximum projection confocal image of glial fibrillary acidic protein (GFAP) 
immunostaining from a standard chow fed mouse. b, Representative maximum 
projection confocal image of GFAP immunostaining from a high fat chow fed 
mouse. c, Mean number of GFAP immunoreactive (GFAP+) cells from tissue 
sections of the NTS from standard (S) and high fat chow fed (HF) mice (n = 9-10 
mice per group, 43.09 ± 8.19 vs 67.9 ± 7.47 cells, p = 0.038, unpaired t-test). d, 
Number of GFAP+ cells within anatomical subdivisions of the NTS from standard 
and high fat chow fed mice (n=9-10 mice per group, Two-way ANOVA, food, p = 
0.0018, F(1,51) = 10.81, rostrocaudal position, p = 0.034, F(2,51) = 3.63, interaction, 
p = 0.7, F(2,51) = 0.36, Sidak’s post-hoc test). AP = area postrema, GFAP = glial 
fibrillary acidic protein, NTS = nucleus of the solitary tract. Scale bars = 50 µm. 
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3.3.3 | High fat chow induced hyperphagia increased the morphological 
complexity of GFAP immunoreactive astrocytes in the postremal NTS 
Given that GFAP makes up intermediate filaments of the astrocyte cytoskeleton, 
changes in its expression can result in changes to cytoskeletal morphology. To 
assess whether this was the case in our experiment, pNTS astrocytes from a 
subset of mice were randomly selected for morphological analysis by an 
investigator blinded to the experimental groups. Selected cells were ‘traced’ 
(digitally reconstructed using simple neurite tracer FIJI) to yield a 3 dimensional 
digital object on which to make measurements (Figure 3.3.3 a-c) (Ferriera et al., 
2014). Sholl analysis was used to quantify the morphological complexity of these 
traced cells (Sholl, 1953; Ferriera et al., 2014). In this analysis, concentric rings 
of increasing radius (3 µm increments) were drawn around the cell’s soma 
(Figure 3.3.3 d). The number of times processes of the cell intersect a given ring 
was quantified and plotted to give the Sholl profile of the cell (Figure 3.3.3 e). A 
cell with greater morphological complexity will give a greater “Sholl profile”. 
 Sholl analysis revealed that astrocytes from the pNTS of high fat chow fed mice 
had a greater morphological complexity than those from standard chow fed 
controls (Figure 3.3.4 a). In addition, these cells had a greater number of 
processes than those from standard chow fed controls (Figure 3.3.4 b, 6.78 ± 
0.41 vs 8.62 ± 0.38 processes per cell, p = 0.0017, unpaired t-test). Analysis of 
the mean enclosing radius (the farthest radius from the soma where a process 
intersects with the Sholl circle) showed no difference between the groups (Figure 
3.3.4 c, 22.50 ± 1.02 vs 24.47 ± 1.12 μm, p = 0.20, unpaired t-test). Taken 
together, this suggests that astrocytes upregulate GFAP to form more processes 
rather than to extend existing ones. Representative traces from one mouse per 
group are shown (Figure 3.3.4 d, e). 
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Figure 3.3.3 | Sholl analysis permits quantitative analysis of GFAP 
immunoreactive astrocyte morphological complexity. a, Maximum projection 
image of GFAP immunoreactivity from a single astrocyte. Note: this image is to 
clearly display the tracing and analysis and is not representative of the images 
used for statistical analysis in subsequent figures. b, Tracing results from Simple 
Neurite Tracer overlaid with the GFAP immunoreactivity of the selected cell. c, 
Tracing results from Simple Neurite Tracer. d, Sholl radii used for analysis 
overlaid with tracing results from Simple Neurite Tracer. e, Sholl profile of the 
selected cell. Scale bars = 10 µm. 
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Figure 3.3.4 | High fat chow induced hyperphagia increased the 
morphological complexity of GFAP immunoreactive astrocytes in the 
pNTS. a, Mean Sholl profile of postremal NTS GFAP+ astrocytes of standard and 
high fat chow fed mice (n = 35-50 cells from 4-5 mice per group, Two-way 
ANOVA, food, p < 0.0001, F(1,1079) = 23.24, distance from soma, p < 0.0001, 
F(12,1079) = 108.3, interaction, p = 0.04, F(12,1079) = 1.83, Sidak’s post-hoc test). b, 
Number of processes of individual pNTS GFAP+ astrocytes from standard (S) 
and high fat chow fed (HF) mice (n = 35-50 cells from 4-5 mice per group, 6.77 ± 
0.41 vs 8.62 ± 0.38 processes, p = 0.0017, unpaired t-test). c, Enclosing radius 
of individual pNTS GFAP+ astrocytes from standard (S) and high fat chow fed 
(HF) mice (n = 35-50 cells from 4-5 mice per group, 22.50 ± 1.02 vs 24.47 ± 1.12 
μm, p = 0.20, unpaired t-test) d, Representative traces of five astrocytes from a 
standard chow fed mouse. e, Representative traces of five astrocytes from a high 
fat chow fed mouse. Scale bar = 25 μm. * = p < 0.05, ** = p < 0.01. 
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3.3.4 | Overnight fasting did not increase the number of GFAP immunoreactive 
astrocytes in the NTS 
NTS astrocytes have been implicated in signalling negative energy balance, 
namely hyperglycaemia induced by 2-deoxyglucose (McDougal et al., 2013; 
McDougal, Hermann and Rogers, 2013; Rogers et al., 2018). Astrocytes of the 
ARC have also been shown to be activated by a 24 hour fast (N. Chen et al., 
2016). We examined NTS astrocyte activation using the same criteria as above 
(3.3.2 & 3.3.4) in mice that had been fasted overnight for 12 to 14 hours and 
compared it to those maintained on standard chow. In some of the standard chow 
fed control mice there was very low GFAP immunoreactivity relative to the fasted 
mice, however others were comparable to fasted mice (Figure 3.3.5 a, b). Due 
to this variation there was no significant difference overall in the number of 
GFAP+ cells per tissue section between the two groups (Figure 3.3.5 c, 49.09 ± 
17.29 vs 71.17 ± 6.41 cells; p = 0.27, unpaired t-test). When the cell counts were 
binned by rostrocaudal position there were no statistically significant differences 
between the groups in the rNTS, pNTS or cNTS (Figure 3.3.5 d, two-way ANOVA 
with Sidak’s post-hoc test).  
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Figure 3.3.5 | Overnight fasting did not change the number of GFAP 
immunoreactive astrocytes in the NTS. a, Representative maximum projection 
confocal image of GFAP immunostaining from a standard chow fed mouse. b, 
Representative maximum projection confocal image of GFAP immunostaining 
from a fasted mouse. c, Mean number of GFAP+ cells from tissue sections of the 
NTS from standard chow fed and fasted mice (n = 5 mice per group, 49.09 ± 
17.29 vs 71.17 ± 6.41 cells, p = 0.27, unpaired t-test). d, Number of GFAP+ cells 
within anatomical subdivisions of the NTS from standard chow fed and fasted 
mice (n = 5 mice per group, Two-way ANOVA, fast, p = 0.072, F(1,24) = 3.55, 
rostrocaudal position, p = 0.52, F(2,24) = 0.67, interaction, p = 0.81, F(2,24)= 0.22, 
Sidak’s post-hoc test, p > 0.05 for all comparisons). AP = area postrema, GFAP 
= glial fibrillary acidic protein, NTS = nucleus of the solitary tract. Scale bars = 50 
µm 
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3.3.5 | Overnight fasting increased the morphological complexity of pNTS GFAP 
immunoreactive astrocytes 
Sholl analysis showed that astrocytes in the pNTS of fasted mice had greater 
morphological complexity than those from standard chow control mice (Figure 
3.3.6 a). These cells had a greater number of processes in the pNTS of fasted 
mice when compared to standard chow fed control mice (Figure 3.3.6 b, 5.82 ± 
0.31 vs 7.44 ± 0.40; p = 0.0018, unpaired t-test). There was no difference in the 
mean enclosing radius between the two groups (Figure 3.3.6 c, 24.18 ± 0.91 vs 
25.86 ± 0.98 μm; p = 0.21, unpaired t-test). This indicates that in fasted mice, 
astrocytes in the pNTS send out more processes without extending existing 
processes. Representative traces from one mouse per group are shown (Figure 
3.3.6 d, e). 
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Figure 3.3.6 | Overnight fasting increased the morphological complexity of 
GFAP immunoreactive astrocytes in the pNTS. a, Mean Sholl profile of 
postremal NTS GFAP+ astrocytes of standard chow fed and fasted mice (n = 50 
cells from 5 mice per group, Two-way ANOVA, fast, p < 0.0001, F(1,1470)=17.41, 
distance from soma, p < 0.0001, F(14,1470)=178.7, interaction, p = 0.058, 
F(14,1470)=1.66, Sidak’s post-hoc test). b, Number of processes of individual pNTS 
GFAP+ astrocytes from standard chow fed and fasted mice (n = 50 cells from 5 
mice per group, 5.82 ± 0.31 vs 7.44 ± 0.40 processes, p = 0.0018, unpaired t-
test). c, Enclosing radius of individual pNTS GFAP+ astrocytes from standard 
and high fat chow fed mice (n = 50 cells from 5 mice per group, 24.18 ± 0.91 vs 
25.86 ± 0.98 μm, p = 0.21, unpaired t-test) d, Representative traces of five 
astrocytes from a standard chow fed mouse. e, Representative traces of five 
astrocytes from a fasted mouse. Scale bar = 25 μm. * = p < 0.05, ** = p < 0.01. 
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3.3.6 | Prolonged consumption of a high fat diet results in greater body weight 
To assess the effects of long-term deviations from energy balance we fed mice 
either high fat chow or standard chow for 13 weeks. Mice on a high fat chow 
quickly developed an increased body weight relative to the start of the experiment 
and greater body weight relative to standard chow fed controls (Figure 3.3.7 a, 
b, Week 13 body weight 30.45 ± 1.20 vs 45.88 ± 1.78 g; p < 0.0001, two-way 
ANOVA with Sidak’s post-hoc test). Owing to this greater weight gain this cohort 
of mice were determined to be DIO. 
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Figure 3.3.7 | 13 weeks of high fat diet intake increased body weight in mice. 
a, Mean body weight of standard chow and high fat chow fed mice over the 
duration of the feeding period (n = 4-5 mice per group, two-way ANOVA, diet, p 
< 0.0003, F(1,7) = 42.99, week, p < 0.0001, F(12,84) = 50.56, interaction, p < 0.0001, 
F(12,84) = 20.78, Sidak’s post-hoc test). b, Mean change in body weight of standard 
chow and high fat chow fed mice over the duration of the feeding period (n = 4-5 
mice per group, two-way ANOVA, diet, p < 0.0002, F(1,7) = 49.43, week, p < 
0.0001, F(12,84) = 50.56; interaction, p < 0.0001, F(12,84)=20.78, Sidak’s post-hoc 
test). * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. 
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3.3.7 | GFAP immunoreactivity in the NTS was not increased in mice after 13-
weeks of consumption of a high fat diet 
After 13 weeks on either a high fat diet or standard chow (control), mice were 
perfused and tissue sections stained for GFAP. There was no clear difference in 
GFAP immunoreactivity between either of the groups (Figure 3.3.8 a, b). Indeed, 
when the number of GFAP+ cells was quantified across the whole NTS there was 
no significant difference in the number of GFAP+ cells per tissue section between 
the groups (Figure 3.3.8 c, 98.42 ± 13.57 vs 98.85 ± 5.92 cells; p = 0.98, unpaired 
t-test). When these cell counts were binned by rostrocaudal region there were no 
statistically significant differences between the groups in the rNTS, pNTS or cNTS 
(Figure 3.3.8 d, two-way ANOVA with Sidak’s post-hoc test). This shows that 
within the NTS the response to a long term high fat diet is distinct from the 
response to the initial intake. Of note, the baseline number of GFAP+ cells in the 
standard chow fed group was elevated over numbers seen in acute experiments. 
This is likely due to the age of the animals since they were 3 months older (the 
length of the diet) than mice used in acute experiments. It has been documented 
that in the NTS and the brain in general that GFAP mRNA and immunoreactivity 
increases with age (Nichols et al., 1993; Hardy et al., 2018). 
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Figure 3.3.8 | 13 weeks of high fat diet intake did not change the number of 
GFAP immunoreactive astrocytes in the NTS. a, Representative maximum 
projection confocal image of NTS GFAP immunostaining from a standard chow 
fed mouse. b, Representative maximum projection confocal image of NTS GFAP 
immunostaining from a 13 week high fat chow fed mouse. c, Mean number of 
GFAP+ cells from tissue sections from the NTS of standard diet (SD) and 13 
week high fat diet (HFD) fed mice (n = 4-5 mice per group, 98.42 ± 13.57 vs 98.85 
± 5.92 cells, p = 0.98, unpaired t-test). d, Number of GFAP+ cells within 
anatomical subdivisions of NTS from standard and high fat chow fed mice (n = 4-
5 mice per group, Two-way ANOVA, diet, p = 0.85, F(1,21)  =   0.04, rostrocaudal 
position, p = 0.002, F(2,21)  = 9.03, interaction, p = 0.93, F(2,21) =  0.08, Sidak’s post-
hoc test, p > 0.05 for all comparisons). AP = area postrema, GFAP = glial fibrillary 
acidic protein, NTS = nucleus of the solitary tract. Scale bars = 50 µm. 
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3.3.8 | 13 week consumption of a high fat diet increased the process number 
and maximum process length of pNTS astrocytes 
Morphological tracing and Sholl analysis of randomly selected pNTS astrocytes 
showed no significant difference in the Sholl profile between the groups (Figure 
3.3.9 a). However, these cells did have a greater number of processes in the DIO 
mice when compared with the standard chow group (Figure 3.3.9 b, 5.93 ± 0.36 
vs 7.36 ± 0.41 processes per cell; p = 0.012, unpaired t-test). Furthermore, the 
enclosing radius of these cells was greater in DIO mice compared with standard 
chow fed mice (Figure 3.3.9 c, 29.55 ± 1.04 vs 33.00 ± 1.21 μm; p = 0.037, 
unpaired t-test). This indicates that despite not observing a difference in Sholl 
profile, these cells did have subtle morphological alterations, namely more 
processes and longer processes. Representative traces from one animal per 
group are shown (Figure 3.3.9 d,e). 
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Figure 3.3.9 | 13 weeks of high fat diet intake increased the number of 
processes and enclosing radius of GFAP immunoreactive astrocytes in the 
pNTS. a, Mean Sholl profile of postremal NTS GFAP+ astrocytes of standard diet 
and 13 week high fat diet fed mice (n = 40-50 cells from 4-5 mice per group, Two-
way ANOVA, Diet, p < 0.0001, F(1,1408) = 30.46; Distance from soma, p < 0.0001, 
F(15,1408) = 146.7; interaction, p = 0.94, F(15,1408) = 1.66; Sidak’s post-hoc test, p > 
0.05 for all comparisons). b, Number of processes of individual pNTS GFAP+ 
astrocytes from standard diet (SD) and 13 week high fat diet (HFD) fed mice (5.93 
± 0.36 vs 7.36 ± 0.41 processes, n = 40-50 cells from 4-5 mice per group, p = 
0.012, unpaired t-test). c, Enclosing radius of individual pNTS GFAP+ astrocytes 
from standard diet and 13 week high fat diet (HFD) fed mice (29.55 ± 1.04 vs 
33.00 ± 1.21 μm, n = 50 cells from 5 mice per group, p = 0.037, unpaired t-test) 
d, Representative traces of five astrocytes from a standard diet fed mouse. e, 
Representative traces of five astrocytes from a 13 week high fat diet mouse. 
Scale bar = 25 μm. 
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3.3.9 | Using nested analysis to evaluate the effect of mouse on cellular 
morphology 
In the morphological analyses presented above we use individual cells as data 
points. This does not meet the assumptions of the statistical tests used since 
each cell is not truly independent and the experimental manipulation (i.e. the diet) 
is applied to the mouse making mouse the experimental unit (Lazic, Clarke-
Williams and Munafò, 2018). To account for this we used a nested (or 
hierarchical) statistical analysis which allows cells to be grouped by the mouse 
they belong to. This analysis showed that, when accounting for the influence of 
which replicate the cell originated from there was a significantly greater amount 
of processes per cell in the overnight high fat chow fed group compared to 
standard chow fed controls (Figure 3.3.10 b). The same was true of the fasted 
group when compared to their standard chow fed controls (Figure 3.3.10 e). 
There was no statistically significant difference in process number between cells 
from 13 week high fat diet fed mice and their standard chow fed controls (Figure 
3.3.10 h). 
Applying this analysis to the Sholl profile was not possible since two-way nested 
analysis is not possible. Instead we compared the sum of the number of Sholl 
intersections for each cell between groups with mouse as a nested variable. None 
of these comparisons reached statistical significance (Figure 3.3.10 a, d, g). This 
may mean that variation between mice in a group accounts for the difference or 
alternatively that by reducing the dimensionality of the data our measurements 
are less sensitive. 
Finally nested analysis of enclosing radius showed there was no statistically 
significant differences between any of the experimental groups and their 
respective controls (Figure 3.3.10 c, f, i). 
139 
 
 
Figure 3.3.10 | Morphological analysis with mouse as a nested variable. a, 
Sum of Sholl intersections for pNTS GFAP+ astrocytes of standard chow and 
overnight high fat chow fed mice with mouse as a nested variable (n = 35-50 cells 
from 4-5 mice per group, nested t-test, p = 0.11). b, Number of processes per cell 
for pNTS GFAP+ astrocytes of standard chow and overnight high fat chow fed 
mice with mouse as a nested variable (n = 35-50 cells from 4-5 mice per group, 
nested t-test, p = 0.04). c, Enclosing radius for pNTS GFAP+ astrocytes of 
standard chow and overnight high fat chow fed mice with mouse as a nested 
variable (n = 35-50 cells from 4-5 mice per group, nested t-test, p = 0.43). d, Sum 
of Sholl intersections for pNTS GFAP+ astrocytes of standard chow and overnight 
fasted mice with mouse as a nested variable (n = 50 cells from 5 mice per group, 
nested t-test, p = 0.15). e, Number of processes per cell for pNTS GFAP+ 
astrocytes of standard chow and overnight fasted mice with mouse as a nested 
140 
 
variable (n = 50 cells from 5 mice per group, nested t-test, p = 0.04). f, Enclosing 
radius for pNTS GFAP+ astrocytes of standard chow and overnight fasted mice 
with mouse as a nested variable (n = 50 cells from 5 mice per group, nested t-
test, p = 0.45). g, Sum of Sholl intersections for pNTS GFAP+ astrocytes of 
standard chow and 13 weeks high fat diet fed mice with mouse as a nested 
variable (n = 40-50 cells from 4-5 mice per group, nested t-test, p = 0.11). h, 
Number of processes per cell for pNTS GFAP+ astrocytes of standard chow and 
13 weeks high fat diet mice with mouse as a nested variable (n = 40-50 cells from 
4-5 mice per group, nested t-test, p = 0.04). i, Enclosing radius for pNTS GFAP+ 
astrocytes of standard chow and 13 weeks high fat diet mice with mouse as a 
nested variable (n = 40-50 cells from 4-5 mice per group, nested t-test, p = 0.43). 
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3.4 | Discussion 
In this chapter we have shown that in the mouse NTS, GFAP+ astrocytes show 
morphological alterations in response to dietary perturbations. In particular, the 
hyperphagia following presentation of high fat chow drove an increase in the 
number of GFAP+ astrocytes in the pNTS which manifested as an increase in 
branching of GFAP+ astrocyte processes. Less consistent was the response to 
overnight fasting; there was no statistically significant difference in the number of 
GFAP+ NTS astrocytes observed between fed and fasted animals but there was 
a difference in the cellular morphology, potentially suggestive of functional 
changes in astrocytes. Finally, prolonged intake of a high fat diet induced weight 
gain but had no effect on the number of GFAP+ NTS astrocytes. We did however 
observe subtle changes in the morphology of these cells, which again may reflect 
subtle changes in astrocyte function. 
3.4.1 | Comparisons between NTS and hypothalamic astrocyte responses to 
energy balance manipulation 
In the hypothalamus, glial alterations are seen following all three of the 
manipulations presented in this chapter; fasting, acute and chronic high fat 
feeding. In mice and rats fed a high fat diet there is an immediate (24 – 72 hours) 
increase in GFAP mRNA, immunoreactivity and protein quantity in the 
mediobasal hypothalamus (Thaler et al., 2012; Buckman et al., 2015). We show 
here that this is true of the NTS at an even shorter latency from food intake (12 – 
14 hours). In the ARC, fasting induces greater GFAP expression and 
morphological complexity of GFAP+ astrocyte processes (Fuente-Martín et al., 
2012; N. Chen et al., 2016). The morphological reorganization also occurs in the 
NTS although in the absence of detectable increases in GFAP immunoreactivity. 
Finally, it is well documented that diet-induced obesity resulting from 
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consumption of a high fat diet increases GFAP expression and alters 
morphological organisation of astrocytes throughout the hypothalamus (Thaler et 
al., 2012; Buckman et al., 2013). The brainstem response in this case appears to 
be distinct since we did not observe any changes in the number of GFAP+ cells 
and only observed subtle morphological differences. 
Of note, three studies that inhibit inflammatory nuclear factor kappa b (NF-κB) 
signalling in all GFAP-expressing astrocytes report feeding phenotypes, namely, 
increased initial intake of a high fat diet following initial exposure, resistance to 
the obesity phenotype when already on a high fat diet and protection from 
metabolic dysfunction and weight gain on a high fat diet (Buckman et al., 2015; 
Douglass et al., 2017; Zhang et al., 2017). Although these studies attribute the 
observed effects to ARC astrocytes, the contribution of NTS astrocytes identified 
here as responsive to high fat diet intake cannot be ruled out. 
3.4.2 | Comparisons to other stimuli shown to modify NTS astrocyte GFAP 
expression or morphology 
In mice and rats, inhalation of either ozone gas or low oxygen air results in greater 
NTS GFAP immunoreactivity and astrocyte branching within 24 hours (Araneda 
et al., 2008; Tadmouri, Champagnat and Morin-Surun, 2014; Stokes et al., 2017; 
De La Zerda et al., 2018). This observed increase in GFAP is reduced when 
microglia are inhibited with minocycline, indicating a cross talk between these two 
cell populations (Stokes et al., 2017). We did not measure microglia number or 
morphology in our acute studies, but it is possible that communication between 
these two glial cell classes contributes to astrocyte activation and downstream 
effects on feeding. 
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3.4.3 | Evidence for physiological consequences of astrocyte reorganisation 
The consequences of the observed NTS astrocyte morphological plasticity are of 
particular interest for further study. In the magnocellular nuclei of the 
hypothalamus (the supraoptic nucleus [SON] and the magnocellular division of 
the paraventricular hypothalamic nucleus [PVHM]), astrocytes display a 
remarkable process plasticity in response to physiological stimuli (Theodosis et 
al., 2004). In these nuclei, oxytocinergic (OXT) neurons project to the 
hypophyseal circulation to initiate and control parturition, lactation and fluid 
homeostasis. During physiological states when the activity of these neurons is 
required, for example lactation, the processes of neighbouring astrocytes retract 
from the cell bodies and dendrites of OXT neurons (Theodosis et al., 2004). This 
has numerous consequences on the synaptic function of these neurons.  
The reduced astrocyte presence in the synapse leads to elevations of 
extracellular K+ (Coles and Poulain, 1991). This decreases the outward 
electrochemical gradient for K+ and thus increases neuronal excitability and the 
burst firing pattern required for lactation. Secondly, glutamate clearance is 
decreased, leading to elevated extrasynaptic glutamate and concurrent reduction 
of presynaptic release by negative feedback (Oliet, Piet and Poulain, 2001). 
Increased extracellular space can also facilitate greater volume transmission 
(Piet et al., 2004). Finally, reduced glial coverage of somata and dendrites allows 
for more synapses to contact the neurons (Theodosis et al., 2004). Together, the 
plasticity of astrocyte processes modulates the firing of OXT neurons and their 
downstream physiological/behavioural functions (Oliet and Bonfardin, 2010).  
In our experiment we performed morphological analysis on GFAP+ processes. 
As GFAP is an intermediate filament protein constituent of the astrocyte 
cytoskeleton, in reality what we observe using this method only represents 
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around 10% of the total cell volume (Shigetomi et al., 2013). Astrocytes consist 
of large GFAP+ processes and far finer GFAP- processes. In conditions that 
increase hypothalamic GFAP+ morphological complexity (fasting, high fat diet, 
NF-κB activation), finer GFAP- processes labelled by Golgi staining retract 
(Zhang et al., 2017). When activated in this fashion it appears that astrocytes may 
retract their finer processes to increase the number and complexity of larger 
GFAP+ processes.  
This suggests that in our experiment, particularly in the 12 hour high fat chow fed 
mice, that the astrocytes ramify and possibly retract processes from synapses in 
a fashion analogous to those of the SON and PVHM. This would need to be 
conclusively demonstrated in future studies by repeating the nutritional 
manipulations followed by Golgi staining (or other methods to label the wider 
extent of fine astrocyte processes). If this were to be confirmed, there could be 
several significant impacts on neuronal communication in the NTS. Firstly, this 
may result in increased extracellular K+ which can increase NTS neuron 
excitability by modulation of the A-type K+ current (Accorsi-Mendonca et al., 
2015). Secondly, it likely increases synaptic glutamate through reduced 
glutamate reuptake which in the NTS also increases neuronal activity and 
autonomic outflow from the NTS (Matott et al., 2016; Matott, Kline and Hasser, 
2017; Yamamoto and Mifflin, 2018). The predicted increase in extracellular space 
may allow for greater volume transmission of neuromodulators e.g. serotonin and 
acetylcholine which excite NTSTH neurons (Cui, Roberts, Zhao, Zhu, et al., 2012; 
Page, Zhu and Appleyard, 2018). Finally, it may allow ultrastructural remodelling 
of synapses onto NTS neurons, increasing vagal influence over these neurons. 
145 
 
3.4.4 | Opposing stimuli generate similar responses 
Somewhat paradoxical is our finding that bidirectional acute changes in energy 
balance (12 hour high fat chow and fasting) both induce morphological changes 
in NTS astrocytes. This is also observed in the ARC which is home to both 
orexigenic ARCAgRP and anorexigenic ARCPOMC neuronal populations (Buckman 
et al., 2015; N. Chen et al., 2016). What remains to be investigated is the degree 
of heterogeneity exhibited by ARC astrocytes: does an individual astrocyte 
respond to both fasting and feeding? Or are there distinct populations of fasting-
responsive and feeding-responsive astrocytes? 
To date, the majority of evidence suggests the NTS predominantly contains 
anorexigenic neurons but there is some evidence that a subset of NTSTH neurons 
can stimulate glucoprivic feeding (Aklan et al., 2020). It is possible that the 
changes are most pronounced in two sub-populations of astrocytes. Ca2+ imaging 
from NTS slices shows that ~40% of astrocytes respond to low glucose or 2-
deoxyglucose while ~40% respond to the GLP1-R receptor agonist exendin-4 
(McDougal et al., 2013; Reiner et al., 2016). What has not been demonstrated is 
whether these are two distinct populations of astrocytes whose activation may 
serve to drive opposing physiological responses. This could be clarified by 
exposing slices to each condition (0.1 mM glucose and exendin-4) sequentially 
and measuring single-cell [Ca2+]i responses to identify if individual NTS astrocytes 
bidirectionally respond to these opposing energy cues.  
3.4.5 | Potential signals that activate NTS astrocytes 
In these studies, acute high fat chow induced hyperphagia caused the greatest 
change in NTS GFAP immunoreactivity and morphology of GFAP+ processes. 
The signals underlying induction of these changes are not clear from our results 
but several possibilities exist.  
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NTS astrocytes are able to directly sense glutamate release from the vagus nerve 
via Ca2+-permeable AMPA receptors on their cell surface (McDougal, Hermann 
and Rogers, 2011; Accorsi-Mendonça et al., 2013). Opening of these receptors 
allows Ca2+ into the cell which acts at ryanodine receptors to liberate Ca2+ from 
intracellular stores, thus further increasing intracellular Ca2+ (McDougal, Hermann 
and Rogers, 2011).  
Moreover, astrocytes of the NTS and wider brainstem are responsive to 
endocrine cues including the GLP1-R agonist exendin-4, leptin and ghrelin 
(Reiner et al., 2016; Marina et al., 2017; Stein et al., 2020). This raises the 
possibility that NTS astrocytes may integrate and summate synaptic and 
endocrine signals of satiety. However, neither LepRb nor GLP1-R fluorescent 
reporter mice show labelling of NTS astrocytes (Garfield et al., 2012; Cork et al., 
2015). Additionally astrocytes do not show increased p-STAT3 activation in 
response to leptin injection (Ellacott, Halatchev and Cone, 2006). Because of 
these discrepancies, the endocrine sensing function of NTS astrocytes in vivo in 
mice remains to be convincingly demonstrated. 
In the fasted animals it is possible that NTS astrocytes were activated by low 
blood glucose since overnight fasting depletes liver glycogen and lowers blood 
glucose in mice (Ayala et al., 2010). Some NTS astrocytes have been shown to 
be directly glucose sensitive and involved in mounting the counter regulatory 
response to hypoglycaemia (Marty et al., 2005; McDougal et al., 2013; Rogers, 
Ritter and Hermann, 2016; Rogers et al., 2018). Therefore, it is possible that low 
glucose may have contributed to astrocyte changes observed in this instance. 
Additionally, the pancreatic islet cells can activate vagal neurons by release of 5-
HT and thus direct synaptic signalling from vagal sensory neurons innervating 
pancreatic islets may also play a role in this activation (Makhmutova et al., 2019). 
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Finally, in DIO mice we did not detect a difference in the number of astrocytes or 
the Sholl profile. This is in contrast to the ARC where astrocyte activation 
accompanies general tissue inflammation and microglial activation in DIO mice 
and rats (Zhang et al., 2008; Thaler et al., 2012). It is possible that this chronic 
astrocyte activation is driven by tissue inflammation in the hypothalamus. It has 
not yet been investigated whether markers of inflammation are present in the 
NTS of DIO mice but if not then this may explain the observed difference. 
Alternatively, this may indicate a loss of sensitivity in the activation mechanism 
induced by 12 hours high fat chow potentially contributing to continued caloric 
excess by impairing this proposed satiety mechanism.  
We did not measure meal patterning or food intake in our study since the mice 
were group housed. The high fat chow is more energy dense than standard chow 
and DIO mice may eat less food by mass than the standard diet fed controls but 
a greater number of calories. This could result in less gastric distention, 
potentially resulting in low gut to brain vagal signalling. If this is the main driver of 
NTS astrocyte activation in the short term high fat paradigm then this may explain 
the lack of effect in the DIO paradigm.  
3.5 | Conclusion 
To conclude we have identified that NTS astrocytes respond with morphological 
changes robustly in response to short term intake of a high fat chow suggesting 
that similarly to their ARC counterparts, they may mediate physiological 
responses to increases in food intake (i.e. corresponding decreases in food 
intake). In addition, we observed an unexpected morphological change in the 
NTS astrocytes of fasted mice, potentially mediated by hypoglycaemia. Finally, 
only very subtle alterations in astrocyte morphology were observed in diet 
148 
 
induced obese mice which may reflect changes in the eating behaviour of these 
animals, but this would need to be confirmed with further studies. 
Investigating the consequence of this morphological NTS astrocyte activation for 
subsequent food intake will clarify their role in energy homeostasis circuitry. 
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Chapter 4 
 
 
 
 
 
Chemogenetic control of DVC astrocytes and effects on 
energy homeostasis 
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4.1 | Introduction 
Within the last fifteen years, neuroscience research has undergone a revolution 
with the rapid advances in technologies for direct manipulation and monitoring of 
genetically defined neural cell types in awake, behaving animals (Sternson and 
Roth, 2014; Adamantidis et al., 2015; Roth, 2016; Luo, Callaway and Svoboda, 
2018). This has allowed, with an unprecedented level of precision, the generation 
of causal evidence for the contributions of populations of neural cells to a wide 
range of specific behaviours. 
As discussed in section 1.1.2.1, a number of populations of nucleus of the 
solitary tract (NTS) neurons have been interrogated in this fashion. 
Chemogenetic stimulation of NTS neurons with designer receptors exclusively 
activated by designer drugs (DREADDs) has been shown to predominantly 
suppress food intake when activated but also with some evidence for modulation 
of blood glucose control, endogenous analgesia and the rewarding/aversive 
nature of food (Zhan et al., 2013; Cerritelli et al., 2016; D’Agostino et al., 2016, 
2018; Roman, Derkach and Palmiter, 2016; Alhadeff et al., 2017; Shi et al., 2017; 
Roman, Sloat and Palmiter, 2017; Han et al., 2018; Boychuk et al., 2019; Holt, 
Richards, et al., 2019; Cheng et al., 2020). 
In addition to neurons, optogenetic and chemogenetic methodologies have been 
applied to non-neuronal cells to show causality in their function (Bang, Kim and 
Lee, 2016). From these studies, the utility of the Gq-coupled DREADD (hM3Dq) 
and ligand clozapine-N-oxide (CNO) to drive increased [Ca2+]i and modulate local 
neurons and alter behaviour has been established (Bonder and McCarthy, 2014; 
N. Chen et al., 2016; Martin-Fernandez et al., 2017; Adamsky et al., 2018; Durkee 
et al., 2019). Due to this, we will henceforth refer to stimulation of astrocyte Gq-
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GCPR signalling by this hM3Dq-CNO method as chemogenetic activation of 
astrocytes.  
Using this methodology, diverse roles of astrocytes in numerous brain regions 
have been elucidated. For example, in the nucleus accumbens (NAc) core, 
chemogenetic activation of astrocytes suppresses ethanol and cocaine seeking 
following abstinence (Bull et al., 2014; Scofield et al., 2015). Along with 
corroborating evidence this suggests that NAc astrocyte hypoactivity can bias 
rats towards relapse (Scofield et al., 2016). Chemogenetic activation of 
astrocytes in the CA1 region of the hippocampus induces synaptic plasticity and 
strengthens contextual and fear memories, an effect that is not observed when 
CA1 neurons are chemogenetically activated (Adamsky et al., 2018). In contrast, 
chemogenetic activation of astrocytes in the central extended amygdala (CeA) 
reduces conditioned fear learning, suggesting distinct roles for astrocytes in 
different circuits contributing to the same behaviour (Martin-Fernandez et al., 
2017). Thus, chemogenetic activation of astrocytes is established for studying 
their role as circuit elements that modulate behaviour. 
In the context of the regulation of energy homeostasis, of particular interest are a 
handful of studies examining the effect of chemogenetic manipulation of 
astrocytes in the arcuate nucleus (ARC) on feeding behaviour. The first study 
from Yang and colleagues showed that activation of ARC astrocytes with hM3Dq 
and CNO produced a modest decrease in baseline food intake during the dark 
phase and an increase during the light phase. Furthermore, they showed that this 
activation reduced the orexigenic action of ghrelin while potentiating the anorexic 
effect of leptin. Finally, they used complementary methodology and claimed to 
demonstrate that chemogenetic ‘inhibition’ of astrocytes with the Gi-coupled 
DREADD (hM4Di) and CNO produced opposing effects to activation on hormonal 
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but not baseline food intake (Yang, Qi and Yang, 2015). Despite the bidirectional 
effect observed in this study, the ability of hM4Di to inhibit astrocyte signalling 
remains to be demonstrated (Durkee et al., 2019). The second study from Chen 
and colleagues published shortly after the work of Yang et al, used similar 
methodology and also reported a modest increase in feeding during the light 
phase (N. Chen et al., 2016). Recently, detailed meal pattern analysis revealed 
that stimulation of hM4Di in ARC astrocytes increased meal size and duration 
without an effect on total food intake (Nuzzaci et al., 2020). This effect was 
coincident with reduced astrocytic contact onto ARCPOMC neurons. It therefore 
appears that chemogenetic modulation of ARC astrocytes is sufficient to alter 
food intake at baseline and modulate hormone-induced feeding. 
4.2 | Aims and hypothesis 
The aim of the experiments in this chapter were to validate the use of hM3Dq to 
activate NTS astrocytes and to characterise the subsequent effects on behaviour 
and neural circuit activation. We hypothesised that applying this chemogenetic 
methodology to astrocytes in the NTS and wider dorsal vagal complex (DVC) 
would reduce food intake by exciting neighbouring appetite-suppressing neurons. 
Given that other functions have been demonstrated to be regulated by NTS 
neurons, we postulated that this manipulation would also have other effects on 
other physiological functions: those involved in endogenous analgesia (NTSPOMC) 
(Cerritelli et al., 2016). Finally, we hypothesized that activating Gi-coupled 
signalling in DVC astrocytes, putatively inhibiting astrocyte activity, would 
potentiate re-feeding after a fast and reduce the appetite-suppressive effect of 
cholecystokinin (CCK). 
153 
 
4.3 | Results 
4.3.1 | A viral-genetic strategy for chemogenetic activation of DVC astrocytes 
In order to ascertain the consequences of NTS astrocyte activation on feeding 
behaviour we utilized DREADDs. Adeno-associated viral (AAV) vectors 
containing single stranded RNA encoding either the hM3Dq receptor fused to the 
fluorescent reporter mCherry under the GFAP promoter or identical vectors 
containing mCherry only were used (Figure 4.3.1 a). The mCherry only AAV 
vectors were used as controls to enable any impact of the surgical procedure, 
injection of viral vector and/or CNO treatment on behaviour to be observed. The 
AAV vectors were delivered to the NTS by stereotactic surgery (Figure 4.3.1 b). 
Following surgery, immunoreactivity for the reporter mCherry confirmed 
successful injection and transduction (Figure 4.3.1 c). This indicates the utility of 
this strategy for delivery of viral vectors to the NTS. Given that infection was not 
limited to the NTS and instead consistently covered the extent of the DVC and to 
a varying degree neighbouring nuclei (Figure 4.3.1 c), these mice are 
subsequently referred to as DVC::GFAPhM3Dq and DVC::GFAPmCherry mice for 
AAV-hM3Dq_mCherry and AAV-mCherry injected mice, respectively. 
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Figure 4.3.1 | Strategy for chemogenetic control of DVC astrocytes. a, 
Schematic of viral vectors used to create DVC::GFAPhM3Dq and DVC::GFAPmCherry 
mice. b, Schematic showing anatomy of target region. c, Representative section 
showing immunoreactivity (IR) against hM3Dq_mCherry in and around the DVC. 
AP = area postrema, HGN = hypoglossal nucleus, NTS = nucleus of the solitary 
tract, X = dorsal motor nucleus of the vagus. Scale bar = 500 μm. 
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4.3.2 | Quantification of viral infection 
In the first cohort of mice an injection protocol using four injections per side was 
used. This resulted in a wide infection of the dorsal portion of the caudal 
brainstem. In these mice the caudal NTS (cNTS) and postremal (pNTS) were 
reliably transduced with hM3Dq_mCherry (Figure 4.3.2 a, b). The transduction 
in the rostral NTS (rNTS) was more variable with only 50% of mice showing 
mCherry immunoreactivity at Bregma -7.08 (Figure 4.3.2 c). The transduction of 
neighbouring nuclei was variable between mice. 
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Figure 4.3.2 | AAV vector spread in individual DVC::GFAPhM3Dq mice. a, Left, 
quantification of mCherry immunoreactivity from DVC::GFAPhM3Dq mice (n = 6) in 
the caudal DVC (Bregma -7.92 mm). Right, representative image of mCherry 
immunoreactivity in the caudal DVC. b, Left, quantification of mCherry 
immunoreactivity from DVC::GFAPhM3Dq mice (n = 6) in the postremal DVC 
(Bregma -7.48 mm). Right, representative image of mCherry immunoreactivity in 
the postremal DVC. c, Left, quantification of mCherry immunoreactivity from 
DVC::GFAPhM3Dq mice (n = 6) in the rostral DVC (Bregma -7.08 mm). Right, 
representative image of mCherry immunoreactivity in the rostral DVC. Brightness 
6 = six mice had mCherry IR in this region. 4V = fourth ventricle, AP = area 
postrema, NTS = nucleus of the solitary tract, X = dorsal motor nucleus of the 
vagus. Scale bars = 500 μm. 
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4.3.3 | Cell type specificity of viral infection 
Double-immunohistochemistry was used to examine the cell type transduced by 
the viral injections. mCherry immunoreactivity revealed a ‘honeycomb’ pattern in 
the DVC where very fine glial processes were labelled but staining was absent 
from certain cell bodies. When quantified it was seen that 91.2% of GFAP 
immunoreactive cells were mCherry immunoreactive (Figure 4.3.3 a). Since 
GFAP labels primary processes while hM3Dq_mCherry is a receptor expressed 
on the cell surface the patterns of staining were distinct but were seen to 
associate with one another and were easily distinguished from GFAP-negative 
mCherry-negative cell bodies (putative neurons). In contrast, 0.2% of NeuN 
immunoreactive cells were mCherry immunoreactive (Figure 4.3.3 b). This 
indicates that appropriate cell type specificity was achieved.  
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Figure 4.3.3 | Expression of hM3Dq_mCherry in DVC astrocytes. a, 
Immunoreactivity for GFAP and mCherry in a DVC::GFAPhM3Dq mouse. Closed 
arrow shows a GFAP-positive cell, open arrow shows a GFAP-negative putative 
neuron. 91.5 ± 1.6% of GFAP-positive cells had mCherry immunoreactivity (242 
of 265 cells from n = 4 mice). b,  Immunoreactivity for NeuN and mCherry in a 
DVC::GFAPhM3Dq mouse. Closed arrow shows a NeuN-positive cell, open arrow 
shows a NeuN-negative putative astrocyte. 0.2 ± 0.2% of NeuN-positive cells had 
mCherry immunoreactivity (1 of 509 cells from n = 4 mice). Scale bars = 25 μm. 
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4.3.4 | Chemogenetic activation of DVC astrocytes induced morphological 
plasticity 
In previous experiments we had used GFAP immunoreactivity and morphology 
as an indicator of astrocyte activation. To assess the utility of hM3Dq to activate 
DVC astrocytes mice were injected with the ligand CNO (0.3 mg/kg 
intraperitoneal [i.p.]) and perfused 2-3 hours later. Immunohistochemistry for 
GFAP showed greater GFAP immunoreactivity in DVC::GFAPhM3Dq mice when 
compared with DVC::GFAPmCherry mice (Figure 4.3.4 a, b). When the cells were 
traced, Sholl analysis showed that randomly selected pNTS astrocytes from 
DVC::GFAPhM3Dq mice had greater morphological complexity when compared 
with those from DVC::GFAPmCherry mice (Figure 4.3.4 c). These cells had a 
greater number of processes in DVC::GFAPhM3Dq mice than DVC::GFAPmCherry 
mice (Figure 4.3.4 d, 6.14 ± 0.29 vs 7.88 ± 0.43 processes; p = 0.0015, unpaired 
t-test). In addition, these cells had a greater enclosing radius in DVC::GFAPhM3Dq 
mice than DVC::GFAPmCherry mice (Figure 4.3.4 e, 25.29 ± 1.02 vs 30.30 ± 1.41 
μm; p = 0.0063, unpaired t-test). This indicates that our strategy indeed induced 
activation of DVC astrocytes when stimulated with CNO (0.3 mg/kg i.p.). 
Given that multiple cells from the same mouse were taken as individual data 
points (discussed in more detail in section 3.3.9), this analysis was repeated 
including the mouse as a nested variable (Figure 4.3.4 h-j). These analyses did 
not reach statistical significance indicating that all mice do not contribute equally 
to the observed difference in figures 4.3.4 c-e and suggesting that the 
morphological alterations induced by chemogenetic activation of DVC astrocytes 
were not uniform across mice.  
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Figure 4.3.4 | Chemogenetic activation increased morphological complexity 
of DVC astrocytes. DVC::GFAPmCherry and DVC::GFAPhM3Dq were injected with 
CNO (0.3 mg/kg i.p.) and perfused 2-3 hours later. a, Representative GFAP 
immunoreactivity from a DVC::GFAPmCherry mouse. b, Representative GFAP 
immunoreactivity from a DVC::GFAPhM3Dq mouse. c, Sholl profile of pNTS 
astrocytes of DVC::GFAPmCherry and DVC::GFAPhM3Dq mice (n = 35-40 cells from 
4 mice per group, Two-way ANOVA, DREADD, p < 0.0001, F(1,1440) = 63.05, 
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Distance from soma, p < 0.0001, F(19,1440)  = 167.0, interaction, p < 0.0001, 
F(19,1440)  = 3.49, Sidak’s post-hoc test). d, Number of processes of individual 
pNTS astrocytes of DVC::GFAPmCherry and DVC::GFAPhM3Dq mice (n = 35-40 cells 
from 4 mice per group, 6.14 ± 0.29 vs 7.88 ± 0.43, p = 0.0015, unpaired t-test). 
e, Enclosing radius of individual pNTS astrocytes of DVC::GFAPmCherry and 
DVC::GFAPhM3Dq mice (n = 35-40 cells from 4 mice per group, 25.29 ± 1.02 vs 
30.30 ± 1.41 μm, p = 0.0063, unpaired t-test). f, Representative traces of 5 cells 
from a DVC::GFAPmCherry mouse. g, Representative traces of 5 cells from a 
DVC::GFAPhM3Dq mouse. h, Sum of Sholl intersections of pNTS astrocytes of 
DVC::GFAPmCherry and DVC::GFAPhM3Dq mice with mouse as a nested variable (n 
= 35-40 cells from 4 mice per group, nested t-test, p = 0.08). i, Number of 
processes for pNTS astrocytes of DVC::GFAPmCherry and DVC::GFAPhM3Dq mice 
with mouse as a nested variable (n = 35-40 cells from 4 mice per group, nested 
t-test, p = 0.07). j, Enclosing radius for pNTS astrocytes of DVC::GFAPmCherry and 
DVC::GFAPhM3Dq mice with mouse as a nested variable (n = 35-40 cells from 4 
mice per group, nested t-test, p = 0.11). Scale bars in a and b = 50 μm. Scale bar 
in g = 25 μm. * = p < 0.05, ** = p < 0.01, **** = p < 0.0001. 
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4.3.5 | Chemogenetic activation of DVC astrocytes suppressed food intake 
Our aim was to understand the consequences of NTS/DVC astrocyte activation 
on food intake. To this end, mice were individually housed and habituated to 
experimenter handling and i.p. injections. On the first test day DVC::GFAPhM3Dq 
and DVC::GFAPmCherry mice had i.p. injections of saline (vehicle) at the beginning 
of the dark phase and their food intake was monitored for 24 hours. The following 
day the mice had CNO (1 mg/kg i.p.) and their food intake was again measured. 
In DVC::GFAPhM3Dq mice, CNO produced a robust suppression of food intake 
when compared with saline. This was evident from the cumulative food intake 
(Figure 4.3.5 a) and the rate of food intake (Figure 4.3.5 b). In contrast, in 
DVC::GFAPmCherry mice there was no difference in either cumulative food intake 
(Figure 4.3.5 c) or the rate of food intake (Figure 4.3.5 d). This shows that 
chemogenetic activation of DVC astrocytes, but not the ligand CNO alone, 
suppressed food intake in mice. 
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Figure 4.3.5 | Chemogenetic activation of DVC astrocytes suppressed food 
intake. a, Cumulative food intake of DVC::GFAPhM3Dq mice following injection of 
saline or CNO (1 mg/kg i.p.) (n = 6 mice, Two-way repeated measure [RM] 
ANOVA, CNO, p = 0.03, F(1,5) = 8.97, Time, p < 0.0001, F(5,25) = 278.5, interaction, 
p = 0.002, F(5,25) = 5.44, Sidak’s post-hoc test). b, Cumulative food intake of 
DVC::GFAPmCherry mice following injection of saline or CNO (1 mg/kg i.p.) (n = 6 
mice, Two-way RM ANOVA, CNO, p = 0.98, F(1,5) > 0.0005, Time, p < 0.0001, 
F(5,25) = 508.4, interaction, p = 0.53, F(5,25) = 0.84, Sidak’s post-hoc test, p > 0.05 
for all comparisons). c, Rate of food intake of DVC::GFAPhM3Dq mice following 
injection of saline or CNO (1 mg/kg i.p.) (n = 6 mice, Two-way RM ANOVA, CNO, 
p = 0.03, F(1,5) = 8.52, Time, p < 0.0001, F(5,25) = 10.78, interaction, p = 0.14, 
F(5,25)= 1.86, Sidak’s post-hoc test). d, Rate of food intake of DVC::GFAPmCherry 
mice following injection of saline or CNO (1 mg/kg i.p.) (n = 6 mice, Two-way RM 
ANOVA, CNO, p = 0.84, F(1,5) = 0.04, Time, p < 0.0002, F(5,25) = 7.32, interaction, 
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p = 0.17, F(5,25) = 1.72, Sidak’s post-hoc test, p > 0.05 for all comparisons). * = p 
< 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001. 
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4.3.6 | Expression of hM3Dq outside the DVC did not account for the effect of 
CNO on food intake 
Reporter expression was consistent within the DVC but varied in nuclei outside 
the DVC between mice. This allowed us to examine the relationship between the 
transduced area at the rostrocaudal level of the pNTS and the magnitude of CNO-
induced feeding suppression in DVC::GFAPhM3Dq mice. Given that the DVC was 
reliably transduced in all mice (Figure 4.3.6 a, b), a larger transduction area 
represents greater extra-DVC hM3Dq expression. A linear regression analysis of 
this relationship revealed no relationship between the size of the transduced area 
and the effect of CNO injection on food intake in the DVC::GFAPhM3Dq mice 
(Figure 4.3.6 c). This suggests that the transduction of neighbouring nuclei is 
unlikely to account for the effect on food intake.  
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Figure 4.3.6 | Expression of hM3Dq outside the DVC did not account for the 
effect of CNO on food intake. a, Representative image showing expression of 
hM3Dq_mCherry in the pNTS of a DVC::GFAPhM3Dq mouse. b, Quantification of 
mCherry immunoreactivity from DVC::GFAPhM3Dq mice (n = 6) in the postremal 
DVC (Bregma -7.48 mm). c, Relationship between transduced area of postremal 
section (Bregma -7.48 mm) and the CNO-induced reduction of food intake 
(calculated as control food intake (saline) minus CNO food intake 4 hours post 
injection) (Linear regression slope = -0.04, not significantly different from zero p 
= 0.93). Brightness 6 = six mice had mCherry IR in this region. 4V = fourth 
ventricle, AP = area postrema, NTS = nucleus of the solitary tract, X = dorsal 
motor nucleus of the vagus. Scale bars = 500 μm. 
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4.3.7 | Chemogenetic activation of DVC astrocytes reproducibly suppressed food 
intake 
To ascertain whether repeated CNO injections would continue to suppress food 
intake, the experiment was repeated in the same mice 4 weeks later. Again, CNO 
injection at the beginning of the dark phase suppressed food intake in 
DVC::GFAPhM3Dq mice (Figure 4.3.7 a, b) but not DVC::GFAPmCherry mice (Figure 
4.3.7 c, d). This shows that the effect could be reliably produced allowing for 
further experiments. 
Furthermore, body weight measured at 8 hours post injection was significantly 
lower on the CNO day than the saline day in DVC::GFAPhM3Dq mice (Figure 4.3.7 
e, 28.81 ± 0.68 vs 27.21 ± 0.58 g; p = 0.003, paired t-test) but was unchanged in 
DVC::GFAPmCherry mice (Figure 4.3.7 f, 29.46 ± 0.36 vs 29.52 ± 0.36 g; p = 0.79, 
paired t-test). This shows that chemogenetic DVC astrocyte activation 
suppressed food intake resulting in loss of body weight. This suggests that 
chemogenetic activation of DVC astrocytes did not stimulate compensatory 
changes in energy expenditure to maintain body weight. 
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Figure 4.3.7 | Chemogenetic activation of DVC astrocytes reproducibly 
suppressed food intake. a, Cumulative food intake of DVC::GFAPhM3Dq mice 
following injection of saline or CNO (1 mg/kg i.p.) (n = 6 mice, Two-way RM 
ANOVA, CNO, p = 0.0018, F(1,5) = 36.18, Time, p < 0.0001, F(5,25) = 178.5, 
interaction, p < 0.0001, F(5,25) = 15.16, Sidak’s post-hoc test). b, Cumulative food 
intake of DVC::GFAPmCherry mice following injection of saline or CNO (1 mg/kg 
i.p.) (n = 6 mice, Two-way RM ANOVA, CNO, p = 0.99, F(1,5) < 0.0002, Time, p < 
0.0001, F(5,25) = 682.4, interaction, p = 0.41, F(5,25) = 1.044, Sidak’s post-hoc test, 
p > 0.05 for all comparisons). c, Rate of food intake of DVC::GFAPhM3Dq mice 
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following injection of saline or CNO (1 mg/kg i.p.). d, Rate of food intake of 
DVC::GFAPmCherry mice following injection of saline or CNO (1 mg/kg i.p.) (n = 6 
mice, Two-way RM ANOVA, CNO, p = 0.95, F(1,5) = 0.005, Time, p < 0.0001, F(5,25) 
= 18.85, interaction, p = 0.17, F(5,25) = 1.69, Sidak’s post-hoc test, p > 0.05 for all 
comparisons). e, Body weight measured 8 hours after lights off in 
DVC::GFAPhM3Dq mice after injection of saline or CNO (1 mg/kg i.p.) (n = 6 mice, 
28.81 ± 0.68 vs 27.21 ± 0.58 g, p = 0.003, paired t-test). f, Body weight measured 
8 hours after lights off in DVC::GFAPmCherry mice after injection of saline or CNO 
(1 mg/kg i.p.) (n = 6 mice, 29.46 ± 0.36 vs 29.52 ± 0.36 g, p = 0.79, paired t-test). 
* = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** = p < 0.0001.  
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4.3.8 | Chemogenetic activation of DVC astrocytes suppressed food intake at a 
lower dose of CNO 
It is recommended that CNO is used at the lowest effective dose to minimise 
potential off-target effects (Roth, 2016). With this in mind, we sought to 
investigate the effect on food intake in DVC::GFAPhM3Dq mice of treatment with 
the lowest dose of CNO shown to effectively activate astrocytes: 0.3 mg/kg (N. 
Chen et al., 2016). Repeating the experiment as above with 0.3 mg/kg CNO 
produced identical effects namely reduced cumulative food intake (Figure 4.3.8 
a), rate of food intake (Figure 4.3.8 c) and body weight (Figure 4.3.8 e, 28.89 ± 
0.69 vs 27.93 ± 0.55g, p = 0.016, paired t-test) relative to saline. Similarly, there 
were no effects in DVC::GFAPmCherry mice (Figure 4.3.8 b, d, f). Direct 
comparison of both doses showed a similar magnitude of food intake suppression 
relative to saline in DVC::GFAPhM3Dq mice (Figure 4.3.8. g, h). Since the effect 
size of this lower dose was comparably to the higher one, 0.3 mg/kg CNO i.p. 
was used for subsequent chemogenetic activation experiments except for 
Section 4.3.13. 
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Figure 4.3.8 | Chemogenetic activation of DVC astrocytes with 0.3 mg/kg 
CNO suppressed food intake. a, Cumulative food intake of DVC::GFAPhM3Dq 
mice following injection of saline or CNO (0.3 mg/kg i.p.) (n = 6 mice, Two-way 
RM ANOVA, CNO, p = 0.0007, F(1,5) = 55.7, Time, p < 0.0001, F(5,25) = 331.3, 
interaction, p < 0.0001, F(5,25) = 15.64, Sidak’s post-hoc test). b, Cumulative food 
intake of DVC::GFAPmCherry mice following injection of saline or CNO (0.3 mg/kg 
i.p.) (n = 6 mice, Two-way RM ANOVA, CNO, p = 0.33, F(1,5) = 1.15, Time, p < 
0.0001, F(5,25) = 506.7, interaction, p = 0.18, F(5,25) = 1.65, Sidak’s post-hoc test, p 
> 0.05 for all comparisons). c, Rate of food intake of DVC::GFAPhM3Dq mice 
following injection of saline or CNO (0.3 mg/kg i.p.) (n = 6 mice, Two-way RM 
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ANOVA, CNO, p = 0.0009, F(1,5) = 49.15, Time, p = 0.0001, F(4,20) = 9.94, 
interaction, p < 0.0001, F(4,20) = 11.07, Sidak’s post-hoc test). d, Rate of food 
intake of DVC::GFAPmCherry mice following injection of saline or CNO (0.3 mg/kg 
i.p.) (n = 6 mice, Two-way RM ANOVA, CNO, p = 0.76, F(1,5) = 0.10, Time, p < 
0.0001, F(4,20) = 29.57, interaction, p = 0.07, F(4,20) = 2.56, Sidak’s post-hoc test, p 
> 0.05 for all comparisons). e, Body weight measured 8 hours after lights off in 
DVC::GFAPhM3Dq mice after injection of saline or CNO (0.3 mg/kg i.p.) (n = 6 mice, 
28.89 ± 0.69 vs 27.93 ± 0.55g, p = 0.016, paired t-test). f, Body weight measured 
8 hours after lights off in DVC::GFAPmCherry mice after injection of saline or CNO 
(0.3 mg/kg i.p.) (n = 6 mice, 29.59 ± 0.43 vs 29.83 ± 0.47g, p = 0.29, paired t-
test). g, 4 hour food intake in DVC::GFAPhM3Dq mice following injection with 
different doses of CNO or corresponding volumes of saline (n = 6 mice). * = p < 
0.05, **** = p < 0.0001. 
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4.3.9 | Chemogenetic activation of DVC astrocytes suppressed food intake 
following an overnight fast 
Hunger is a very strong behavioural motivator and is able to overcome other 
behavioural stimuli including drive to sleep, chronic pain, anxiety and 
reproductive instincts (Burnett et al., 2016; Padilla et al., 2016; Alhadeff et al., 
2018; Goldstein et al., 2018; X.-Y. Li et al., 2019). However, strong satiety signals 
are sufficient to suppress food intake even in mice that are given access to food 
after fasting (Essner et al., 2017). To assess whether this was the case for 
chemogenetic DVC astrocyte activation, DVC::GFAPhM3Dq and DVC::GFAPmCherry 
mice were fasted for 12 hours during the dark phase. 15-30 minutes prior to lights 
on mice received CNO (0.3 mg/kg i.p.) and food was returned at lights on. 
Cumulative food intake during re-feeding after this fast was lower in 
DVC::GFAPhM3Dq mice when compared with DVC::GFAPmCherry (Figure 4.3.9 a). 
The rate of food intake in DVC::GFAPhM3Dq mice was far lower than 
DVC::GFAPmCherry within the first hour (Figure 4.3.9 b). Body weight had returned 
to pre-fasting levels in DVC::GFAPmCherry mice 8 hours after re-introduction while 
in DVC::GFAPhM3Dq mice weight regain was lower (Figure 4.3.9 c, 99.51 ± 0.65 
vs 95.24 ± 1.47 %, p = 0.024 unpaired t-test). This shows that even in the 
presence of a strong homeostatic drive to feed, DVC astrocyte activation is 
sufficient to reduce food intake. 
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Figure 4.3.9 | Chemogenetic activation of DVC astrocytes suppressed food 
intake during re-feeding after a 12 hour fast. DVC::GFAPmCherry and 
DVC::GFAPhM3Dq mice were fasted for 12 hours during the dark phase then 
injected with CNO 30 minutes prior to reintroduction of food at the onset of the 
light phase. a, Cumulative food intake (n = 6 mice per group, Two-way ANOVA, 
DREADD, p = 0.01, F(1,10) = 10.03, Time, p < 0.0001, F(7,70) = 310.5, interaction, p 
= 0.0053, F(7,70) = 3.20, Sidak’s post-hoc test). b, Rate of food intake (n = 6 mice 
per group, Two-way ANOVA, DREADD, p = 0.007, F(1,10)= 11.4, Time, p < 0.0001, 
F(6,60) = 18.55, interaction, p < 0.0001, F(6,60) = 8.35, Sidak’s post-hoc test). c, 
Body weight (% of pre-fasting weight) 8 hours after refeeding (n = 6 mice per 
group, 99.51 ± 0.65 vs 95.24 ± 1.47 %, p = 0.024 unpaired t-test). * = p < 0.05, ** 
= p < 0.01, **** = p < 0.0001. 
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4.3.10 | Chemogenetic activation of DVC astrocytes did not induce conditioned 
place aversion 
Strong satiety signals and malaise inducing agents can evoke negative affective 
states (e.g. nausea) (Maniscalco and Rinaman, 2018). To probe the affective 
salience of chemogenetic DVC astrocyte activation and CNO alone, we 
performed a conditioned place aversion (CPA) assay in DVC::GFAPhM3Dq and 
DVC::GFAPmCherry mice using CNO as a conditioning stimulus (Figure 4.3.10 a). 
On the initial day mice in either group showed no preference for either chamber. 
Mice were then conditioned with one trial in each chamber after injection of either 
CNO (0.3 mg/kg i.p.) or saline in a randomised, counterbalanced fashion (i.e. 
across the group the order of saline or CNO and the chamber to which each 
stimulus was conditioned was varied to control for drug order or chamber effects). 
Following conditioning, DVC::GFAPhM3Dq mice did not show a preference or 
aversion for the CNO paired chamber over the saline one (Figure 4.3.10 b, c), 
indicating that DVC astrocyte activation is not sufficient to induce CPA in this 
paradigm. Secondly, DVC::GFAPmCherry mice did not show a preference or 
aversion for the CNO paired chamber indicating that CNO alone is not sufficient 
to induce CPA (Figure 4.3.10 b, d).  
As a positive control, we conditioned a separate cohort of mice using lithium 
chloride (LiCl [150 mg/kg i.p.]) as a stimulus. LiCl has been shown to be aversive 
in longer conditioning paradigms (3-4 sessions) (Le Merrer et al., 2011; Longoni 
et al., 2011; Sanjakdar et al., 2015; T. Zhang et al., 2019) but following our 
protocol it did not cause mice to avoid the LiCl-paired chamber (Figure 4.3.10 f). 
This limits the conclusions we can draw from our chemogenetic conditioning 
experiments. 
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Figure 4.3.10 | Chemogenetic activation of DVC astrocytes did not induce 
conditioned place aversion. a, Schematic of the conditioning protocol. b, 
Representative tracks of a DVC::GFAPhM3Dq (top, blue) and a DVC::GFAPmCherry 
(bottom, red) mouse during the final trial. c, Percentage of the trial spent in the 
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saline- and CNO-paired chamber before (initial) and after (final) conditioning 
sessions in DVC::GFAPhM3Dq mice (n = 6 mice, Two-way RM ANOVA, CNO, p = 
0.32, F(1,10) = 1.09, Conditioning, p = 0.96, F(1,10) = 0.002, interaction, p = 0.57, 
F(1,10) = 0.35, Sidak’s post-hoc test, p > 0.05 for all comparisons). d, Percentage 
of the trial spent in the saline- and CNO-paired chamber before and after 
conditioning sessions in DVC::GFAPmCherry mice. (n = 4 mice, Two-way RM 
ANOVA, CNO, p = 0.76, F(1,6) = 0.10, Conditioning, p = 0.78, F(1,6) = 0.08, 
interaction, p = 0.23, F(1,6) = 1.81, Sidak’s post-hoc test, p > 0.05 for all 
comparisons). e, Percentage of the trial spent in the saline- and LiCl-paired 
chamber before and after conditioning sessions. (n = 7 mice, Two-way RM 
ANOVA, LiCl, p = 0.48, F(1,12) = 0.54, Conditioning, p = 0.8, F(1,12) = 0.06, 
interaction, p = 0.38, F(1,12) = 0.82, Sidak’s post-hoc test, p > 0.05 for all 
comparisons). 
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4.3.11 | Chemogenetic activation of DVC astrocytes did not acutely effect 
locomotion 
A second indicator of malaise in mice is reduced locomotion. We were able to 
assess this by examining the distance travelled during the 45 minute conditioning 
trials (i.e. 15 minutes after mice had been injected with CNO or saline) of our CPA 
paradigm (Figure 4.3.11 a). This analysis showed no significant difference in 
distance travelled between saline and CNO trials in DVC::GFAPhM3Dq mice 
(Figure 4.3.11 b, 10260 ± 1101 vs 7501 ± 1183 cm, p = 0.18, paired t-test). 
Furthermore, CNO did not alter locomotion in DVC::GFAPmCherry mice (Figure 
4.3.11 c, 9773 ± 991.1 vs 9870 ± 896.3 cm, p = 0.94, paired t-test).  
Finally, in this experiment LiCl (150 mg/kg i.p.) did reduce distance travelled 
compared with saline (Figure 4.3.11 d, 6316 ± 360.9 vs 3261 ± 343.4 cm, p = 
0.007, paired t-test) thus indicating that this measure is sensitive to acute malaise 
and suggesting chemogenetic DVC astrocyte activation suppresses food intake 
independent of malaise, but further work would be required to conclusively 
demonstrate this. 
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Figure 4.3.11 | Chemogenetic activation of DVC astrocytes did not suppress 
locomotion. a, Schematic of the conditioning protocol. b, Distance travelled 
during conditioning sessions for DVC::GFAPhM3Dq mice (n = 6 mice, 10260 ± 1101 
vs 7501 ± 1183 cm, p = 0.18, paired t-test). c, Distance travelled during 
conditioning sessions for DVC::GFAPmCherry mice (n = 5 mice, 9773 ± 991.1 vs 
9870 ± 896.3 cm, p = 0.94, paired t-test). d, Distance travelled during conditioning 
sessions in mice injected with saline or LiCl (n = 7 mice, 6316 ± 360.9 vs 3261 ± 
343.4 cm, p = 0.007, paired t-test). 
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4.3.12 | Chemogenetic activation of DVC astrocytes reduced food seeking 
independent of locomotion and drinking 
To observe the behaviour of mice during DVC astrocyte activation we placed 
mice in their home cages under a video camera. Food was removed from the 
hopper and two pellets were placed in the far side of the cage from the nest 
(Figure 4.3.12 a). Mice were injected with CNO at the beginning of the dark 
phase, returned to their home cage and recorded for 3 hours. During the 3 hour 
period food intake was lower in DVC::GFAPhM3Dq mice compared with 
DVC::GFAPmCherry mice (Figure 4.3.12 b, 0.79 ± 0.10 vs 0.21 ± 0.14 g, p = 0.028, 
unpaired t-test). During this same time period DVC::GFAPhM3Dq mice entered the 
food zone fewer times than DVC::GFAPmCherry mice (Figure 4.3.12 c, 118.3 ± 12 
vs 30.67 ± 15.38 entries, p = 0.011, unpaired t-test). Analysing the first hour in 10 
minute bins revealed that the DVC::GFAPmCherry mice immediately began eating 
as evidenced by the number of entries to the zone in the first 10 minutes while 
DVC::GFAPhM3Dq mice did not (Figure 4.3.12 d). The relationship between food 
intake and the number of food zone entries revealed a strong positive correlation 
indicating this is a reliable metric for assessing food seeking behaviour rather 
than general exploration or unrelated entries to the zone (Figure 4.3.12 e, R2 = 
0.98, p = 0.0002). Between groups there was no difference in the total time spent 
moving (Figure 4.3.12 f, 1518 ± 147.4 vs 1100 ± 536.2 seconds, p = 0.49, 
unpaired t-test), the total distance travelled (Figure 4.3.12 g, 11801 ± 1809 vs 
10147 ± 5158 cm, p = 0.78, unpaired t-test) or the entries to the water spout zone 
(Figure 4.3.12 h, 82 ± 8.67 vs 61 ± 30.66 entries, p = 0.55, unpaired t-test). This 
indicates the effects of DVC astrocyte activation on food intake are independent 
of locomotion or fluid intake. Additionally, it suggests that DVC::GFAPhM3Dq mice 
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have a reduced drive to eat following CNO injection given that food seeking is 
lower and zone entries correlate with intake. 
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Figure 4.3.12 | Chemogenetic activation of DVC astrocytes suppressed food 
seeking independent of locomotion or drinking. a, Image of the recording set 
up indicating the home cage, food zone, spout zone and mouse. b, Food intake 
during the 3 hour recording period (n = 3 mice per group, 0.79 ± 0.10 vs 0.21 ± 
0.14 g, p = 0.028, unpaired t-test). c, Food zone entries during the 3 hour 
recording period (n = 3 mice per group, 118.3 ± 12 vs 30.67 ± 15.38 entries, p = 
0.011, unpaired t-test). d, Food zone entries during the first hour of the recording 
period in 10 minute bins (n = 3 mice per group, Two-way ANOVA, DREADD, p = 
0.0052, F(1,4) = 30.81, Time, p < 0.0019, F(5,20) = 5.74, interaction, p < 0.013, F(5,20) 
= 3.85, Sidak’s post-hoc test). e, Relationship between total food intake and total 
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entries to the food zone (linear regression slope = 141.8, significantly non-zero p 
= 0.0002). f, Time spent moving during the 3 hour recording period (n = 3 mice 
per group, 1518 ± 147.4 vs 1100 ± 536.2 seconds, p = 0.49, unpaired t-test). g, 
Distance travelled during the 3 hour recording period (n = 3 mice per group, 
11801 ± 1809 vs 10147 ± 5158 cm, p = 0.78, unpaired t-test). h, Spout zone 
entries during the 3 hour recording period (n = 3 mice per group, 82 ± 8.67 vs 61 
± 30.66 entries, p = 0.55, unpaired t-test).   **** = p < 0.0001. 
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4.3.13 | Chemogenetic activation of DVC astrocytes is not analgesic 
A population of NTS neurons expressing pro-opiomelanocortin (NTSPOMC) have 
been shown to produce analgesia when chemogenetically activated (Cerritelli et 
al., 2016). To assess whether these neurons were potentially recruited in our 
manipulation we compared tail flick responses to 51 °C water immersion in 
DVC::GFAPmCherry and DVC::GFAPhM3Dq before and after CNO (1 mg/kg i.p.). 
There were no significant differences between the groups either at baseline 
(before CNO injection) or at any of the measured points (15 minute intervals for 
60 minutes after CNO injection) in the raw withdrawal latency (Figure 4.3.13 a). 
To remove the influence of baseline differences between animals all values were 
also plotted as a percentage of each mouse’s own baseline measurement. This 
confirmed that there was no difference in the withdrawal latency between 
DVC::GFAPmCherry and DVC::GFAPhM3Dq mice (Figure 4.3.13 b). This suggests 
that DVC astrocyte activation is again selective for feeding rather than a general 
activation of NTS circuitry. 
185 
 
 
Figure 4.3.13 | Chemogenetic activation of DVC astrocytes did not increase 
tail-flick latency. a, Raw latency to withdraw the tail from 51 °C water before 
(baseline) and at 15 minute intervals after CNO (1 mg/kg i.p.) (n = 6 mice per 
group, Two-way ANOVA, DREADD, p = 0.68, F(1,10)= 0.18, Time, p < 0.0001, 
F(4,40)= 11.74, interaction, p = 0.93, F(4,40)= 0.21, Sidak’s post-hoc test, p > 0.05 
for all comparisons). b, Normalised latency to withdraw the tail from 51 °C water 
at 15 minute intervals after CNO (1 mg/kg i.p.) (n = 6 mice per group, Two-way 
ANOVA, DREADD, p = 0.13, F(1,10)= 2.80, Time, p < 0.0001, F(4,40)= 13.42, 
interaction, p = 0.47, F(4,40)= 0.91, Sidak’s post-hoc test, p > 0.05 for all 
comparisons). Data collected by Dr Fiona Holmes, University of Bristol. 
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4.3.14 | Chemogenetic activation of DVC astrocytes reduced nocturnal feeding 
and refeeding after a fast in mice with restricted viral transduction 
The experiments described above were from a cohort of mice that received 
angled AAV vector injections at four sites across the NTS which resulted in 
spread through the DVC. In an attempt to further restrict the virus expression, we 
generated a second cohort of DVC::GFAPhM3Dq mice and DVC::GFAPmCherry 
controls that received only one injection per side (Figure 4.3.14 a-c). In these 
mice injection with CNO (0.3 mg/kg i.p.) reduced cumulative food intake (Figure 
4.3.14 d), rate of food intake (Figure 4.3.14 e) and refeeding after a 12 hour fast 
(Figure 4.3.14 f, g) with a similar magnitude and duration when compared with 
the previous cohort. This lower AAV vector injection volume was used for the 
experiments described below with the exception of c-FOS immunohistochemistry 
in Figures 4.3.15, 4.3.16 and 4.3.17 which was performed on the original cohort. 
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Figure 4.3.14 | Lower AAV vector injection volume is still sufficient to 
suppress feeding. a, Schematic of viral vectors used to create DVC::GFAPhM3Dq 
and DVC::GFAPmCherry mice. b, Schematic showing anatomy of target region. c, 
Representative section showing immunoreactivity against hM3Dq_mCherry in 
and around the DVC. DVC::GFAPhM3Dq mice were injected i.p. with saline or CNO 
(0.3 mg/kg) 30 minutes prior to the beginning of the dark-phase. d, Cumulative 
food intake (n = 4 mice, Two-way RM ANOVA, CNO, p < 0.0001, F(1,18) = 335.1, 
Time, p < 0.0001, F(5,18) = 112.0, interaction, p < 0.0001, F(5,18) = 18.64, Sidak’s 
post-hoc test). e, Rate of food intake (n = 4 mice, Two-way RM ANOVA, CNO, p 
= 0.0036, F(1,3) = 69.45, Time, p = 0.0019, F(4,12) = 8.25, interaction, p < 0.0001, 
F(4,12) = 16.03, Sidak’s post-hoc test). DVC::GFAPmCherry and DVC::GFAPhM3Dq 
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mice were fasted for 12 hours during the dark phase then injected i.p. with CNO 
(0.3 mg/kg) 30 minutes prior to reintroduction of food at the onset of the light 
phase. f, Cumulative food intake (n = 3-4 mice per group ,Two-way ANOVA, 
DREADD, p = 0.038, F(1,5) = 7.818, Time, p < 0.0001, F(7,35) = 168.0, interaction, 
p = 0.026, F(7,35) = 2.67, Sidak’s post-hoc test). g, Rate of food intake (n = 3-4 
mice per group, Two-way ANOVA, DREADD, p = 0.029, F(1,5) = 9.29, Time, p = 
0.0001, F(6,30) = 6.73, interaction, p < 0.0001, F(6,30) = 11.21, Sidak’s post-hoc 
test). * = p < 0.05, ** = p < 0.01, **** = p < 0.0001. AP = area postrema, HGN = 
hypoglossal nucleus, NTS = nucleus of the solitary tract, X = dorsal motor nucleus 
of the vagus. Scale bar = 500 μm. * = p < 0.05, ** = p < 0.01, *** = p < 0.001, **** 
= p < 0.0001. 
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4.3.15 | Chemogenetic activation of DVC astrocytes induced c-FOS 
immunoreactivity in the NTS and AP 
Immunoreactivity for the immediate early gene product c-FOS as a marker of 
cellular activation was assessed to quantitate the extent of DVC activation in 
DVC::GFAPhM3Dq and DVC::GFAPmCherry mice. To this end, DVC::GFAPhM3Dq 
and DVC::GFAPmCherry mice were injected with CNO 2-3 hours prior to 
perfusion fixation followed by immunohistochemistry for c-FOS.  
There was greater c-FOS immunoreactivity in the NTS and AP of 
DVC::GFAPhM3Dq than DVC::GFAPmCherry mice following injection of CNO (0.3 
mg/kg i.p.) (Figure 4.3.15 a-c). Reflective of this, there were more c-FOS 
immunoreactive cells in the NTS of DVC::GFAPhM3Dq mice than DVC::GFAPmCherry 
mice (Figure 4.3.15 d, 29 ± 5 vs 113.7 ± 19.6 cells, p = 0.002, unpaired t-test). 
This was also true for the AP where there were more c-FOS immunoreactive cells 
in DVC::GFAPhM3Dq mice than DVC::GFAPmCherry mice (Figure 4.3.15 e, 11.8 ± 
3.2 vs 63.2 ± 17.2 cells, p = 0.014, unpaired t-test). This shows that activation of 
DVC astrocytes stimulates neighbouring neurons. 
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Figure 4.3.15 | Chemogenetic activation of DVC astrocytes induced c-FOS 
immunoreactivity in the NTS and AP. a, Diagram showing region of interest for 
imaging and cell counting. b, Representative image from a DVC::GFAPmCherry 
mouse. c, Representative image from a DVC::GFAPhM3Dq mouse. d, Number of 
c-FOS immunoreactive cells in the NTS of DVC::GFAPmCherry and 
DVC::GFAPhM3Dq mice perfused 2-3 hours after injection of CNO (0.3 mg/kg i.p.) 
(n = 6 mice per group, 29 ± 5 vs 113.7 ± 19.6 cells, p = 0.002, unpaired t-test). e, 
Number of c-FOS immunoreactive cells in the AP of DVC::GFAPmCherry and 
DVC::GFAPhM3Dq mice perfused 2-3 hours after injection of CNO (0.3 mg/kg i.p.) 
(n = 6 mice per group, 11.8 ± 3.2 vs 63.2 ± 17.2 cells, p = 0.014, unpaired t-test). 
AP = area postrema, NTS = nucleus of the solitary tract. Scale bars = 50 µm. 
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4.3.16 | Chemogenetic activation of DVC astrocytes induced c-FOS 
immunoreactivity in the lPBN 
Since circuits controlling food intake are distributed across the brain, changes in 
food intake require long-range neuronal communication. Astrocytes do not 
project outside their resident brain nuclei and therefore we hypothesised that 
activation of DVC astrocytes was increasing the activity of local neurons and 
signalling to downstream circuits. The lateral parabrachial nucleus (lPBN) has 
been identified as a major projection target of satiety signalling NTS neurons and 
its role in meal termination is well described (Carter et al., 2013; Campos et al., 
2016; Roman, Derkach and Palmiter, 2016; Palmiter, 2018). Consistent with our 
hypothesis there was greater c-FOS immunoreactivity in the lPBN of 
DVC::GFAPhM3Dq than DVC::GFAPmCherry mice following injection of CNO (0.3 
mg/kg) (Figure 4.3.16 a-c). Reflective of this, there were more c-FOS 
immunoreactive cells in the lPBN of DVC::GFAPhM3Dq mice than 
DVC::GFAPmCherry mice (Figure 4.3.16 d, 17.5 ± 4.49 vs 89.33 ±11.08 cells, p = 
0.0001, unpaired t-test). This shows that chemogenetic activation of DVC 
astrocytes recruits local neurons to excite downstream nuclei involved in meal 
termination and satiety. 
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Figure 4.3.16 | Chemogenetic activation of DVC astrocytes induced c-FOS 
immunoreactivity in the lPBN. a, Diagram showing region of interest for 
imaging and cell counting. b, Representative image from a DVC::GFAPmCherry 
mouse. c, Representative image from a DVC::GFAPhM3Dq mouse. d, Number of 
c-FOS immunoreactive cells in the lPBN of DVC::GFAPmCherry and 
DVC::GFAPhM3Dq mice perfused 2-3 hours after injection of CNO (0.3 mg/kg i.p.) 
(n = 6 mice per group, 17.5 ± 4.49 vs 89.33 ±11.08 cells, p = 0.0001, unpaired t-
test). lPBN = lateral parabrachial nucleus, scp = superior cerebellar peduncle. 
Scale bars = 50 µm. 
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4.3.17 | Chemogenetic activation of DVC astrocytes did not induce c-FOS 
immunoreactivity in the PVH 
The paraventricular nucleus of the hypothalamus (PVH) is a second major 
projection target of satiety signalling NTS neurons (Rinaman, 2010; D’Agostino 
et al., 2016). There was no difference in c-FOS immunoreactivity in the PVH 
between DVC::GFAPhM3Dq and DVC::GFAPmCherry mice following injection of CNO 
(0.3 mg/kg) (Figure 4.3.17 a-c). Reflective of this, there was no statistically 
significant difference in the number of c-FOS immunoreactive cells in the PVH of 
DVC::GFAPhM3Dq mice and DVC::GFAPmCherry mice (Figure 4.3.17 d, 75.5 ± 12.05 
vs 77.33 ± 8.58 cells, p = 0.9, unpaired t-test). However, in DVC::GFAPmCherry 
mice PVH c-FOS immunoreactivity was greater than in the lPBN and DVC 
possibly due to the stress of injection/preparation for perfusion (Füzesi et al., 
2016). This may occlude detection of c-FOS induced by chemogenetic activation 
of DVC astrocytes due to the high baseline. 
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Figure 4.3.17 | Chemogenetic activation of DVC astrocytes did not induce 
c-FOS immunoreactivity in the PVH. a, Diagram showing region of interest for 
imaging and cell counting. b, Representative image from a DVC::GFAPmCherry 
mouse. c, Representative image from a DVC::GFAPhM3Dq mouse. d, Number of 
c-FOS immunoreactive cells in the PVH of DVC::GFAPmCherry and 
DVC::GFAPhM3Dq mice perfused 2-3 hours after injection of CNO (0.3 mg/kg i.p.) 
(n = 6 mice per group, 75.5 ± 12.05 vs 77.33 ± 8.58 cells, p = 0.9, unpaired t-
test). 3V = third ventricle, PVH = paraventricular nucleus of the hypothalamus. 
Scale bars = 50 µm. 
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4.3.18 | Stimulation of Gi-GPCR signalling in DVC astrocytes did not alter 
nocturnal food intake in DVC::GFAPhM4Di mice 
The ‘inhibitory’ DREADD hM4Di hyperpolarises neurons and inhibits 
neurotransmitter release (Roth, 2016). Its effect when expressed in astrocytes is 
unknown but it has been successfully used to potentiate the feeding effects of 
ghrelin and blunt the effects of leptin when expressed on ARC astrocytes (Yang, 
Qi and Yang, 2015). Opposing effects were observed with hM3Dq in this paper 
suggesting that this DREADD did indeed inhibit ARC astrocytes (Yang, Qi and 
Yang, 2015). Stimulation of hM3Dq but not hM4Di induced expression of c-FOS 
in astrocytes showing hM4Di does not activate ARC astrocytes, at least at the 
level of gene expression (Yang, Qi and Yang, 2015). A systematic investigation 
of hM3Dq and hM4Di in hippocampal and cortical astrocytes however showed 
that both DREADDs stimulated astrocyte [Ca2+]i increases, although by distinct 
intracellular mechanisms (Durkee et al., 2019).  
We aimed to determine the effect of hM4Di in DVC astrocytes and to this end 
generated a cohort of DVC::GFAPhM4Di mice using one injection of AAV-GFAP-
hM4Di_mCherry per side (Figure 4.3.18 a-c). A cohort of DVC::GFAPmCherry mice 
were generated as a control group. To assay the effect of astrocyte Gi-GPCR 
signalling on feeding we measured food intake from the beginning of the dark 
phase after injection of saline or CNO (0.3 mg/kg i.p.) and found there was no 
difference in the cumulative food intake (Figure 4.3.18 d) or rate of food intake 
(Figure 4.3.18 f) in DVC::GFAPhM4Di. Correspondingly, there was no difference 
in body weight measured 6 hours after injection of saline or CNO (Figure 4.3.18 
h, 26.85 ± 0.90 vs 27.00 ± 0.89 g, p = 0.33, paired t-test). The same was true of 
DVC::GFAPmCherry mice although a slight reduction in cumulative food intake 
appeared to be induced by CNO at 12 and 24 hours post-injection which had not 
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been observed in any of the previous 4 experiments where food intake was 
measured (Figure 4.3.18 e, g, i). 
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Figure 4.3.18 | Stimulation of Gi-GPCR signalling in DVC astrocytes did not 
increase food intake. a, Schematic of viral vectors used to create 
DVC::GFAPhM4Di and DVC::GFAPmCherry mice. b, Schematic showing anatomy of 
target region. c, Representative section showing immunoreactivity against 
hM4Di_mCherry in and around the DVC. d, Cumulative food intake of 
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DVC::GFAPhM4Di mice following injection of saline or CNO (0.3 mg/kg i.p.) (n = 6 
mice, Two-way RM ANOVA, CNO, p = 0.40, F(1,5) = 0.83, Time, p < 0.0001, F(5,25) 
= 482.8, interaction, p = 0.78, F(5,25) = 0.49, Sidak’s post-hoc test, p > 0.05 for all 
comparisons). e, Cumulative food intake of DVC::GFAPmCherry mice following 
injection of saline or CNO (0.3 mg/kg i.p.) (n = 6 mice, Two-way RM ANOVA, 
CNO, p = 0.17, F(1,5) = 2.54, Time, p < 0.0001, F(5,25) = 689.8, interaction, p = 
0.0023, F(5,25) = 5.109, Sidak’s post-hoc test).  f, Rate of food intake of 
DVC::GFAPhM4Di mice following injection of saline or CNO (0.3 mg/kg i.p.) (n = 6 
mice, Two-way RM ANOVA, CNO, p = 0.41, F(1,5) = 0.80, Time, p < 0.0001, F(4,20) 
= 23.42, interaction, p = 0.74, F(4,20) = 0.48, Sidak’s post-hoc test, p > 0.05 for all 
comparisons). g, Rate of food intake of DVC::GFAPmCherry mice following injection 
of saline or CNO (0.3 mg/kg i.p.) (n = 6 mice, Two-way RM ANOVA, CNO, p = 
0.15, F(1,5) = 2.81, Time, p < 0.0001, F(4,20) = 22.89, interaction, p = 0.86, F(4,20) = 
0.32, Sidak’s post-hoc test, p > 0.05 for all comparisons). h, Body weight 
measured 6 hours after lights off in DVC::GFAPhM4Di mice after injection of saline 
or CNO (0.3 mg/kg i.p.) (26.85 ± 0.90 vs 27.00 ± 0.89 g, n = 6 mice; p = 0.33, 
paired t-test). i, Body weight measured 6 hours after lights off in 
DVC::GFAPmCherry mice after injection of saline or CNO (0.3 mg/kg i.p.) (26.42 ± 
0.32 vs 26.40 ± 0.27 g, n = 6 mice; p = 0.92, paired t-test). AP = area postrema, 
HGN = hypoglossal nucleus, NTS = nucleus of the solitary tract, X = dorsal motor 
nucleus of the vagus. Scale bar = 500 μm. ** = p < 0.01, **** = p < 0.0001. 
 
 
 
199 
 
4.3.19 | A greater dose of CNO did not alter feeding behaviour in DVC::GFAPhM4Di 
mice 
It is unclear from the literature whether CNO has a similar efficacy at hM3Dq and 
hM4Di. To ensure we were not missing an effect by using a low dose of CNO we 
repeated the feeding study with a higher dose (1 mg/kg i.p.). These studies 
yielded almost identical results; there was no difference in the cumulative food 
intake (Figure 4.3.19 a) or rate of food intake (Figure 4.3.19 c) in 
DVC::GFAPhM4Di mice. Again, there was no difference in body weight when 
measured 6 hours after injection (Figure 4.3.19 e) in DVC::GFAPhM4Di mice. In 
DVC::GFAPmCherry mice there was no major effect, although again a slightly 
reduced cumulative food intake was observed at 24 hours post-injection,, 
although paradoxically smaller than with a lower dose of CNO (Figure 4.3.19 b, 
d, f).  
To ensure we were not missing an effect in subsequent experiments and since 
no major effects were observed in DVC::GFAPmCherry mice, 1 mg/kg i.p. CNO was 
used for subsequent hM4Di experiments.  
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Figure 4.3.19 | Stimulation of Gi-GPCR signalling in DVC astrocytes with 1 
mg/kg CNO did not increase food intake. a, Cumulative food intake of 
DVC::GFAPhM4Di mice following injection of saline or CNO (1 mg/kg i.p.) (n = 6 
mice, Two-way RM ANOVA, CNO, p = 0.62, F(1,5) = 0.29, Time, p < 0.0001, F(5,25) 
= 382.9, interaction, p = 0.51, F(5,25) = 0.88, Sidak’s post-hoc test, p > 0.05 for all 
comparisons). b, Cumulative food intake of DVC::GFAPmCherry mice following 
injection of saline or CNO (1 mg/kg i.p.) (n = 6 mice, Two-way RM ANOVA, CNO, 
p = 0.18, F(1,5) = 2.50, Time, p < 0.0001, F(5,25) = 458.6, interaction, p = 0.002, 
F(5,25) = 4.98, Sidak’s post-hoc test).  c, Rate of food intake of DVC::GFAPhM4Di 
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mice following injection of saline or CNO (1 mg/kg i.p.) (n = 6 mice, Two-way RM 
ANOVA, CNO, p > 0.99, F(1,5)<0.0001, Time, p < 0.0001, F(4,20) = 10.59, 
interaction, p = 0.41, F(4,20) = 1.05, Sidak’s post-hoc test, p > 0.05 for all 
comparisons). d, Rate of food intake of DVC::GFAPmCherry mice following injection 
of saline or CNO (1 mg/kg i.p.) (n = 6 mice, Two-way RM ANOVA, CNO, p = 0.08, 
F(1,5) = 4.86, Time, p < 0.0001, F(4,20) = 14.46, interaction, p = 0.52, F(4,20) = 0.83, 
Sidak’s post-hoc test, p > 0.05 for all comparisons). e, Body weight measured 6 
hours after lights off in DVC::GFAPhM4Di mice after injection of saline or CNO (1 
mg/kg i.p.) (26.73 ± 0.80 vs 27.15 ± 0.80, p = 0.41, paired t-test). f, Body weight 
measured 6 hours after lights off in DVC::GFAPmCherry mice after injection of saline 
or CNO (1 mg/kg i.p.) (26.22 ± 0.32 vs 26.18 ± 0.21, p = 0.82, paired t-test). **** 
= p < 0.0001. 
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4.3.20 | Stimulation of Gi-GPCR signalling in DVC astrocytes did not affect 
refeeding after a 12 hour fast in DVC::GFAPhM4Di mice 
It is possible that regular nocturnal feeding does not engage NTS satiety 
signalling to a large degree since inhibition of specific populations of NTS neurons 
often does not affect normal feeding (D’Agostino et al., 2018; Holt, Richards, et 
al., 2019; Cheng et al., 2020). Thus, to stimulate a large amount of feeding in a 
short period of time and subsequent activation of satiety pathways (Wu et al., 
2014), we fasted DVC::GFAPhM4Di mice for 12 hours during the dark phase. Prior 
to lights on they received an injection of CNO (1 mg/kg i.p.) followed by an 
injection of saline (see 4.3.21 below) and had food intake measured periodically 
for 24 hours. During re-feeding after a fast there was no difference in cumulative 
food intake between DVC::GFAPhM4Di and DVC::GFAPmCherry mice (Figure 4.3.20 
a). There was also no difference between groups in rate of food intake (Figure 
4.3.20 b). This suggests that stimulation of Gi-GPCRs on DVC astrocytes does 
not impair satiety signalling driven by voracious refeeding following a fast. It is 
possible however that the mice are consuming as much food as physically 
possible in this paradigm however given that our cumulative food intake is 
approximately the same as that seen in mice refed after a 36 hour fast, indicating 
a potential celling effect (Wu et al., 2014). 
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Figure 4.3.20 | Stimulation of Gi-GPCR signalling in DVC astrocytes did not 
increase food intake after a 12 hour fast. DVC::GFAPmCherry and 
DVC::GFAPhM4Di mice (n = 6/group) were fasted for 12 hours during the dark 
phase then injected with CNO (1 mg/kg i.p.) 30 minutes prior to reintroduction of 
food at the onset of the light phase. a, Cumulative food intake (n = 6 mice per 
group, Two-way ANOVA, DREADD, p = 0.65, F(1,10) = 0.22, Time, p < 0.0001, 
F(7,70) = 960.2, interaction, p = 0.66, F(7,70) = 0.76, Sidak’s post-hoc test, p > 0.05 
for all comparisons). b, Rate of food intake (n = 6 mice per group, Two-way 
ANOVA, DREADD, p = 0.98, F(1,10) < 0.0001, Time, p < 0.0001, F(6,60) = 51.02, 
interaction, p < 0.99, F(6,60) = 0.06, Sidak’s post-hoc test, p > 0.05 for all 
comparisons). 
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4.3.21 | Stimulation of Gi-GPCR signalling in DVC astrocytes attenuated 
cholecystokinin-induced satiety 
CCK is a peptide released from enteroendocrine cells in the digestive system 
following a meal. It acts on CCK receptors on vagal sensory neurons to stimulate 
signalling to the NTS and suppress further food intake and therefore is a vagally-
mediated satiety signal. We wanted to assess whether Gi-GPCR signalling in 
DVC astrocytes would impair vagally-mediated satiety. As such, mice were fasted 
overnight and injected with CNO (1 mg/kg i.p.) followed by either saline (data 
shown above, Section 4.3.20) or CCK (3.5 μg/kg i.p.). As expected, CCK 
suppressed refeeding after a fast in DVC::GFAPmCherry mice as evidenced by 
reduced cumulative food intake (Figure 4.3.21 b) and reduced rate of food intake 
within the first hour (Figure 4.3.21 d). This was also true of DVC::GFAPhM4Di mice 
although the magnitude of reduction in cumulative food intake was lower (Figure 
4.3.21 a) and the suppression of food intake rate had a shorter duration (Figure 
4.3.21 c). Comparison between the two groups of mice showed that while 
cumulative food intake was lower 4 hours after refeeding in DVC::GFAPmCherry 
mice, this was not the case in DVC::GFAPhM4Di mice (Figure 4.3.21 e, f). This is 
potentially suggestive of reduced effect of CCK in DVC::GFAPhM4Di mice. 
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Figure 4.3.21 | Stimulation of Gi-GPCR signalling in DVC astrocytes 
attenuated CKK-induced satiety after a 12 hour fast. DVC::GFAPmCherry and 
DVC::GFAPhM4Di mice were fasted for 12 hours during the dark phase then 
injected with CNO (1 mg/kg i.p.) 30 minutes prior to the onset of the light phase. 
At the onset of the light phase mice were injected with saline or CKK (3.5 μg/kg 
i.p.) and food was returned to the cages. a, Cumulative food intake of 
DVC::GFAPhM4Di mice (n = 6 mice, Two-way RM ANOVA, CCK, p = 0.007, F(1,5) 
= 19.34, Time, p < 0.0001, F(7,35) = 645.7, interaction, p = 0.01, F(7,35) = 3.10, 
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Sidak’s post-hoc test). b, Cumulative food intake of DVC::GFAPmCherry mice (n = 
6 mice, Two-way RM ANOVA, CCK, p = 0.002, F(1,5) = 38.36, Time, p < 0.0001, 
F(7,35) = 814, interaction, p < 0.0001, F(7,35) = 11.72, Sidak’s post-hoc test). c, Rate 
of food intake of DVC::GFAPhM4Di mice (Two-way RM ANOVA, CCK, p = 0.0054, 
F(1,5) = 11.4, Time, p < 0.0001, F(6,30) = 15.14, interaction, p < 0.0001, F(6,30) = 8.06, 
Sidak’s post-hoc test). d, Rate of food intake of DVC::GFAPmCherry mice (Two-way 
RM ANOVA, CCK, p = 0.0013, F(1,5) = 41.54, Time, p < 0.0001, F(6,30) = 13.2, 
interaction, p < 0.0001, F(6,30) = 17.31, Sidak’s post-hoc test). e, 4 hour cumulative 
food intake after a 12 hour fast in DVC::GFAPmCherry and DVC::GFAPhM4Di mice 
following injection of CNO and either saline or CCK prior to refeeding. f, 
Difference between group means of the data in e for within group comparisons 
(n = 6 mice per group, One-way RM ANOVA, CCK, p = 0.024, Sidak’s post-hoc 
test). Error bars show 95% confidence interval. * = p < 0.05, *** = p < 0.001, **** 
= p < 0.0001. 
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4.3.22 | Stimulation of Gi-GPCR signalling in DVC astrocytes did not induce c-
FOS immunoreactivity in the NTS 
To examine whether Gi-GPCR signalling in DVC astrocytes activated 
neighbouring neurons in the NTS, DVC::GFAPhM4Di mice and DVC::GFAPmCherry 
mice were injected with CNO (1 mg/kg) and perfused 2-3 hours later. Examination 
of c-FOS immunoreactivity showed very low levels which was comparable 
between the groups (Figure 4.3.22 a-c). Quantifying the number of c-FOS 
immunoreactive cells in the NTS showed there was no difference between the 
groups (Figure 4.3.22 d, n = 5 mice per group; 7.6 ± 4.23 vs 9.2 ± 2.50 cells, p = 
0.75, unpaired t-test). This suggests that in contrast to stimulation with hM3Dq, 
stimulation of hM4Di in DVC astrocytes does not excite neighbouring neurons.   
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Figure 4.3.22 | Stimulation of Gi-GPCR signalling in DVC astrocytes did not 
induce c-FOS immunoreactivity in the NTS. a, Diagram showing region of 
interest for imaging and cell counting. b, Representative image from a 
DVC::GFAPmCherry mouse. c, Representative image from a DVC::GFAPhM4Di 
mouse. d, Number of c-FOS expressing cells in the NTS of DVC::GFAPmCherry 
and DVC::GFAPhM4Di mice perfused 2-3 hours after injection of CNO (0.3 mg/kg 
i.p.) (n = 5 mice per group, 7.6 ± 4.23 vs 9.2 ± 2.5 cells, p = 0.75, unpaired t-test). 
AP = area postrema, NTS = nucleus of the solitary tract. Scale bar = 50 µm. 
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4.4 | Discussion 
In this chapter we have shown that DREADD-mediated activation of DVC 
astrocytes caused a potent, reversible decrease in food intake. This effect 
persisted even following a 12 hour fast and was independent of locomotion or 
endogenous analgesic effects and appears to be mediated by engagement of 
local and downstream neuronal circuits. We also showed that manipulation of Gi-
GPCR related signalling did not recapitulate the effects of Gq-GPCR activation 
nor did it show any indication of inhibiting the astrocyte effect on nocturnal or fast-
induced refeeding. There was however a modest attenuation of the satiating 
effect of CCK on refeeding after a fast. 
4.4.1 | Comparisons to ARC astrocytes 
ARC astrocytes have previously been implicated in the regulation of food intake. 
In the hypothalamus these glia are responsive to short-term energy imbalance, 
both fasting and acute high-fat feeding (Fuente-Martín et al., 2012; Thaler et al., 
2012; Buckman et al., 2015), and direct manipulation of their activity using 
DREADDs alters food intake (Yang, Qi and Yang, 2015; N. Chen et al., 2016). 
Both studies using activating DREADDs in ARC astrocytes show a modest 
increase in food intake during the light-phase, when mice are not typically eating 
(Yang, Qi and Yang, 2015; N. Chen et al., 2016). In contrast, it appears from our 
observations that chemogenetic DVC astrocyte activation has more pronounced 
effects on feeding with respect to the magnitude, direction and onset/duration of 
the response.  
The less pronounced impact of chemogenetic modulation of ARC astrocytes on 
feeding behaviour in mice may be due, in part, to the fact that the ARC contains 
at least two neurochemically unique neuronal populations: ARCAgRP and 
ARCPOMC neurons; the activation of which drives and inhibits feeding behaviour, 
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respectively (Aponte, Atasoy and Sternson, 2011; Krashes et al., 2011). As the 
two neuronal populations are anatomically interspersed yet functionally opposite, 
chemogenetic activation of ARC astrocytes may result in modulation of the 
activity of both neuronal populations, making interpretation of the physiological 
impact on feeding complex. With respect to feeding, to date, neurons of the NTS 
have principally been implicated in satiety rather than hunger (Grill and Hayes, 
2012), which may account for the more pronounced physiological effect 
consequent on local astrocytic activation.  
4.4.2 | Potential mechanisms of astrocyte-neuron communication underlying the 
effects induced by chemogenetic activation of DVC astrocytes 
We found that CNO treatment in DVC::GFAPhM3Dq mice decreased food intake, 
yet the underlying molecular mechanisms by which this occurs remain to be 
resolved. Astrocytes can modulate the activity of neurons by mechanisms 
including altered glutamate transport and also via release of neuroactive 
molecules (e.g. glutamate, ATP, d-serine) (Panatier et al., 2006; Gourine et al., 
2010; Araque et al., 2014; Matott, Kline and Hasser, 2017; Papouin, Dunphy, et 
al., 2017; Schwarz et al., 2017). Critically, glutamatergic signalling is the principal 
mechanism for communication between the vagus and second order NTS 
neurons (Doyle and Andresen, 2001) and NTS astrocytes directly sense vagal 
glutamate release via Ca2+-permeable AMPA receptors expressed on the cell 
membrane (McDougal, Hermann and Rogers, 2011). In the NTS, synaptic 
clearing of glutamate by astrocytes has been shown to restrain NTS neuronal 
firing and vagal outflow to cardiorespiratory organs (Matott, Kline and Hasser, 
2017). As such, astrocyte glutamate transport can manipulate the firing rates of 
NTS neurons and alter output from the NTS.  
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In our study, it is unclear how (and indeed if) astrocyte Gq-GPCR activation may 
be linked to altered glutamate uptake; however previous reports have shown that 
altered morphology of astrocytes results in corresponding changes in glutamate 
uptake and neuronal excitability (Oliet, Piet and Poulain, 2001).  
An additional potential mechanism of communication that could be important in 
mediating the effects seen is active gliotransmission (Araque et al., 2014). 
Activation of a GPCR expressed on NTS astrocytes (protease activated receptors 
[PAR]) leads to increased activation of neurons by glutamate, possibly 
exocytosed by astrocytes (Vance, Rogers and Hermann, 2015). Given that 
antagonism of NMDA receptors in the NTS increases meal size (Treece et al., 
1998) it is possible that activation of these receptors by astrocyte-derived 
glutamate or D-serine would reduce food intake, but further study would be 
required to specifically test this. 
4.4.3 | Absence of conditioned place aversion following chemogenetic DVC 
astrocyte activation or LPS conditioning 
Given the reduction in food intake we observed, it was important to evaluate 
whether induction of malaise and/or aversion could be contributing to the effect 
seen, particularly as the DVC is implicated in mediating these responses in 
addition to satiety (Maniscalco and Rinaman, 2018). This is particularly important 
in light of the increase in c-FOS immunoreactivity observed in the lPBN of 
DVC::GFAPhM3Dq mice after CNO treatment, which may indicate the activation of 
a NTS-lPBN pathway previously reported to reduce food intake through 
aversion/negative salience (Roman, Sloat and Palmiter, 2017). To do this we 
used a CPA assay utilizing a protocol previously used by the Pickering group to 
indicate aversive responses/negative salience in response to chemogenetic 
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activation of prefrontal cortex-projecting locus coeruleus neurons (LCPFC) in rats 
(Hirschberg et al., 2017).  
We found that after one conditioning session per agent, CNO treatment in 
DVC::GFAPhM3Dq or DVC::GFAPmCherry mice did not induce CPA. However, since 
the known aversive LiCl agent was unable to induce CPA in this paradigm it 
suggests our assay was likely not sufficiently sensitive to detect/induce CPA in 
this context. As such, the affective properties of DREADD-mediated DVC 
astrocyte activation remain unclear. A longer protocol may have revealed an 
effect since 3 or 4 conditioning sessions with LiCl does induce CPA in mice (Le 
Merrer et al., 2011; Longoni et al., 2011; Sanjakdar et al., 2015; T. Zhang et al., 
2019). We did however find that LiCl injection reduced locomotion during the 
conditioning trial while CNO treatment did not. This suggests LiCl acutely induces 
malaise, an effect that was not seen in the CNO treated mice. 
 Evidence suggests that satiety and aversion exist on a continuum, where in 
some cases aversion may be a manifestation of extreme satiety e.g. associated 
with excessive gastrointestinal distention (Maniscalco and Rinaman, 2018). As 
such, ability of an agent to induce CPA or conditioned taste aversion does not 
necessarily indicate that an effect is non-physiological. For example, exogenous 
CCK can induce satiety or aversion dependent on dose (Swerdlow et al., 1983; 
West et al., 1987; Moran, 2000). Our results suggest that that DREADD-mediated 
DVC astrocyte activation likely does not produce acute malaise, but its emotional 
salience remains unclear and further studies using a longer conditioning protocol 
or a conditioned taste aversion paradigm would be required to explore this. 
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4.4.4 | Does chemogenetic activation recapitulate physiological activity of NTS 
astrocytes 
It is understood that astrocyte Ca2+ signalling is a very complex process of 
desynchronized events in independent microdomains of individual cells (Volterra, 
Liaudet and Savtchouk, 2014; Bindocci et al., 2017). To date this has been best 
studied in forebrain astrocytes and evidence of microdomain signalling in the 
brainstem is lacking, although it likely exists. As such, sustained activation by a 
highly expressed GPCR, such as the hM3Dq in our studies, may yield supra-
physiological levels of [Ca2+]i and may disrupt the nuanced Ca2+-code of 
microdomains. However, a number of studies utilizing Ca2+ imaging in somatic 
and major branches of astrocytes in the NTS and other brainstem nuclei have 
shown large, synchronized [Ca2+]i elevations in response to a range of 
physiological stimuli. For example, work from the labs of Herrman and Rogers 
have shown that NTS astrocytes increase somatic Ca2+ in response to synaptic 
stimulation, PAR activation, GLP1-R activation, LepRb activation and low 
extracellular glucose (Hermann et al., 2009; McDougal, Hermann and Rogers, 
2011, 2013; McDougal et al., 2013; Reiner et al., 2016; Rogers et al., 2018; Stein 
et al., 2020). This suggests that this type of Ca2+ signal is physiologically relevant 
in these cells.  
What is currently lacking is an understanding of the [Ca2+] dynamics of NTS 
astrocytes in vivo throughout the normal daily cycle of food intake. While deep-
brain Ca2+ imaging is technically challenging it is a rapidly evolving field. Indeed 
the Ca2+ activity of neurons in brainstem respiratory regions have been monitored 
in vivo to assess their responses to low ambient oxygen (Bhandare, Huckstepp 
and Dale, 2019). This means that potentially it would be possible to apply similar 
methodology to study NTS astrocyte responses. 
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4.4.5 | Technical limitations of viral spread 
One technical limitation which confounds the interpretation of the results 
presented in this chapter arises from the spread of hM3Dq expression beyond 
the limits of the NTS and DVC. Although we have taken some steps post-hoc to 
strengthen the inferences we can make, future work could examine the possibility 
of ensuring restricted expression to the NTS using a dual-recombinase strategy.  
Cre-lox recombination is a two-component system that utilizes an enzyme, Cre, 
and a recognition site, locus of crossing over p1 (loxP). loxP sites oriented in the 
correct way around the sequence for a protein of interest can be inverted into the 
correct sequence in the presence of Cre to allow for production of the protein  
(Atasoy et al., 2008; Cardin et al., 2009; Sohal et al., 2009). This method is called 
a double-inverted open reading frame (diORF). This is routinely used to direct 
tools for manipulation or monitoring of defined neural populations (e.g. 
DREADDs, opsins, GCaMP) by using Cre-driver mice expressing Cre in a defined 
cell type and crossing or viral injection with DREADD contained in a diORF. 
A similar system Flp-FRT recombination exists (Kranz et al., 2010). This system 
is almost identical to CRE-lox but uses the distinct recombinase Flippase (Flp) 
and recognition site fliappase recognition target (FRT). As such, these can be 
combined to further restrict expression of a knocked in effector to cells only 
expressing both recombinases. 
NTS development is an area that has not received much attention although some 
details are known (Zhang and Ashwell, 2001). Noradrenergic neurons of the NTS 
have been shown to originate from the rhombomeres 3 and 5 marked by 
transcription factor Krox20 (Robertson et al., 2013). As such, it is possible that a 
transcription factor exists to specify NTS fate. Crossing a mouse expressing Flp 
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under this putative transcription factor with the astrocyte-specific Aldh1l1-Cre 
mouse will yield offspring expressing Flp in NTS cells and Cre in astrocytes. 
Injection of a virus containing an inverted diORF-DREADD sequence 
downstream of a FRT-flanked STOP codon (AAV-FRT-STOP-FRT-diORF-
hM3Dq_mCherry) into the DVC would result in expression of the DREADD 
exclusively in NTS astrocytes, thus achieving the spatial and cell type specificity 
required to refine and validate our studies. 
4.4.6 | Specificity of CNO for hM-DREADDs 
It was initially thought that CNO exerted its in vivo effects on DREADD receptors 
by directly binding to their ligand binding domain (Armbruster et al., 2007; Roth, 
2016). However, it has since been demonstrated that a second possible 
mechanism of action in rodents is the metabolism of CNO to clozapine which 
crosses the blood-brain barrier and binds to the DREADD (Gomez et al., 2017). 
This raises the issue of off target effects of clozapine since it is an antagonist of 
D2 dopamine receptors. To account for this all of our chemogenetic manipulation 
experiments were performed in parallel with control mice expressing only 
mCherry. In these mice any off target effects of CNO or its metabolite clozapine 
would be detected. 
4.4.7 | Factors underlying the differential effects of DVC::GFAPhM3Dq and 
DVC::GFAPhM4Di activation on feeding 
At the time of the experiment it was assumed that hM4Di could reduce astrocyte 
activation by reducing transmitter release and lowering intracellular Ca2+. This 
was supported by some evidence from a study showing activation of hM3Dq but 
not hM4Di on ARC astrocytes induces c-FOS immunoreactivity (Yang, Qi and 
Yang, 2015). However, it has now been demonstrated that in some brain regions, 
activation of Gi-coupled GPCRs, including hM4Di, increases [Ca2+]i in astrocytes 
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(Durkee et al., 2019). This is in contrast with its known inhibitory effects in neurons 
(Roth, 2016; Durkee et al., 2019). With this knowledge it is surprising that ours, 
and other studies have not shown the same behavioural outcome with Gi and Gq 
coupled DREADDs (Yang, Qi and Yang, 2015; N. Chen et al., 2016). However, 
the mechanisms of Gq and Gi activation are distinct and thus may have different 
downstream consequences (Durkee et al., 2019).  Therefore, in our studies it 
appears that the downstream astrocyte signalling pathways engaged result in 
distinct behavioural effects (either suppression of nocturnal food intake [hM3Dq] 
or no effect on nocturnal food intake but modulation of hormone induced satiety 
[hM4Di]). 
4.5 | Conclusion 
To summarise, in this chapter we describe the first genetic manipulation of 
astrocytes in the NTS and wider DVC and demonstrate that chemogenetic 
activation of these cells reduces nocturnal and fast-induced food intake. This 
activation is independent of effects on locomotion and endogenous analgesia 
while its emotional salience remains elusive. Chemogenetic activation of DVC 
astrocytes activates local neurons and those in the downstream lPBN as 
evidenced by c-FOS expression. Finally, stimulation of Gi-GPCR signalling in 
DVC astrocytes did not affect nocturnal or fast induced feeding but attenuated 
the satiating effect of CCK. This provides the first causal evidence that modulation 
of DVC astrocyte signalling can alter food intake and related behaviours. 
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Chapter 5 
 
 
 
 
 
Electrophysiological interrogation of astrocyte 
neuromodulation in the NTS 
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5.1 | Introduction 
To date, studies using electrophysiology to assay nucleus of the solitary tract 
(NTS) neurons have elucidated the features of these neurons in general and have 
characterised specific neurochemical populations (Doyle et al., 2004; Appleyard 
et al., 2005, 2007; Bailey et al., 2008; Thek et al., 2019). Neurons in the NTS 
receive glutamatergic input from vagal afferents fibres in the solitary tract (ST) 
which is modulated pre- and post-synaptically by a wide range of 
neurotransmitters and conditions (Cui, Li and Appleyard, 2011; Cui, Roberts, 
Zhao, Andresen, et al., 2012; Cui, Roberts, Zhao, Zhu, et al., 2012; Zhao et al., 
2015; Roberts et al., 2017; Page, Zhu and Appleyard, 2018). Of interest to our 
studies have been those studies examining NTS astrocytes. An emergent theme 
in this literature is that, in the NTS, glutamate homeostasis and glutamatergic 
transmission are under the tight control of and modulated by astrocytes (Accorsi-
Mendonça et al., 2013; Lin et al., 2013; Nagase et al., 2014; Accorsi-Mendonca 
et al., 2015; Matott et al., 2016; Matott, Kline and Hasser, 2017; Talman, Dragon 
and Lin, 2017; Yamamoto and Mifflin, 2018; Accorsi-Mendonça, Bonagamba and 
Machado, 2019). In this chapter we investigate two potential mechanisms of glial 
modulation of neighbouring neurons in the NTS. 
First, we examined whether NTS neurons are sensitive to D-serine, a known 
gliotransmitter, and whether this sensitivity was modulated by dietary state. D-
serine is of interest since it is an endogenous co-agonist of NMDA receptors 
(NMDA-R) and either D-serine or glycine are necessary for channel opening. NTS 
neurons require NMDA-R for sustained activation under high frequency ST 
stimulation in ex vivo slices (Zhao et al., 2015). This indicates the potential 
importance of this receptor in the integration of synaptic input from the periphery. 
Injection of NMDA-R antagonists into the NTS increases meal size in rats 
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implicating this receptor in controlling satiety (Treece et al., 1998; Hung et al., 
2006). This is further supported by data showing that enhancing glycine 
availability in the NTS and wider dorsal vagal complex (DVC) by injection of 
glycine or chemical or genetic inhibition of its transporter decreases food intake 
in rats refeeding after a fast (Yue et al., 2016).  
In the hippocampus and hypothalamus NMDA-R excitation is potently modulated 
by D-serine derived from local astrocytes (Panatier et al., 2006; Papouin, Dunphy, 
et al., 2017; Adamsky et al., 2018; Robin et al., 2018). Combined, these data led 
us to hypothesise that NTS neurons would be sensitive to D-serine and this 
excitability would be modulated following physiological manipulations impacting 
activity of local astrocytes: 12 hour high fat chow intake, see Chapter 3. This 
experiment additionally afforded the opportunity to assess the population activity 
of NTS neurons following acute hyperphagia, something that had not previously 
been investigated. 
Second, we examined the effects of blocking astrocyte glutamate uptake on 
synaptic integration in NTS neurons expressing tyrosine hydroxylase (NTSTH 
neurons). These neurons were chosen since their chemogenetic activation 
reduces food intake (Roman, Derkach and Palmiter, 2016; Aklan et al., 2020) and 
the features of their synaptic profile are very well described (Appleyard et al., 
2007) and subject to modulation by a wide variety of conditions (Cui, Li and 
Appleyard, 2011; Cui, Roberts, Zhao, Andresen, et al., 2012; Cui, Roberts, Zhao, 
Zhu, et al., 2012; Roberts et al., 2017; Page, Zhu and Appleyard, 2018). 
Glutamate reuptake is a key function of astrocytes and blockade of transporters 
alters transmission across the ST→NTS synapse leading to cardiorespiratory 
depression, mediated by increased parasympathetic output (Matott et al., 2016; 
Matott, Kline and Hasser, 2017; Yamamoto and Mifflin, 2018). We sought to build 
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upon and refine these studies by examining how inhibiting astrocyte glutamate 
transporters changes activity at the ST→NTSTH synapse which is known to 
mediate satiety (Appleyard et al., 2007; Roman, Derkach and Palmiter, 2016; 
Aklan et al., 2020). 
5.2 | Aims and hypotheses 
In the experiments described in this chapter we first aimed to assess the 
population response of NTS neuronal activity to high fat chow intake, exogenous 
application of NMDA-R agonists and whether the latter was regulated by the 
former. We hypothesised that multi-unit (MU) firing rate would be greater at rest 
in NTS slices from high fat chow fed mice than standard chow fed controls. We 
also hypothesised that the response to D-serine would be lower in slices from 
high fat fed mice indicative of higher D-serine availability at rest. 
Secondly, we aimed to assess the contribution of astrocytic glutamate reuptake 
to synaptic integration of vagal cues in NTSTH neurons. We hypothesised that the 
amplitude of ST-evoked excitatory postsynaptic currents (EPSCs) would be 
reduced while the frequency of spontaneous EPSCs would be increased. 
5.3 | Results 
5.3.1 | Perforated Multi-Electrode Array allows population recording in the NTS 
As discussed earlier (Section 1.2.2.1), the organisational logic of NTS 
neurochemical populations is not well understood compared to other brain 
regions (e.g. cortex, hippocampus, and cerebellum). Studies using targeted 
single-cell recordings in mice expressing fluorescent proteins in cell types of 
interest (Doyle et al., 2004) have successfully characterised the 
electrophysiological features of numerous classes of NTS neuron (Appleyard et 
221 
 
al., 2005, 2007; Bailey et al., 2008; Thek et al., 2019). However, population level 
responses in NTS neuronal activity have not been studied.  
Here, our interest was in observing changes in electrical activity of NMDA-
responsive NTS neurons as a population across the nucleus, irrespective of 
neurochemical identity. To achieve unbiased recordings, we used a perforated 
multi-electrode array (pMEA) to record extracellular neural activity across the 
NTS in ex vivo slices. (Figure 5.3.1 a). This approach has recently been used to 
record activity in two hypothalamic nuclei and has certain advantages over single 
cell recordings (Hanna et al., 2017, 2020). Namely, neuronal activity across a 
complex, neurochemically diverse brain area can be simultaneously recorded 
and the spatial positions of activity within the recorded section are known. Each 
electrode site (channel) allows the extracellular recording of neuronal activity. 
This multi-unit activity (MUA) includes voltage ‘spikes’ (indicative of neuronal 
action potential firing) and thus the combined firing rate of units (neurons) in the 
vicinity of the electrode is measured by recording the frequency of these spikes 
for a given channel (MU firing rate). 
Arrays in a 6x10 electrode configuration provided sufficient coverage to record 
from the entire medial-lateral and dorsal-ventral extent of the NTS on a given side 
(Figure 5.3.1 a-c). For the experiment, slices were left to acclimatise on the MEA 
for half an hour before recording began. The baseline period was 20 minutes 
followed by bath application of NMDA for 10 minutes, NMDA + D-serine for the 
following 10 minutes and finally a 10 minute aCSF ‘wash’ period (Figure 5.3.2 a, 
b). Channels with MUA which was increased by bath application of 30 μM NMDA 
were judged to have active, viable cells in the vicinity of the recording electrode. 
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Figure 5.3.1 | pMEA recording set up for NTS. a, 6x10 array of electrodes 
(black dots). b, ex vivo NTS-containing brain slice on the pMEA in aCSF held 
down by a harp. c, annotated image showing positions of electrodes and atlas 
overlay to indicate electrode positions relative to the NTS. Scale bars = 500 µm. 
AP = area postrema, NTS = nucleus of the solitary tract. 
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Figure 5.3.2 | Recording protocol and drug treatments. a, Representative 
firing rate of NMDA-responsive channels on a single pNTS slice during the 
recording (n = 34 channels from one slice, bin size = 1 minute). b, Schematic of 
recording protocol illustrating the different periods and durations of drug 
treatments. This schematic is aligned to the x-axis of a. 
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5.3.2 | High fat chow hyperphagia increased the firing rate of NTS channels at 
baseline 
In order to assess the impact of high fat chow induced hyperphagia on NTS 
neuronal firing, 300μm coronal slices containing the NTS were obtained from 
mice fed either standard chow or high fat chow for 12 hours during the dark 
phase. As in previous experiments, mice fed a high fat chow for this period had 
a greater energy intake during the feeding period than those in the standard chow 
control group (Figure 5.3.3 a, 11.26 ± 0.48 vs 18.77 ± 0.71 kcal; p < 0.0001, 
unpaired t-test). Since these mice were not perfused the contents of the stomach 
were able to be accurately measured. Mice fed a high fat chow had greater 
stomach contents (by mass) at the end of the 12 hour feeding period than those 
in the standard chow control group (Figure 5.3.3 b, 0.45 ± 0.033 vs 1.20 ± 0.096 
g; p < 0.0001, unpaired t-test).  
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Figure 5.3.3 | Food intake and stomach contents of experimental mice. a, 
Energy intake during the 12 hour period prior to brain tissue collection of mice fed 
standard and high fat chow (11.26 ± 0.48 vs 18.77 ± 0.71 kcal; n= 5 mice/group 
p < 0.0001, unpaired t-test). b, Stomach contents of mice fed either standard 
chow or high fat chow (0.45 ± 0.033 vs 1.20 ± 0.096 g; n= 5 mice/group p < 
0.0001, unpaired t-test) This panel is also shown in Figure 3.3.1 d. 
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Given the high dimensionality of this data (50000 samples/sec x 59 channels x 
3000 seconds x 20 slices) an analytical pipeline was employed to aid in the 
extraction of relevant data (Figure 5.3.4 a). From the experiments we obtained 
20 slice recordings (1,180 channels) from ten mice. 650 of these channels did 
not meet the inclusion criteria (based on channel location and activity) and were 
discarded from further analysis. Of the remaining 530 channels, baseline firing 
rate and response to drug applications were compared between feeding groups. 
The mean baseline MU firing rate was greater on NTS channels in slices from 
high fat fed mice compared with standard chow fed controls (Figure 5.3.5 a, 0.12 
± 0.305 vs 0.3 ± 0.98 Hz; median ± interquartile range, p < 0.0001, Mann-Whitney 
test). These data, like other population recordings, are heavily skewed in the 
direction of low frequency (Buzsáki and Mizuseki, 2014). To better visualise the 
distribution and compare the differences the same data are also shown against 
a logarithmic10 y-axis (Figure 5.3.5 b). 
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Figure 5.3.4 | Analysis pipeline for pMEA recordings. a, Flow chart for channel 
selection and grouping for further analysis. b, The number of pNTS channels per 
slice included in statistical analysis did not differ between groups (n = 5 slices, 30 
± 4.9 vs 29.8 ± 7 channels, p = 0.98, unpaired t-test). cNTS = caudal nucleus of 
the solitary tract, HF = high fat chow fed, pNTS = postremal nucleus of the solitary 
tract, rNTS = rostral nucleus of the solitary tract, S = standard chow fed. 
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Figure 5.3.5 | Greater baseline MU firing rate of channels across the NTS 
from mice fed high fat chow for 12 hours compared to standard chow fed 
controls. a, Baseline MU firing rate of channels across the NTS of standard chow 
and high fat chow fed mice (0.12 ± 0.305 vs 0.3 ± 0.98 Hz, n = 265 channels/group 
from 10 slices from 5 mice/group, p < 0.0001, Mann-Whitney test). b, Baseline 
MU firing rate of channels across the NTS of standard chow and high fat chow 
fed mice displayed on a logarithmic scale. Data are presented as median ± 
interquartile range. 
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5.3.3 | High fat chow hyperphagia increased the firing rate of pNTS channels at 
baseline 
In our previous experiment we found that the astrocyte GFAP-response to 12 
hour intake of high fat chow was most pronounced in the postremal NTS (pNTS) 
(Section 3.3.2). In addition, the literature shows that this is the region in which 
most gut-innervating vagal afferents terminate and is where appetite regulating 
neurons are abundant (Grill and Hayes, 2012; Williams et al., 2016; Han et al., 
2018; Bai et al., 2019). Because of this, we focussed on the pNTS for further 
analysis. Of the recorded slices, 1 per animal covered the pNTS with an equal 
number of channels that met the inclusion criteria between mice in the different 
diet groups (Figure 5.3.4 a, n = 149-150, n = 5 slices per group, 1 slice per 
mouse). Although there was variation in the number of suitable channels per slice 
this variation was equal between the different diet groups (Figure 5.3.4 b). The 
baseline MU firing rate was greater in channels in the pNTS of mice fed a high 
fat chow than from standard chow fed mice (Figure 5.3.6 a 0.12 ± 0.34 vs 0.37 ± 
1.15 Hz; median ± interquartile range, p < 0.0001, Mann-Whitney test). Again, 
the logarithmic plot is also shown (Figure 5.3.6 b). Since the MEA also gives 
spatial information (i.e. the electrode position is known) the approximate location 
of each electrode relative to the central canal was calculated and plotted with the 
colour of the point corresponding to firing rate for standard chow fed mice (Figure 
5.3.6 c) and high fat chow fed mice (Figure 5.3.6 d). This shows that high fat 
chow intake for 12 hours elevates neuronal population activity in the NTS. 
Since the experimental manipulation (the diet) was applied to mice and the 
activity of many channels was recorded simultaneously, the possibility of 
individual channels influencing one another means they are not truly independent 
samples (Lazic, Clarke-Williams and Munafò, 2018). To account for this the data 
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were also analysed with slice (or mouse since only one slice per mouse is used) 
as a nested variable. Since the data were not normally distributed the data were 
first transformed by y=log(x) to allow for parametric statistical testing. This 
analysis (Figure 5.3.6 e) shows that elevated firing in high fat chow fed channels 
is statistically significant when the influence of slice is accounted for. 
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Figure 5.3.6 | Greater baseline MU firing rate of channels in the postremal 
NTS (pNTS) from mice fed a high fat chow for 12 hours compared to 
standard chow fed controls. a, Baseline MU firing rate of channels in the pNTS 
of standard chow and high fat chow fed mice (0.12 ± 0.34 vs 0.37 ± 1.15 Hz; n = 
149-150 channels/group from 5 slices from 5 mice/group, p < 0.0001, Mann-
Whitney test). b, Baseline MU firing rate of channels in the pNTS of standard 
chow and high fat chow fed mice against a logarithmic scale. c, Heat map 
showing approximate electrode locations and baseline MU firing rate for standard 
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chow fed mice (n = 150 channels from 5 slices from 5 mice). d, Heat map showing 
approximate electrode locations and baseline MU firing rate for high fat chow fed 
mice (n = 149 channels from 5 slices from 5 mice). e, Baseline MU firing rate with 
slice as a nested variable (n = 145-150 channels/group from 5 slices from 5 
mice/group, p = 0.035, nested t-test on y=log(x) transformed data). Data are 
presented as median ± interquartile range. 
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5.3.4 | Firing rate of channels in cNTS and rNTS at baseline 
For each mouse, in addition to the pNTS slice, recordings were made from a 
second slice. The initial aim was to record from the caudal NTS (cNTS) but in 
situations where this slice was unsuitable, the rostral NTS (rNTS) was used. As 
with the pNTS the baseline MU firing rate of channels from the cNTS again 
indicated a greater firing rate in high fat chow fed mice than standard chow fed 
controls (Figure 5.3.7 a, b). Likewise, the baseline MU firing rate of channels 
from the rNTS indicate a greater firing rate in high fat chow fed mice than standard 
chow fed controls (Figure 5.3.7 c, d). By chance, the group sizes within the rNTS 
and cNTS recordings were unbalanced (See Figure 5.3.4). The data are not 
suitable for statistical hypothesis testing, particularly as in two groups (rNTS high 
fat chow and cNTS standard chow) all the data were obtained from a single 
mouse. As such, all subsequent analysis was only performed on the data 
obtained from pNTS slices. 
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Figure 5.3.7 | Firing was greater in slices from high fat chow fed mice in the 
cNTS and rNTS. a, Baseline MU firing rate of channels in the cNTS of standard 
chow and high fat chow fed mice (n = 28 channels from 1 slice from 1 mouse 
[Standard Chow], n = 73 channels from 4 slices from 4 mice [High Fat Chow]). b, 
Baseline MU firing rate of channels in the cNTS of standard chow and high fat 
chow fed mice against a logarithmic scale. c, Baseline MU firing rate of channels 
in the rNTS of standard chow and high fat chow fed mice (n = 87 channels from 
4 slices from 4 mice [Standard Chow], n = 43 channels from 1 slice from 1 mouse 
[High Fat Chow]). d, Baseline MU firing rate of channels in the rNTS of standard 
chow and high fat chow fed mice against a logarithmic scale. Data are presented 
as median ± interquartile range. 
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5.3.5 | NMDA increased MU firing rate in pNTS channels and this effect was 
potentiated by co-application of D-serine 
In the hippocampus and hypothalamus, astrocytes gate the excitability of 
postsynaptic neurons by modulating extracellular D-serine levels and, by proxy, 
NMDA-mediated excitability since NMDA receptors rely on glutamate and a co-
agonist (either D-serine or glycine) for activation (Panatier et al., 2006; Papouin, 
Dunphy, et al., 2017; Robin et al., 2018). In order to ascertain whether D-serine 
could regulate neuronal activity in the pNTS, we tested the population response 
to application of D-serine in the presence of saturating concentrations of NMDA. 
After baseline firing rates were established, agonists for the NMDA-R were added 
to the bath. In both feeding groups bath application of NMDA increased the MU 
firing rate (Figure 5.3.8 a). This effect was potentiated by the co-application of D-
serine with NMDA (Figure 5.3.8 a). When the slice was returned to being 
perfused with aCSF (washout) MU firing rate decreased (Figure 5.3.8 a). Of note, 
the mean MU firing rate of channels in slices from high fat chow fed mice was 
higher than standard chow fed mice throughout the whole recording. 
MU firing rates during the final 180 seconds of each application window were 
quantified for statistical analysis. In pNTS, channels in slices from standard chow 
fed mice there was a statistically significant increase in MU firing rate in the 
presence of NMDA relative to the baseline rate (Figure 5.3.8 b, c). In the 
presence of NMDA and D-serine there was a statistically significant increase in 
MU firing rate compared to the baseline rate and NMDA alone (Figure 5.3.8 b, 
c). This was also true of pNTS channels in slices from mice fed a high fat chow 
(Figure 5.3.8 d, e). This indicates that, as a population, NMDA responsive 
neurons in the NTS are sensitive to D-serine and identifies D-serine as a 
candidate gliotransmitter capable of exciting these neurons. 
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Analysis accounting for the slice as a nested variable showed that NMDA 
increased MU firing rate and NMDA + D-serine further increased this firing on 
channels from standard chow fed mice (Figure 5.3.9 a). The effect of NMDA was 
also observed in high fat fed mice although co-application of NMDA + D-serine 
did not further increase MU firing rate (Figure 5.3.9 b). This is potentially 
indicative of a differential response to D-serine in different slices from high fat 
chow fed mice. 
Spike waveforms are shown from a representative recording (Figure 5.3.10). The 
shape of these waveforms is influenced by the proximity of a neuron to the 
recording electrode and ought to be stable throughout a recording. On the 
majority of these channels the waveform is the same shape between baseline 
(Figure 5.3.10 a) and drug treatments (Figure 5.3.10 b). This indicates that the 
same neurons are firing between the treatments. However, on some channels 
(e.g. channel 68) the waveform changes between the baseline and treatment 
periods which suggests a previously silent neuron has begun firing in response 
to drug treatment. Further analysis using principle component analysis and spike 
sorting could permit the separation of individual neurons in these instances. 
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  MU firing rate (Hz) 
Figure 5.3.8 | Bath application of NMDA increases MU firing rate in the pNTS 
and this effect is potentiated by co-application of D-serine. a, Mean (± SEM) 
MU firing rate of pNTS channels from standard chow and high fat chow fed mice 
throughout the duration of recording (n = 149-150 channels/group from 5 slices 
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from 5 mice/group). b, Heat maps showing the approximate position and MU 
firing rate of channels in the pNTS of standard chow fed mice in the different drug 
windows. c, MU firing rate of channels in the pNTS of standard chow fed mice at 
rest, during bath application of NMDA and during bath application of NMDA + D-
serine (n = 150 channels/group from 5 slices from 5 mice/group, Friedman test, 
p < 0.0001, Dunn’s multiple comparisons test). d, Heat maps showing the 
approximate position and MU firing rate of channels in the pNTS of high fat chow 
fed mice in the different drug windows. e, MU firing rate of channels in the pNTS 
of high fat chow fed mice at rest, during bath application of NMDA and during 
bath application of NMDA + D-serine (n = 149 channels/group from 5 slices from 
5 mice/group, Friedman test, p < 0.0001, Dunn’s multiple comparisons test). **** 
= p < 0.0001. Data are presented as median ± interquartile range with the 
exception of panel a. 
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Figure 5.3.9 | NMDA-R agonists enhance MU firing in pNTS slices. a, MU 
firing rate of channels in the pNTS of standard chow fed mice at rest, during bath 
application of NMDA and during bath application of NMDA + D-serine with slice 
as a nested variable (n = 150 channels/group from 5 slices from 5 mice/group, 
nested One-way ANOVA performed on y=log(x) transform of data, p < 0.0001, 
F(2,447) = 150.9 Tukey’s multiple comparisons test). b, MU firing rate of channels 
in the pNTS of high fat chow fed mice at rest, during bath application of NMDA 
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and during bath application of NMDA + D-serine with slice as a nested variable 
(n = 149 channels/group from 5 slices from 5 mice/group, nested One-way 
ANOVA performed on y=log(x) transform of data, p = 0.0008, F(2,12) = 13.74, 
Tukey’s multiple comparisons test). * = p < 0.05, ** = p < 0.01, *** = p < 0.001,  
**** = p < 0.0001. 
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Figure 5.3.10 | Representative spike waveforms. a, Representative spike 
waveforms from a single pNTS slice during the baseline period. b, Representative 
spike waveforms from the same slice during the NMDA and NMDA + D-serine 
periods. 
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5.3.6 | In the pNTS channels from high fat chow fed mice showed greater 
responses to NMDA-R agonists 
As mentioned above, D-serine and glycine are co-agonists for the NMDA-R. In 
order to examine the relative contributions of the glutamate site, the co-agonist 
site and whether these were regulated by nutritional state, we compared the 
relative changes in MU firing rate evoked by the different drug treatments 
between feeding groups.  
The application of NMDA alone resulted in an increase in MU firing rate. Since 
this saturating concentration is assumed to activate all available NMDA-Rs, 
subtracting the NMDA MU firing rate from the baseline MU firing rate shows the 
residual ‘glutamate capacity’ (Figure 5.3.11 a). The glutamate capacity is 
indicative of the number of unbound glutamate NMDA-R sites and is inverse to 
baseline agonist (glutamate and D-serine) availability. There was no statistically 
significant difference in glutamate capacity between the two diet groups (Figure 
5.3.11 b, 1.02 ± 2.16 vs 1.31 ± 4.04 Hz, median ± interquartile range, p = 0.08, 
Wilcoxon matched-pairs test). This suggests that there is no difference in the 
ambient glutamate and D-serine availability at rest between diet groups.  
The co-application of NMDA and D-serine resulted in an increase in MU firing 
rate relative to NMDA alone in both diet groups. This saturating concentration is 
assumed to activate all of the co-agonist sites of NMDA-Rs (Papouin, Dunphy, et 
al., 2017), thus subtracting the NMDA + D-serine MU firing rate from the NMDA 
MU firing rate shows the ‘co-agonist capacity’ (Figure 5.3.11 a). The co-agonist 
capacity is indicative of the number of unbound co-agonist NMDA-R sites and is 
inverse to baseline D-serine and glycine availability. Since astrocytes show 
morphological changes induced by the acute high fat chow stimulus we 
hypothesised that co-agonist capacity would be lower in this group than standard 
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chow fed, indicating elevated baseline D-serine levels in the NTS. The reverse 
was true, co-agonist capacity was greater in the high fat chow fed group 
suggesting that occupancy of the co-agonist site at rest is lower in this group 
(Figure 5.3.11 c, 0.48 ± 1.05 vs 0.9 ± 2.69 Hz, median ± interquartile range, p = 
0.0005, Wilcoxon matched-pairs test). 
Finally, indicative of total possible NMDA-R mediated MU firing, the maximum 
capacity was calculated by subtracting the NMDA + D-serine MU firing rate from 
the baseline MU firing rate (Figure 5.3.11 a). The maximum NMDA-R capacity 
was greater in the high fat chow fed group compared with the standard chow fed 
group (Figure 5.3.11 d, 1.65 ± 3.30 vs 2.20 ± 6.59 Hz, median ± interquartile 
range, p = 0.023, Wilcoxon matched-pairs test). This indicates that there is 
greater potential for NMDA-R excitability in slices from high fat fed mice 
compared with those fed standard chow. This suggests, in contrast to our 
hypothesis, that in fact the elevated baseline firing rate is not controlled by the 
increased availability of endogenous agonists for the NMDA-R, instead these 
channels are more excitable by NMDA-R agonism as indicated by the greater 
maximum NMDA-R capacity, suggesting perhaps that the number of receptors is 
upregulated in this condition.  
When these agonist capacity analyses were repeated with the inclusion of slice 
as a nested variable none of the comparisons reached statistical significance 
(Figure 5.3.11 e-g). This indicates that observed differences in the above 
analyses may originate from differences between slices rather than a uniform 
effect of agonists in slices from different diet groups. 
Overall, this study shows that independent of greater baseline MU firing rate, that 
MU activity in slices from high fat diet fed mice is more sensitive to combined 
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application of agonists for both the glutamate and co-agonist sites of the NMDA-
R, which may reflect a difference in receptor number. 
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Figure 5.3.11 | Total capacity of NMDA-R mediated firing and co-agonist 
capacity of NMDA-R mediated firing are greater in pNTS channels from high 
fat chow fed mice. a, Schematic describing how the different components of 
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NMDA-dependent MU firing rate are calculated. b, Glutamate capacity (NMDA 
MU firing rate – baseline MU firing rate) of pNTS channels in slices from standard 
chow fed (S) and high fat chow fed (HF) mice (1.02 ± 2.16 vs 1.31 ± 4.04 Hz, n = 
149-150 channels/group from 5 slices from 5 mice/group, p = 0.08, Wilcoxon 
matched-pairs test). c, Co-agonist capacity (NMDA + D-serine MU firing rate – 
NMDA MU firing rate) of pNTS channels in slices from S and HF fed mice (0.48 
± 1.05 vs 0.9 ± 2.69 Hz, n = 149-150 channels/group from 5 slices from 5 
mice/group, p = 0.0005, Wilcoxon matched-pairs test). d, Maximum capacity 
(NMDA + D-serine MU firing rate – baseline MU firing rate) of pNTS channels in 
slices from S and HF fed mice (1.65 ± 3.30 vs 2.20 ± 6.59 Hz, n = 149-150 
channels/group from 5 slices from 5 mice/group, p = 0.023, Wilcoxon matched-
pairs test). e, Glutamate capacity (NMDA MU firing rate – baseline MU firing rate) 
of pNTS channels from S and HF fed mice with slice as a nested variable (n = 
149-150 channels/group from 5 slices from 5 mice/group, p = 0.67, nested t-test). 
f, Co-agonist capacity (NMDA + D-serine MU firing rate – NMDA MU firing rate) 
of pNTS channels from S and HF fed mice with slice as a nested variable (n = 
149-150 channels/group from 5 slices from 5 mice/group, p = 0.38, nested t-test). 
g, Maximum capacity (NMDA + D-serine MU firing rate – baseline MU firing rate) 
of pNTS channels from S and HF mice with slice as a nested variable (n = 149-
150 channels/group from 5 slices from 5 mice/group, p = 0.51, nested t-test). All 
nested tests were performed on data transformed by y=log(x). Data are 
presented as median ± interquartile range with the exception of panel a. 
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5.3.7 | Whole-cell patch clamp in the horizontal slice to investigate glial 
glutamate reuptake 
In addition to gliotransmission, astrocytes can also modulate neuronal excitability 
by regulating extracellular glutamate levels. Since glutamate is the primary 
transmitter at the ST→NTS synapse this is a very important process. Indeed, in 
rats, pharmacological blockade of the primary glutamate transporter excitatory 
amino acid transporter 2 (EAAT2) increases parasympathetic output to the 
cardiovascular system in an AMPA-R dependent manner (Matott, Kline and 
Hasser, 2017; Yamamoto and Mifflin, 2018).  
To examine the effects of EAAT2 blockade on appetite-suppressing neurons in 
the mouse brain we made whole cell patch clamp recordings of fluorescent cells 
in horizontal brainstem slices from mice expressing enhanced green fluorescent 
protein (EGFP) in TH cells (TH-EGFP mice). In this preparation the solitary tract 
is preserved which allows for its electrical stimulation (Figure 5.3.12 a). In 
addition, NTSTH neurons can be visualised for patch clamp by their expression of 
EGFP (Appleyard et al., 2007). We used a recording protocol where in the voltage 
clamp configuration, ‘spontaneous’ activity was recorded for 1 second followed 
by a 10 pulse @ 50 Hz stimulation train to measure ‘evoked’ activity. The 
remainder of the protocol (total length 6 seconds) was a measure of 
‘asynchronous’ activity, a type of non-time locked, activity-dependent 
phenomenon observed at this synapse (Peters et al., 2010; Wu, Fenwick and 
Peters, 2014). A representative trace from this protocol is shown in Figure 5.3.12 
b. 
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Figure 5.3.12 | Patch clamp recording in the horizontal brainstem slice. a, 
Example of a horizontal slice at 4X magnification. b, Representative trace from 
10 sweeps of the recording protocol, mean of 10 sweeps in black, individual 
sweeps in grey. 4V = fourth ventricle, NTS = nucleus of the solitary tract, ST = 
solitary tract. 
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5.3.8 | DHK reduced the size of evoked EPSCs into NTSTH neurons 
The size of evoked EPSCs were measured in aCSF (baseline), dihydrokainic acid 
(DHK [100 µM]), and after being returned to aCSF (washout) (A representative 
trace from the baseline condition is shown in Figure 5.3.13 a). As previously 
observed (Appleyard et al., 2007), NTSTH neurons showed large time-locked 
EPSCs and frequency-dependent depression with repeated stimulation (Figure 
5.3.13 a). Representative mean (of 10 sweeps) EPSCs from each condition are 
shown in Figure 5.3.13 b. Quantification of EPSC amplitude showed that the size 
of the first evoked EPSC was reduced by DHK (402.4 ± 88.43 vs 319.6 ± 87.37 
pA) and did not recover with 10 minutes of washout (Figure 5.3.13 c). 
Importantly, in cells that were untreated but had aCSF fed through the drug 
delivery system for the same period, there was no change in evoked EPSC 
amplitude (Figure 5.3.13 d). Looking at the amplitude of the first EPSC over the 
whole recording period shows a step-wise decrease during the DHK period 
before plateau of this effect in the washout (Figure 5.3.13 e). This is suggestive 
of a true effect of DHK rather than a gradual ‘run down’ of the evoked response. 
There was no observed change in the ratio of EPSC2/EPSC1 (paired-pulse ratio) 
although this ratio was heterogeneous between cells which makes mechanistic 
conclusions difficult (Figure 5.3.13 f). Taken together this shows that inhibition of 
astrocyte glutamate transport reduces fidelity of communication between vagal 
afferents and NTSTH neurons. This suggests that under normal conditions 
astrocyte glutamate transport contributes to sustaining this synaptic transmission. 
 
 
250 
 
 
Figure 5.3.13 | Effect of DHK on evoked EPSCs in NTSTH neurons. a, 
Representative trace from 10 DHK sweeps (sweeps in grey, mean of 10 sweeps 
in black). b, Representative trace from 10 wash sweeps (sweeps in grey, mean 
of 10 sweeps in black). c, Evoked EPSC amplitude during baseline, DHK and 
wash (n = 8 cells from 5 mice, Two-way RM ANOVA, DHK, p < 0.0001, F(2,70) = 
14.96; Stimulation, p = 0.17, F(4,35) = 1.73, interaction, p = 0.28, F(8,70) = 1.25, 
Sidak’s post-hoc test). d, Evoked EPSC during baseline, aCSF and washout (n 
251 
 
= 4 cells from 3 mice, Two-way RM ANOVA, aCSF, p = 0.32, F(2,30) = 1.20, 
Stimulation, p = 0.53, F(4,15) = 0.82, interaction, p = 0.83, F(8,30) = 0.52, Sidak’s 
post-hoc test, p > 0.05 for all comparisons). e, Mean amplitude of EPSC1 
throughout the recording period (n = 8 cells from 5 mice). f, Paired pulse ratio in 
the final minute of each condition (n = 8 cells from 5 mice, One-way RM ANOVA, 
treatment, p = 0.48, F(2,14) = 0.76, Dunnet’s post-hoc test, p > 0.05 for all 
comparisons). *** = P< 0.001. 
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5.3.9 | DHK did not affect the frequency of spontaneous or asynchronous 
EPSCs into NTSTH neurons 
The recording protocol also permitted recording of EPSCs outside of the 
stimulation window. A representative trace of this is shown in Figure 5.3.14 a. 
Note the increased EPSC frequency following stimulation, this is termed 
asynchronous release and is shown to be mediated by glutamate released from 
presynaptic terminals in an activity dependent fashion (Peters et al., 2010). This 
quickly decays and EPSC frequency returns to baseline frequency. Quantification 
of cumulative EPSCs in 0.1s bins over 30 sweeps shows that DHK did not affect 
the spontaneous (prior to stimulation) or asynchronous (immediately after 
stimulation) EPSC frequency (Figure 5.3.14 b). Statistical analysis of the 
cumulative EPSCs in the time bins immediately before and immediately after 
stimulation showed that there was no difference in pre stimulation (i.e. 
spontaneous EPSC) or post stimulation (i.e. asynchronous EPSC) between 
aCSF and DHK (Figure 5.3.14 c). The amplitude of spontaneous and 
asynchronous EPSCs was decreased upon bath incubation with DHK (Figure 
5.3.14 d). This suggests that, contrary to our hypothesis, the accumulation of 
glutamate in the synapse did not lead to increased spontaneous activation of 
postsynaptic receptors. However in agreement with the observed reduction in 
evoked EPSC amplitude, the amplitude of spontaneous and asynchronous 
EPSCs was reduced by DHK. This is potentially indicative of reduced presynaptic 
release of glutamate for a given release event. 
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Figure 5.3.14 | DHK did not affect the frequency of spontaneous and 
asynchronous EPSCs in NTSTH neurons. a, Representative trace from a single 
sweep with the stimulation window omitted for clarity. b, Quantification of the 
cumulative number of EPSCs in 0.1 ms bins across 30 sweeps. c, Number of 
EPSC events in the bin immediately prior to stimulation (pre) or immediately 
following stimulation (post) at baseline and following bath application of DHK (n 
= 8 cells from 5 mice, Two-way RM ANOVA, Stimulation, p < 0.0001, F(1,14) = 
28.29, DHK, p = 0.87, F(1,14) = 0.025, interaction, p = 0.92, F(1,14) = 0.01, Sidak’s 
post-hoc test). d, Frequency distribution of EPSC amplitudes across 30 sweeps. 
Bins are ± 5 pA. (n = 8 cells from 5 mice, Two-way RM ANOVA, Bin, p < 0.0001, 
F(24,150) = 5.3.22, DHK, p < 0.0001, F(1,150) = 26.28, interaction, p = 0.04, F(1,14) = 
0.01, Sidak’s post-hoc test). ** = p < 0.01, *** = p < 0.001. 
 
 
 
 
 
 
 
 
 
 
255 
 
5.4 | Discussion 
In this chapter we have used two different electrophysiological methods to 
interrogate two potential mechanisms of astrocyte-neuron communication in the 
NTS. First, we show that high fat chow intake results in greater MU activity in the 
NTS and that these neurons are able to sense exogenous D-serine. Second, we 
show that blockade of EAAT2 modulates the integration of vagal signals by 
NTSTH neurons raising the possibility that this process may be plastic in the intact 
brain. 
5.4.1 | Perforated Multi-Electrode Array allows population recording in the NTS 
By utilising the pMEA we were able to record multi-unit activity at 59 sites across 
the NTS simultaneously. Despite this advantage, a certain level of detail is lost 
when compared with single cell recordings. For example, we were not able to 
separate individual units by spike sorting. Additionally. due to measuring 
extracellular spikes we could not use synaptic blockers and as such cannot 
distinguish between intrinsic excitability and network activity. Despite these 
limitations the study provides initial insight into the effects of feeding on multiunit 
activity in the NTS and response to exogenously applied ligands for NMDA-R in 
these conditions. Future studies could focus on understanding this phenomenon 
in greater detail, perhaps by single cell recording to ascertain whether increased 
firing following high fat chow intake is a function of greater intrinsic excitability, 
greater synaptic input or some combination of the two. Furthermore, by 
combining this preparation with direct manipulation of astrocytes (e.g. using 
chemogenetics), neuron-glia interactions may be better studied. 
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5.4.2 | Assessment of the differential contribution of NMDA-R agonist binding 
sites to MU firing rate 
We analysed differences in MU activity between drug conditions in our pMEA 
experiment and compared these between the diet groups to infer the state of 
NMDA-R ligand binding in the baseline period. However, this analysis was 
dependent on some assumptions; that the capacity for NMDA-R-mediated 
excitability are the same and that the glutamate receptor number (both AMPA-R 
and NMDA-R) is roughly equivalent between groups. It appears that at least one 
of these assumptions is wrong, given that the maximum capacity for NMDA-R 
excitability is greater in mice from the high fat diet fed group. This suggests that 
perhaps there is an upregulation of NMDA-R which means not only are neurons 
in these slices more excited (i.e. greater baseline MU firing rate), but they have 
greater NMDA-R excitability (i.e. greater maximum NMDA-R capacity). This limits 
the inferences of baseline agonist availability we can draw from the glutamate 
capacity and co-agonist capacity analyses. 
Another limitation of the study, alluded to above, is that it does not differentiate 
between the contribution of the different glutamate receptor subtypes to the 
effects seen. Addition of bath application of a specific NMDA-R antagonist at 
40mins (i.e. NMDA + D-serine + NMDA-R antagonist) prior to wash out would 
have enabled the contribution of non-NMDA glutamatergic receptor activation to 
the baseline firing to be revealed and would also have provided additional 
confidence in the specificity of the effects seen. Future studies, e.g. using 
radioligand binding, could be used to specifically determine the impact of 12 hour 
high fat diet consumption on NTS ionotropic glutamate receptor expression.  
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5.4.3 | Mechanisms underlying EAAT2 blockade reducing evoked EPSC in 
NTSTH neurons 
We found that bath application of DHK reduced the evoked EPSC resulting from 
ST stimulation in NTSTH neurons. We hypothesised that this was due to reduced 
glutamate being taken into the astrocyte and therefore not returned to the 
presynaptic neuron as glutamine. This could be tested by repeating the 
experiment and adding glutamine to the aCSF during DHK treatment to see if the 
effect is rescued. Alternatively, increased synaptic glutamate may activate 
presynaptic mGlu-Rs which reduce presynaptic glutamate release as a negative 
feedback mechanism (Oliet, Piet and Poulain, 2001). In future work this could 
also be further explored using specific inhibitors of mGlu-Rs. Similarly we found 
the amplitude of spontaneous and asynchronous EPSCs was reduced by DHK 
further suggesting reduced presynaptic glutamate release. 
We did not observe a change in the paired-pulse ratio between conditions 
suggesting there was no change to presynaptic release probability. However, in 
contrast to other reports (Appleyard et al., 2007; Yamamoto et al., 2010), we saw 
heterogeneity in this parameter. Typically in NTS neurons the PPR is low 
indicating a high release probability upon first stimulation but this was variable in 
our sample. 
The effect of DHK in NTSTH neurons in mice differs to that of unlabelled NTS 
neurons in rats. For example, Matott et al found that DHK treatment induced a 
slow inward current that we did not observe (Matott, Kline and Hasser, 2017). 
They also found that spontaneous EPSCs were greater in DHK than at baseline 
which we did not. However, in our study we were not recording true spontaneous 
EPSCs since we were stimulating every 6 seconds which potentially interferes 
with, or masks changes in spontaneous EPSCs.  
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In further contrast to our study, Matott et al found that evoked EPSC amplitude 
was not reduced by DHK. It is unclear whether the conflicting outcomes between 
our studies and those of Matott et al represents either a species difference, 
differences in stimulation protocol, or a specific feature of vagal afferents 
connected to NTSTH neurons. This is intriguing since vagal afferents synapsing 
onto specific neuronal subtypes may have unique features masked in studies 
looking at unlabelled neurons. Both their study and ours found no change in the 
number of asynchronous events with DHK (Matott, Kline and Hasser, 2017). 
Since we have shown that neuronal firing and astrocyte morphology are altered 
following dietary manipulation it would be of interest in future studies to examine 
the effect of diet on EAAT2 glutamate uptake in the NTS and downstream effects 
on synaptic integration in NTSTH neurons. This could perhaps be achieved by 
whole-cell patch clamp recordings from NTS astrocytes in slices from standard 
chow and high fat chow fed mice in which EAAT2-dependent inward currents 
(indicative of transporter capacity) can be measured by focal application of D-
aspartate (Huda, McCrimmon and Martina, 2013; Matott, Kline and Hasser, 
2017). 
5.5 | Conclusion 
To conclude, in this chapter we have shown that MU neuronal activity is elevated 
in mice fed a high fat chow for 12 hours. This excitability may be mediated by 
greater sensitivity of neurons to endogenous NMDA-R agonists (i.e. glutamate 
and D-serine) possibly due to an increase in receptor number.  Secondly, we 
have shown that synaptic integration of vagal glutamate is impaired in NTSTH 
neurons when astrocyte EAAT2 is pharmacologically blocked. This suggests 
under normal conditions astrocyte EAAT2 glutamate uptake supports synaptic 
transmission from vagal afferents to these satiety signalling neurons. D-serine 
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gliotransmission and glutamate reuptake are two mechanisms by which 
astrocytes, activated after intake of high fat chow, may modulate neuronal 
signalling in the NTS to influence satiety. 
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Conclusion and outlook 
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6.1 | Key findings and contributions to scientific knowledge 
This project had three main aims:  
1) Identify the responses of NTS astrocytes to short and long term deviations in 
energy balance 
2) Assess the consequence of NTS/DVC astrocyte activation on food intake and 
related behaviours 
3) Examine potential mechanisms of astrocyte-neuron communication in the NTS 
with relevance to food intake  
The work presented in Chapter 3 of this thesis addressed the first aim by 
manipulating the diet of mice and examining NTS GFAP immunoreactivity then 
using this to assess changes in astrocyte cytoskeletal morphology. We found that 
overnight feeding of high fat chow provided the largest change in these two 
parameters indicating a role for these astrocytes in response to energy excess. 
These studies build on an established literature. Crucially we provide the first link 
between a wealth of literature indicating that GFAP immunoreactivity and 
morphology of astrocytes is highly plastic in the NTS (Table 1.1.1) and the 
understanding that the NTS mediates gut to brain satiety signalling (Grill and 
Hayes, 2012). We achieved this by showing that in a condition of caloric excess 
and stomach distension, NTS GFAP immunoreactivity is greater and the cells 
have a more ramified morphology, indicative of cellular activation.  
The second aim was addressed principally by direct chemogenetic activation of 
NTS astrocytes (and those in the surrounding DVC) and monitoring behavioural 
parameters in freely moving mice (Chapter 4). We found that activation of DVC 
astrocytes was sufficient to significantly reduce feeding under normal conditions 
and when drive to eat was enhanced after a prolonged fast. This was independent 
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of effects on locomotion or nociception. As such we provide the first causal 
evidence that NTS/DVC astrocyte activation reduces food intake and indeed the 
first described genetic manipulation of NTS astrocytes.  
Finally, with respect to aim 3, we are the first to utilise ex vivo NTS slices with 
pMEA to allow for large scale recording of population activity. We show this is 
elevated in mice fed a high fat chow for 12 hours. The electrophysiological studies 
of Chapter 5 represent some steps towards a mechanistic understand of 
astrocyte-neuron communication in the NTS in the context of nutritional 
manipulation but the ability to draw direct conclusions from these studies is limited 
and future work is required.  
Taken together the evidence presented in this thesis is consistent with the 
overarching hypothesis that NTS astrocytes are activated following food intake 
and that the consequence of this activation is to reduce food intake by enhancing 
the activity of satiety signalling neurons (Figure 6.1.1).  
Returning to our framework for central control of food intake (Figure 1.1.3) we 
have identified NTS astrocytes as a node within this circuit likely acting to regulate 
vagal signals of satiety within the NTS. In our experiments, this NTS astrocyte 
activation was artificially driven by hM3Dq but perhaps in vivo it is driven by vagal 
glutamate or hormones released in response to gastrointestinal distention and 
nutrients. Support for this comes from evidence presented in this thesis (Chapter 
3) of astrocyte activation after acute high fat chow intake. NTS astrocyte 
activation appears to modulate NTS satiety signalling neurons either directly (via 
gliotransmitters) or indirectly (by modulating glutamate transport or presynaptic 
transmission) and results in suppression of food intake likely via excitation of 
downstream lPBN neurons (possibly including lPBNCGRP neurons). This appears 
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to intercept ARCAgRP hunger signals since we also observed this effect in mice 
that were refed after a 12 hour fast. 
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Figure 6.1.1 | Summary of the main findings of this thesis as they relate to 
the overarching hypothesis. Simplified diagrammatic representation of the key 
results. NTS astrocytes are activated by acute intake of a high fat chow or direct 
chemogenetic stimulation. This activation causes morphological reorganisation 
of GFAP-immunoreactive processes in both instances. Chemogenetic activation 
of NTS/DVC astrocytes decreases food intake by activation of NTS neurons. In 
high fat chow fed mice there is a coincident increase in NTS neuronal firing which 
accompanies astrocyte activation. The consequences of this are unclear but 
astrocytes may be activated by high fat diet in order to drive compensatory 
changes in food intake (i.e. decreased) by increasing the activity of neighbouring 
satiety signalling neurons. 
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6.2 | Core limitations of work 
Since the specific technical limitations of each study are discussed within the 
results chapters, this section highlights key conceptual limitations of the work 
described in this thesis. 
6.2.1 | Reliance on inducible manipulations to infer function 
A limitation the work presented is that we have utilised an inducible manipulation 
in the form of hM3Dq and hM4Di in order to demonstrate the sufficiency of 
NTS/DVC astrocytes to modulate food intake. This provides crucial evidence to 
demonstrate the potential of these cells to be involved in satiety signalling and is 
a selective and reversible tool. However, in isolation, this approach is limited by 
the fact that the experimenter is inducing a specific type of activity in these cells 
which may not be in the range of its normal signalling repertoire. We arrive at an 
incomplete description of these cells since vital information is lacking on the 
activity throughout normal cycles of food intake and under experimental food 
manipulations in vivo. While we have been able to make inferences about this 
from ex vivo and post-mortem analyses, real time in vivo monitoring of astrocyte 
[Ca2+]i dynamics would be needed to complete the picture.  
Secondly, we demonstrated that chemogenetic activation of NTS/DVC astrocytes 
activated local and downstream neurons at the level of c-FOS expression. 
However, we did not further investigate the molecular/synaptic mechanism(s) by 
which chemogenetic activation of astrocytes exerts its effects on food intake. This 
was predominantly due to technical difficulties in preparing ex vivo brain slices 
from animals that had undergone virus injection surgery. Tissue scarring above 
the NTS where the dura had been removed made obtaining healthy intact slices 
very challenging. We were however able to examine two potential mechanisms 
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in non-virus injected mice using dietary manipulation and selective pharmacology 
(Chapter 5). 
6.2.2 | Reliance on ex vivo and post-mortem measurements to infer real time 
activity 
In Chapter 3 and Chapter 4 were able to show that in fixed brain sections from 
diet manipulated or chemogenetically manipulated mice that protein expression 
(GFAP and/or c-FOS) and cellular morphology were altered compared with 
control mice. From this we inferred that the cells had been activated by the 
experimental stimuli. However, using this indirect, end-point measure does not 
yield insight into the events leading up to this morphological change or its time 
course. For example, we are lacking information on the temporal relationship 
between food intake and [Ca2+]i variation and the signalling events occurring 
between food intake and  the astrocyte cytoskeletal reorganisation we observe. 
From the literature on ARCAgRP neurons we now know that despite showing c-
FOS expression and higher action potential firing in ex vivo slices (Takahashi and 
Cone, 2005), their true activity in vivo is far more dynamic across feeding 
behaviour (Betley et al., 2015; Chen et al., 2015; Mandelblat-Cerf et al., 2015). 
Therefore, there is potentially a far richer picture of NTS astrocyte activity across 
food intake in vivo than our analyses permit us to measure. 
Similarly, in Chapter 5 we demonstrate that multi-unit firing activity is greater in 
the NTS of ex vivo brain slices from mice fed high fat chow for 12 hours when 
compared with slices from mice fed standard chow. This has the same limitations 
in that we are measuring an end point and the actual activity of cells in this brain 
region during feeding and the progression towards satiation remain unknown. 
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In both these analyses, since we are only able to make our measurements at a 
single time point we rely on a between subjects experimental design which comes 
at the expense of statistical power. 
6.2.3 | Use of male mice 
Except for the whole cell patch clamp electrophysiology recordings in Chapter 5, 
all the experiments described in this thesis were performed on male mice. In the 
field there is a growing appreciation of the importance of performing experiments 
on animals of both sexes (Karp et al., 2017). Indeed, there is evidence that 
hypothalamic astrocytes show sexual dimorphism in rodents (Camandola, 2018) 
although the same has not yet been described for the NTS. In addition, there are 
well described sex differences in energy homeostasis in mice, including their 
weight gain and microglial response to feeding of high fat diet (Dorfman et al., 
2017; Wang and Xu, 2019). Designing experiments for both sexes however has 
its own complications since the experiment must be sufficiently powered to detect 
the main effect in the variable of interest and any potential effects of sex. As such 
the field has yet to reach a consensus on best practice (Karp et al., 2017). 
6.3 | Outstanding questions and future directions 
The knowledge generated in this thesis raises some interesting points for further 
consideration and research. These fall into three broad categories: signal 
detection, signal processing and signal propagation. 
6.3.1 | Signal detection: What are the cues that activate NTS astrocytes? 
In Chapter 3 we showed that intake of a high fat diet over 12 hours drove changes 
in protein immunoreactivity and cellular morphology indicative of cellular 
activation. This stimulus likely increases the release of glutamate from vagal 
afferents since these afferents are activated by physical distention and nutrient 
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content (Williams et al., 2016; Bai et al., 2019). Furthermore, ST stimulation 
causes glutamate release which is necessary for meal termination (Andresen and 
Yang, 1990; Treece et al., 1998). In our experiment the stomachs of the high fat 
fed mice were fuller (by mass) and the nutritional content of the food ingested 
was greater. Since NTS astrocytes are closely involved in glutamatergic 
transmission at this synapse, both by expression of AMPA-R and EAAT2 
(McDougal, Hermann and Rogers, 2011; Matott, Kline and Hasser, 2017) these 
nodes represent potential mechanisms by which increases in food intake may 
stimulate NTS astrocytes. For instance, activation of AMPA-R on NTS astrocytes 
by ST-stimulation causes an increase in [Ca2+]i, it is possible that this leads to 
downstream signalling that results in morphological plasticity in addition to other 
signalling like gliotransmission. 
A second potential mechanism is the modulation of astrocyte activity by hormonal 
satiety signals. There is some suggestive evidence in the literature that NTS 
astrocytes increase [Ca2+]i in response to leptin and GLP1 and that this activation 
modulates food intake (Reiner et al., 2016; Stein et al., 2020). Given that NTSPPG 
neurons are activated by food intake and have local terminals in the NTS 
(Kreisler, Davis and Rinaman, 2014; Card et al., 2018) it is possible that these 
neurons are the local source of GLP1 that act in part via astrocytes to inhibit food 
intake. Plasma leptin is elevated in mice fed a short term high fat diet (3 weeks) 
(Briggs et al., 2014) and it is possible it is acutely elevated in our paradigm which 
may activate astrocyte Ca2+ signalling by its action at the LepRb on NTS 
astrocytes (Stein et al., 2020).  A very enticing possibility is the idea that 
astrocytes in fact integrate these hormonal and neuronal cues of satiety and 
modify their homeostatic function (e.g. glutamate reuptake) to promote a 
corresponding reduction of food intake. 
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Figure 6.3.1 | Proposed signals leading to NTS astrocyte activation. 
Simplified diagrammatic representation of post-meal (post-prandial) satiety 
signals that may activate NTS astrocytes. Gut innervating vagal-sensory neurons 
are activated by GI stretch and nutrient content resulting in glutamate release in 
the NTS; this may activate AMPA-Rs on NTS astrocytes leading to [Ca2+]i 
elevations. Secondly this may increase the activity of EAAT2, the main glutamate 
transporter in the NTS. NTSPPG neurons are activated by food intake and may 
release GLP1 in the NTS, in turn this may activate GLP1-Rs on NTS astrocytes 
which has been shown to cause increased [Ca2+]i. Finally post-prandial leptin 
elevations may lead to greater leptin concentrations in the NTS; again activation 
of LepRb on NTS astrocytes leads to increased [Ca2+]i. While the link between 
[Ca2+]i and morphological change is not clear it is likely that the two are related 
since stimulation of Gq-GPCR signalling in NTS astrocytes leads to 
morphological reorganisation. EAAT2 = excitatory amino acid transporter 2, 
GFAP = glial fibrillary acidic protein, GLP1 = glucagon-like peptide, GLP1-R = 
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glucagon-like peptide 1 receptor, LepRb = long form leptin receptor, NTS = 
nucleus of the solitary tract, PPG = preproglucagon, ST = solitary tract. 
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6.3.2 | Signal processing: What is the real time Ca2+ ‘code’ of NTS/DVC 
astrocytes and how does it relate to food intake? 
As discussed above, while we were able to make inferences about astrocyte 
activity during feeding based on the effects of direct manipulation and end-point 
measures, the real time [Ca2+]i dynamics of NTS/DVC astrocytes are unknown. 
In the literature, a series of studies have shown broad somatic [Ca2+]i fluctuations 
in response to various pharmacological stimuli in mouse and rat brain slices 
indicating the presence of this signalling in NTS astrocytes (McDougal, Hermann 
and Rogers, 2011, 2013; Reiner et al., 2016; Rogers et al., 2018; Stein et al., 
2020) but the significance of this in vivo is not known. Future studies may make 
use of coincident advances in genetically encoded Ca2+ indicators (e.g. GCaMP) 
and deep-brain fluorescence recording (e.g. microendoscopy or fibre photometry) 
to record NTS/DVC astrocyte [Ca2+]i dynamics in vivo in awake behaving mice 
(King et al., 2020). As has been shown for ARCAgRP neurons, this information is 
very valuable for understanding the functions of populations of cells as they relate 
to feeding behaviour (Betley et al., 2015; Chen et al., 2015). 
6.3.3 | Signal propagation: How do astrocytes modulate vagal and NTS 
signalling to reduce food intake? 
In Chapter 4 we demonstrated that chemogenetic activation of DVC astrocytes 
reduced food intake and coincidentally induced activation of local neurons and 
downstream satiety circuits. In Chapter 5 we began to investigate mechanisms 
of astrocyte neuromodulation using diet manipulation and pharmacology. 
However, it remains to be demonstrated how exactly activation of DVC astrocytes 
stimulates satiety signalling NTS neurons.  
As discussed in detail in the individual chapter discussions, altered glial 
morphology changes the ability of astrocytes to perform their homeostatic 
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functions that maintain the synaptic microenvironment (Theodosis et al., 2004). 
Thus, in conditions where astrocyte morphology is altered (high fat chow intake 
and chemogenetic activation in our studies), it is possible that homeostatic 
functions of astrocytes are disrupted. This could include modulation of glutamate 
availability at the synapse by altering the proximity of the glutamate transporter 
EAAT2 to synapses (Oliet, Piet and Poulain, 2001). In addition, the physical 
proximity of astrocytes to synapses can modulate diffusion of neuromodulators 
by volume transmission. Some of these modulators e.g. serotonin (5-HT) and 
acetylcholine, alter synaptic transmission across the ST→NTS synapse, 
ultimately acting to increase neuronal activity and suppress food intake (Cui, 
Roberts, Zhao, Zhu, et al., 2012; D’Agostino et al., 2018; Page, Zhu and 
Appleyard, 2018). 
In addition to these homeostatic functions, astrocytes have been demonstrated 
to release gliotransmitters that modulate both the firing of postsynaptic neurons 
and presynaptic neurotransmitter release (Araque et al., 2014). We have shown 
that NTS neurons are sensitive to D-serine and that this sensitivity may be 
modulated by nutritional state (Chapter 5). It is possible that activated astrocytes 
amplify glutamatergic vagal signals by releasing D-serine to increase 
postsynaptic excitability, a process well described in the CA1 region of the 
hippocampus (Papouin, Dunphy, et al., 2017). Secondly, astrocyte-derived ATP 
and adenosine have been implicated in increasing neuronal excitability and 
supporting synaptic transmission in the NTS (Accorsi-Mendonça et al., 2013; 
Rogers, Ritter and Hermann, 2016; Rogers et al., 2018; Mastitskaya et al., 2019). 
These purines are also candidate signalling molecules for mediating the effect of 
astrocyte activation on neighbouring neurons and downstream effects on food 
intake. These factors (homeostatic functions and gliotransmission) may work in 
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concert or independently of one another to exert the excitatory effect of astrocyte 
activation on neighbouring neurons (Figure 6.3.2). 
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Figure 6.3.2 | Potential mechanisms of astrocyte-neuron communication in 
the NTS. Simplified diagrammatic representation of mechanisms by which 
astrocytes may excite neurons. By modulating their physical proximity to the 
synapse astrocyte glutamate transport can be increased or reduced. This may 
lead to greater levels of ambient glutamate which increases postsynaptic 
excitability. Reduced astrocyte ensheathment of synapses may be permissive for 
volume transmission of neuromodulators. Both ACh and 5-HT increase neuronal 
activity in the NTS by pre- and post-synaptic mechanisms, respectively, which 
reduces food intake. Astrocytes may also modulate neuronal excitability by the 
release of gliotransmitters. Astrocyte-derived D-serine could gate the excitability 
of post-synaptic NMDA-Rs. ATP released from astrocytes or its degraded form 
adenosine have been shown to mediate modulation of NTS neurons by P2X-R 
activation. 5-HT = serotonin, 5-HT2C-R = serotonin receptor 2C, ACh = 
acetylcholine, Ado = adenosine, ATP = adenosine triphosphate, EAAT-2 = 
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excitatory amino acid transporter 2, nACh-R = nicotinic acetylcholine receptor, 
NTS = nucleus of the solitary tract, ST = solitary tract. 
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6.3.4 | Outstanding conceptual questions 
In the field of astrocyte research it is still not definitively known how much of the 
documented astrocyte responses are due to true information processing and 
signal integration (Bazargani and Attwell, 2017) or whether these cells are simply 
responding to elevated metabolic demands of active local neurons (Xanthos and 
Sandkühler, 2014). For most of this discussion we have taken the former view 
driven by some key pieces of evidence. Firstly, astrocytes can show distinct, 
sometimes desynchronised, patterns of activity from neighbouring neurons 
(Volterra, Liaudet and Savtchouk, 2014; Bindocci et al., 2017). In some 
experimental preparations, astrocyte detection of a signal precedes that of 
neurons at least at the level of [Ca2+]i response (Rogers, Ritter and Hermann, 
2016; Rogers et al., 2018). Secondly, the blockade of D-serine release from 
astrocytes (a signalling molecule, not a metabolic factor) disrupts information 
processing and memory (Papouin, Dunphy, et al., 2017). Taken together these 
observations suggest that astrocyte activity reflects more than just the metabolic 
demands of neighbouring neurons. 
Neurons are understood to be a very heterogeneous population of cells showing 
an extraordinary range of diversity across the nervous system. Neurons are 
classified based on their morphology, gene expression, neurotransmitters, 
connectivity and electrophysiology (Luo, Callaway and Svoboda, 2008). A brain 
region such as the cortex, which obeys a very ordered circuit organisation has 10 
major neuronal cell types, which can be further subdivided into classes (Harris 
and Shepherd, 2015). In contrast, there are widely considered to be two principal 
broad classes of astrocyte determined by their location alone; those in the white 
matter and those in the grey (Miller and Raff, 1984). Research is beginning to 
show that this is likely a massive underestimation of astrocyte diversity. It appears 
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that between brain regions (Chai et al., 2017; Morel et al., 2017), within brain 
regions (Lanjakornsiripan et al., 2018; Miller et al., 2019; Batiuk et al., 2020; 
Bayraktar et al., 2020) and even within individual circuits (Martín et al., 2015), 
astrocytes are heterogeneous to a level not previously appreciated. This will 
surely be an area of growing interest and future research will hopefully investigate 
what makes NTS astrocytes different from their neighbours in other brain nuclei 
and each other. 
6.4 | Conclusion 
This study has addressed key questions in the field regarding NTS astrocytes 
and food intake by demonstrating that they respond to increases in food intake 
and that their chemogenetic activation reduces feeding by excitation of appetite 
supressing neuronal circuits. This suggests that in normal food intake, NTS 
astrocytes are recruited following a meal possibly, via vagal glutamate, circulating 
leptin, local GLP1 or some combination of these and other as yet unknown 
factors. This activation appears to reduce food intake by increasing the activity of 
NTS neurons which suppress appetite, either by direct excitation and/or 
modulation of vagal afferent input. Future work to better understand how real-
time astrocyte activity relates to food intake will hopefully elucidate the details of 
this astrocyte activation, while detailed electrophysiological studies could better 
identify mechanisms of astrocyte-neuronal communication. 
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